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1. Introduction 
 
1.1 Historic notes, cancer insurgence and pathology 
A neoplasm or tumor is a fluid or solid cell alteration caused by a change in metabolism or 
genetic mutation and abnormal growth. When the regulation and control of the normal cell 
cycle and cellular role fails and the neoplasm is correlated with the insurgence of 
peripheral damage, migration and organism life risk the tumor is defined malignant and 
the pathology is called cancer. The word cancer derives from the Greek carcinos (crab) 
used by Hippocrates to describe the macroscopic features of the pathology (similar to the 
body of a crab with the appendages that represented the blood vessels). Thus, the 
disease was analyzed since ancient times, with the earliest cancer report going up to the 
Egyptians, more than 5000 years ago.[1] Around the 16th century B.C. it is possible to find 
reports about cancer and its cure in both old medicine papyri (Ebers Papyrus, Leyde 
Papyrus and Edwin Smith Papyrus).[1,2] In India, early information about this malignancy 
could even be found in the epic poem Ramayana. In the early century A.C., Aurelius 
Cornelius Celsius observed the formation of secondary tumor after removal of the primary 
one and Claudius Galenus correlated psychosomatic symptoms to cancer progression, 
assessing the black bile theory (body humors) of Hippocrates as cancer origin. In the 
same period, Pedanius Dioscorides drew up a list of botanical remedies for cancer 
disease that was in use for the following 15 centuries. Between the 11th and 12th century 
the Arabian physicians Avenzoar and Averrhoes employed esophageal sounds for cancer 
diagnostic while the pharmacologist Ibn Sina made use of arsenium for systemic therapy. 
During the Renaissance, Gabriele Falloppio made use of caustic pastes to treat malignant 
tumors. Since the 16th untill the end of the 19th century chemotherapy was mainly 
abandoned and surgery became the first line solution for cancer treatment.[1,2] 
Even if the affection is known for several centuries and a lot of research has been 
performed, nowadays cancer diseases represent the second most frequent cause of 
death worldwide, with approximately 13 million of deaths per year (data from World Health 
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Organization, WHO).[3,4] This rate is always increasing due mainly to incidental factors. In 
fact, cancer development has been particularly related to aging and life conditions.[5] The 
increase in life expectancy and new factors or pathologies (like organ transplantation, 
obesity, diabetes, working conditions, tobacco, etc.) make the human body more 
susceptible to cancer. However, because just 5% of the malignant tumors have a 
hereditary source, a concrete reason for the development of the disease is hard to find.[5] 
Cancer has been described as an environment linked illness since most of the cases are 
strictly connected with the life style or the origin of the single person. Bad life attitudes 
(smoke, alcohol), uncontrolled work conditions (e.g. asbestos contact, heavy metal 
powder, benzene inhalation) provoke several hundred thousand cancer cases per year. 
An unbalance diet (e.g. high salt diet, low fruits and vegetables) is also the cause of the 
development of different forms of tumors.[6] There are more than 200 different cancers 
affecting the human body from the most common lung cancer to the less common throat, 
kidney or pancreatic malignancy. They are classified on the basis of the tissue that they 
are affecting or the primary tumor from which they developed. There are 5 main malignant 
tumor classes: carcinomas (the most common one, from epithelial cells), sarcomas (from 
the connective tissue), lymphoma (also called leukemia and most common in children, 
from hematopoietic tissue), blastoma (from not fully differentiated or developed cells, like 
embryos) and germ cell tumor (from pluripotent cells). Despite the localization and 
characteristic of the mother cell, all of them present similar symptoms and proliferation 
stages. In a first phase no referable symptoms could be normally noticed. However, once 
that the malignancy achieves a further development stage cancer is often associated with 
ulceration, local pain and bleeding. The tumor mass can provoke narrowing or blockage of 
organs or blood vessels resulting in function failure.[7] 
Carcinogenesis and cancer development can be subdivided in three main phases. In the 
time the cell will encounter a mutation that will divert the cell from the normal cell cycle 
and modify the proliferative internal control. This mutation could be provoked just by a 
failure in DNA replication or by external induction. Alterations in the regulation of two 
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species of genes can be observed: expression of oncogenes which enhance the growth 
and repression of tumor suppressors which control the entrance of the cell into 
apoptosis.[6,7] Cells in this status are tumorigenetic but still not cancer. A second phase is 
represented by the replication of the mutant cells, which assess and multiply their 
oncogenes and tumor suppressor inhibition genes. This process will create what is called 
a primary malignant tumor or primary cancer. During this phase an enlargement of the 
tumor mass is noticed parallel to the formation of new blood vessels (angiogenesis) to 
provide more nutrients to the cancer cell agglomerate. The last phase and most 
dangerous for the human body is characterized by the possible migration of cancer cells 
from one tissue to another, even quite distant, through blood vessels and the lymphatic 
system. This displacement is called metastasis and is one of the main causes of therapy 
failure and death produced by cancer.[6] 
Beside the symptoms, a number of screenings and tests are used to diagnose cancer. 
The most common methods are X-ray, blood or histological analysis or computer 
tomography (CT). X-ray and CT are non invasive techniques that determine the 
proliferation grade and tumor mass. Histological analysis determines genetic mutations or 
cell abnormalities by direct tissue extraction. Blood tests investigate specific tumor 
markers (cancer antigens like CA15-3, CA 125, beta-2-microglobulin B2M, prostate 
specific antigen PSA, alpha fetoprotein AFP, human chrorionic gonadotropin HCG, etc.) to 
individuate and possibly prevent the tumor development.[8-11] 
Also at cellular level, cancer presents characteristic features, assessing the loss of 
differentiation and genetic mutation. Enzymes (like lactate dehydrogenase LDH), specific 
receptors (like epidermal growth factor receptor EGFR) or hormone receptors (in some 
cell lines, such as MCF-7 breast adenocarcinoma) are just some examples of over-
expressed elements in cancer cells.[12,13] 
During the long history of malignant tumor many remedies have been proposed, screened 
and involved in therapy. In 1955 the United State Congress founded the National Cancer 
Chemotherapy Service Center in response to the first therapeutic successes. It was one 
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of the first organizations in charge to promote and control anticancer research. In 1971, 
following the scientific rush, Richard Nixon declared “war against cancer” (“National 
Cancer Act”, 1971) and since that moment the fundings as well as the therapeutic 
solutions drastically increased.[14] 
For a non metastatic solid malignancy, surgery represents one of the main solutions to 
cure cancer. The ablation of the tumor mass is a first choice treatment to increase life 
expectancy. The discovery of X-Rays in 1895 by Wilhelm Conrad Röntgen followed by the 
implementation with the radium ray by Pierre and Marie Curie opened the era of the 
radiation for diagnostic.[15] Because the radiations demonstrated dangerous cellular effects 
and good penetration capacity, many researchers (e.g. Curie, Abbe) applied ionized 
radiation in cancer therapy. The good result arose the treatment to elective therapy 
involved in half of the cases, in combination with surgery and chemotherapy. 
Chemotherapy is based on active molecules able to penetrate the tissue, reach the 
cancer and induce apoptosis. They are broadly used in different therapeutic cycle phases 
with an efficacy strictly linked to the toxicity of the drug involved. All these prophylaxis just 
in the U.S. cost huge amount of money (for example a pilot study on a possible genome 
atlas in 2007 cost more than 100 million dollar).[16,17] Despite the various strategies and 
treatments, cancer is nowadays still a deadly pathology representing 13% of the death 
causes worldwide (data from WHO). Even if the antitumor therapy results successful the 
patient who overcomes cancer has an increased risk to develop a secondary tumor. All 
the common therapies are aggressive and characterized by a lack of selectivity. Often the 
therapy in itself is another cause of tumor death. 
 
1.2 Origin and state of the organic modern anticancer research 
Despite the great number of efforts done, until the 18th century a stable strategy against 
cancer was still missing. At the end of the 1700 Burrows argued "that whatever has been 
proposed for the curing of cancers, are merely palliative medicines; and that no real 
specific has been hitherto discovered for that fatal disorder, although the physicians of all 
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nations, from the time of Hippocrates to the present, have, by numberless researches and 
experiments, made trial of everything in nature, from the most innocent drug, to the most 
virulent poison, both in the mineral and vegetable kingdoms; yet the disease still baffles 
the power of physic".[1] However, starting with the middle of the last century anticancer 
research drastically advanced. Especially in the field of chemotherapy many research 
groups dedicated their work to study the tumor cell physiology and synthesized new 
effective anticancer drugs. 
The efforts, that during several centuries did not produce effective progress, achieved 
undoubted results by the study of the chemical warfare during the World War I and World 
War II. In consequence of the massive use of mustard gas bombs a large number of the 
civil population died. The autopsies confirmed a drastic reduction of the proliferation of 
somatic cells, especially in lymphoid tissue. The pharmacologists Frederick S. Philips, 
Louis S. Goodman and Alfred Gilman (see figure 1.1) applied this discovery to an animal 
model with lymphoma and observed substantial tumor suppression. Moreover, in 
collaboration with Gustav Linskog they treated a human patient with mustine (a mustard 
derivate) and noticed a reduction of tumor mass in the first days of treatment, proving the 
possible efficacy of the molecule and performing the first step in chemotherapy.[18] 
 
 
 
Figure 1.1: Louis S. Goodman (left), Alfred Gilman (right) and their work on therapeutics (center); picture 
obtained from http://medicine.yale.edu/pharm/about/index.aspx and from “biographical memoirs”, The National 
academy Press http://www.nap.edu/openbook.php?record_id=5406&page=59 
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Almost simultaneously, in 1950s, Sidney Farber (see figure 1.2) observed that folic acid 
(vitamin B9, essential for DNA that in this time was still not discovered) stimulated the 
proliferation of acute lymphoblastic leukemia (ALL). Performing probably the first structure 
activity relationship and drug targeting, Farber treated ALL cells with folic acid antagonists 
such as aminopterin and amethopterin and observed a regression of the tumor.[19] 
Although the resistances opposed to the Farber´s study by the scientific community, the 
pathologist involved amethopterin (now known under the name methotrexate) in the cure 
of children ALL and published its results in the 1948. Just 10 years afterwards 
methotrexate was successfully involved in the treatment of choriocarcinoma, representing 
the first case of cancer cured by a chemotherapeutic and Farber was acknowledged with 
the name of “father of the anticancer chemotherapy”. 
 
 
 
Figure 1.2: Sidney Farber father of the modern anticancer chemotherapy and founder of pediatric pathology; 
picture from DANA-FARBER Cancer Institute, http://www.dana-farber.org/about-us.aspx 
 
As a direct consequence of the work of Farber many metabolites and chemical analogues 
of vital molecules have been investigated for their anticancer activity. A good example is 
the discovery in 1954 of the anti-cancer properties of 6-mercaptopurine or of of 5-
fluorouracil, both the drugs simulating DNA nucleotides.[20,21] The anticancer research 
output grew up significantly and different strategies to achieve potent medicines or an 
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effective therapy have been proposed. An increasing number of studies started to test all 
the chemical and natural drugs for their possible anticancer properties. Between 1954 and 
1996 a great number of natural drugs have been involved in cancer treatment like extracts 
from Vinca Rosea (e.g. vincristine), from Taxus (e.g. paclitaxel) and from Camptotheca 
Acuminata (e.g. topotecan).[22] The total synthesis of drugs like nitrosoureas derivates 
(e.g. fludarabine phosphate) or anthracycline compounds (e.g. daunorubicine, 
doxorubicine) was performed.[23,24] Combined therapy with different anticancer drugs and / 
or with the ablation of the most part of the tumor followed by the chemotherapeutic 
treatment resulted to be successful for the cure of ALL, Hodgkin and non-Hodgkin 
lymphomas as well as for some sarcomas. In 1966, in the ambit of contraceptive 
research, Dora Richardson synthesized for the first time an estrogen receptor antagonist 
called tamoxifen.[25,26] The link between breast cancer and contraception was already 
known and the following clinical trials established tamoxifen and its derivates as 
anticancer agents approved by the Food and Drugs Administration (FDA). Between the 
end of 19th and begin of the 20th century many advances have been made to understand 
the cell physiology. Scientists like Matthias Schleiden, Theodor Schwann, Franz Bauer, 
Richard Altman, Keith Robert Porter and many others put the cell at the base of organism 
life and characterized their organelles.[27] Especially in the second half of the 20th century 
cellular pathways comprehension drastically increased. The advent of advanced 
microscopy (fluorescent, confocal), mass spectrometry applied to biological system 
(proteomics, metabolomics and genomics) found specific pathways, processes or proteins 
present in cancer cells. All those discoveries contributed to the development of the 
targeted therapy in which chemotherapeutics interact selectively with vital cancer 
processes. For example, during 1990s the study of the oncogene Abl-Bcr highlighted the 
production of an analogous of the protein tyrosine kinase in tumors. The selective 
inhibition of this protein has been investigated starting from the screening of a large 
number of molecules, improved by a rational drug design. The results led to the nowadays 
  
Page - 8 - 
 
Introduction Riccardo Rubbiani, PhD thesis 
first line treatment for chronic myelogenous leukemia: Imatinib and its derivates.[28] A 
selection of anticancer molecules is shown in figure 1.3. 
 
 
Figure 1.3: organic anticancer compounds 
 
1.3 Metal complexes in cancer therapy: history and advantages 
Metals play a central role in human life as well as in scientific research. In total 14 metals 
(four of the main groups: Na, K, Ca and Mg; ten of the transition group: Fe, Co, V, Cr, Zn, 
Mo, Cd, Cu and Ni) have a key role in the human body to control osmotic pressure, as 
regulators or messengers and are involved like stabilizers or enzyme cofactors.[29] Metals 
have been used by humans since ancient times. Beside the implication of their good 
conductivity (both for heat and electricity), malleability and ductility our forefathers 
employed them also as medicinal remedies. Examples are transcriptions of gold 
preparations dated at 2500 B.C and mercury ointments used by the Pharaohs or in 
alchemical healing preparations.[30] 
The advent of modern metal based chemotherapy is dated at 1865 when potassium 
arsenite demonstrated anti-leukemia properties.[1] In 1870 Jorgensen synthesized the first 
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metal conjugates and in 1893 the Nobel Prize laureate Werner helped in clarifying their 
chemical configuration.[29] Metal based medicines have been prescribed for various 
pathologies until 1950 under the name of Fowler´s water. In 1909 Paul Ehrlich and co-
workers discovered from a drug screening of several new molecules the anti-syphilitic 
properties of an arsenium based compound: arsphenamide or compound 606, an organo-
arsenamide commercialized in 1910 under the name “Salvarsan”.[31] This was the first 
attempt of drug discovery starting from a large set of substances. Salvarsan was used 
intensively during the first half of the 20th century and contributed extremely to eradicate 
dangerous pathologies. In 1927 Merthiolate (Thiomersal), an organo-mercury compound, 
demonstrated high antibacterial profile. In 1935 Forestier published the first study on gold 
compounds with anti-rheumatic properties.[32] Gold based drugs like Aurothiomalate, 
Aurothiosulfate or the oral administrable Auranofin are still nowadays benchmark drugs in 
that treatment.[33] 
In 1965, Barnett Rosenberg, observing the similarity between the mitotic fuse and an 
electric field assumed that bacteria could also be influenced by it. The serendipitous 
results showed a block in the replication of the microorganism and opened the era of 
metal complexes in anticancer therapy. The following experiments proved that electrolysis 
at the electrode formed an active platinum species responsible of the cytostatic effects.[34] 
The obtained molecule, Cisplatin, was involved successfully in the therapy against 
testicular and ovarian cancer, neck cancer as well as lung cancer.[35,36] Since that day 
many research groups focused on the platinum medicinal chemistry and the main mode of 
action of Cisplatin has been probably disclosed.[37-40] Outside of the cell the concentration 
of chloride anions do not allow exchange reaction between water molecules and the 
chlorido ligands of Cisplatin. When the molecule penetrates into the cell, the low Cl- 
concentration promotes the formation of aqua complexes, replacing the chloride. This 
adduct is the active form of the platinum derivate that penetrating into the nucleus 
interacts with the minor groove of DNA, especially with nucleotide guanine, inducing 
cross-linking of the bases with consequent loss of functionality and arrest in replication. 
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Unfortunately, Cisplatin demonstrated also severe damage to nerves and kidney. Side 
effects included nephrotoxicity and neurotoxicity, nausea vomiting, and hair loss etc.[41,42] 
To try to reduce these problems at the end of the 20th century two other platinum 
derivatives started to be involved in therapy: Carboplatin and Oxaliplatin.[40] Beside the 
side effects another main problem characterized the platinum anticancer category: the 
development of resistance phenomena. Cisplatin and its derivates undergo a high 
metabolization. For example, their reaction with glutathione promotes the drug-extrusion 
by over-expressed specific efflux channels. The new generation of platinum derivatives 
proposed in the last decade many possible solutions to overcome both the problems and 
to find another action mechanism. The coordination of key molecules (like hormones or 
long alkylic backbones) or the use of other oxidation state (Pt(IV)) or configuration 
(transplatinum derivatives) showed the broad patterns pool at researchers disposal in 
bioinorganic chemistry.[43] 
Cisplatin was the first extremely successful bioinorganic drug and nowadays it (or its 
derivatives) is involved in almost 50% of the cancer treatments. Following the affirmation 
of the platinum complexes the scientific world started to put interest in the medicinal 
applications of inorganic chemistry. Preliminary screenings of Cisplatin analogues with 
different metals have been reported. Almost all the atoms between the 4th and the 12th 
group of the periodic table have been used to synthesize new potent drugs.[44] Currently, it 
is established that a single mode of action for a single metal is far to exist. Very often even 
different oxidation states correlate with different modes of action.[43,45-47] 
Ruthenium is the most investigated metal, after platinum, in medicinal chemistry. Many 
reports are already attesting the capacity of this metal in cancer therapy. There are 2 
ruthenium based compounds actually in clinical trials (KP1019 or its more soluble Na 
derivate KP1339 and NAMI-A).[48] Ruthenium complexes are a large and different family of 
compounds with a broad bioactive spectra, from valuable cytotoxic potency to less side 
effects and strong antimetastatic effects (NAMI-A, RAPTA-series).[42] The mode of action 
of ruthenium compounds is still not completely understood, indeed inhibition of enzymes 
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containing a cysteine in the active site (cathepsin B, glutathione reductase) has been 
observed. Some ruthenium complexes can cover more than 30 stereo isomeric 
configurations enabling the drug to interact or bring an opportune functional group to 
appropriate region. This revolutionary concept was used by Meggers and co-workers to 
design kinase inhibitors that manage to reach picomolar IC50 values.
[48,49] 
Metal derivatives of a well established drug were also successful in the field of medicinal 
chemistry. Especially, the use of metallocene moieties (e.g. ferrocene) resulted in 
overcome of the standard drug resistance. That was observed for drugs like ferrocifen (the 
metallocenyl derivative of tamoxifen) able to influence various cancer cell lines, estrogen 
receptor positive as well as negative (ER(-) and ER(+)), and for ferroquine (the 
metallocenyl derivative of chloroquine) active on chloroquine resistant malaria strains.[50,51] 
Promising results have been also obtained with titanium complexes.[52] Dichlorido 
titanocene and its more soluble derivative titanocene Y demonstrated strong 
antiproliferative properties and reached also the clinical trials but failed because of 
metabolization problems.[53] Some of the key molecules witnessing the importance of 
metal complexes in medicine are reported in figure 1.4. 
 
 
Figure 1.4: examples of metal complexes involved in therapy and research or undergone clinical trials 
  
Page - 12 - 
 
Introduction Riccardo Rubbiani, PhD thesis 
 
These are just few examples of the efficacy of metal complexes in cancer therapy. Many 
molecules (e.g. chromocene platensimicyne derivate, silver(I) theobromin, iridium and 
rhodium phenantroline or bisphenantroline, metal porphyrin, carbene complexes, cobalt 
ruthenium and iron bio-conjugates etc.) underwent preliminary studies.[45,54-57] This great 
capability of metal complexes is mainly due to the special features offered by these 
species. Metal complexes present different characteristics being very adaptable and 
effective drugs. Metals possess a multi electron orbital sphere with access to d orbitals 
and a modular stable configuration. The steady state is reached when the environment of 
the metal has 18 electrons (18 VE, e.g. iron). Sometimes when the bond presents an 
increased distance the metal can lose ligands and be stable with a minor number of 
electrons (16 VE, e.g. rhodium) or an increased one (19 VE, e.g. cobalt). They are 
characterized by different oxidation states with different reactivity. In a physiological 
environment there is the presence of many possible substituents and many studies 
describe a typical metal reaction called: ligand exchange reaction.[58,59] 
The ligand exchange reactions confer to the metal the capacity to answer to specific 
chemical environment modification due to their electronic configuration. It is known for 
example that the formation of an aqua complex of Cisplatin is the activation step required 
to achieve antitumor activity. Meanwhile glutathione (a tripeptide present in high 
concentration in the cell) reacts with Cisplatin too, but the product represents one of the 
main processes of intra-cellular drug elimination.[59] 
As reported above the various configurations, hybridization and the inert character of 
some metals suggested the possibility to work with them as molecule scaffold. The 
pioneer work of Meggers and co-workers demonstrated the suitability of the ruthenium or 
iridium stereochemistry to achieve and optimize the enzyme – drug interaction, reaching 
extraordinary inhibition potency.[60] 
Third peculiarity of the metals reactivity is their catalytic properties. During the 19th and 
20th century the chemistry research and industry produced a huge number of catalysts to 
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perform a great number of reactions. Most of them included a metal center carrying the 
activity. This concept can be also applied in the medicinal field when the reactive center of 
the drug is a metal. Examples of a metal complex with an interesting catalytic profile are 
the aminoferrocenyl derivates of Mokhir and co-workers in which cytotoxicity is obtained 
by the catalytic conversion of Fe3+ in Fe2+ self-reproducing in biological conditions and 
inducing reactive oxygen species (ROS) production.[61] Examples of the listed metal 
advantages are reported in figure 1.5. 
 
 
 
Figure 1.5: reactions and advantages of metal based molecules (blue and green pictures from references 60 
and 61) 
 
The first generation of metallodrugs have been characterized by platinum derivates, their 
DNA targeting activity and the efforts of the researchers to achieve better compounds with 
the same mechanism of action. However, an increasing number of reports assess that 
DNA targeting therapy is resulting inadequate.[48,62] Cells with high metabolism (e.g. hairs, 
skin) present the same DNA replication rate as cancer and the genetic material in itself is 
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one of the most controlled cellular macrostructures. With the improvement in technology 
output always more information on cancer metabolism are nowadays available. Fields as 
proteomics, genomics and metabolomics changed the approach of many researchers. 
Mapping the different cellular pathways enables the scientist to pick up crucial elements 
like siRNA, or kinases with a key role for signal translation and cellular counteraction. 
Immuno-techniques discovered characteristic proteins over-expressed in cancer cells as a 
possible new target for drug design. These new findings represent a begin of a second 
generation of metallodrugs that will aim specificity, selectivity towards cancer cells and 
potency. 
 
1.4 A new gold rush 
Gold played a central role in human life since the ancient time and it is probably 
between the first metal discovered by the mankind. It is an inert material with a good 
ductility and conductivity and it is spread in most of the regions of the world. Elaborate 
gold mining techniques have been developed by almost all our forefathers, from 
Alaska to the South African Republic. Reports of gold mines and gold manufactures go 
back to the Cro-Magnon era and in the Turin Museum of Old Art there is an official 
Egyptians map of a gold mine site of more than 4000 years ago. [63] Its excellent 
malleability, price / traceability ratio and impressive colors made of gold an excellent 
ornament material. From the pharaohs to the popes and sovereigns of all the times, 
the royal families and upper class carried gold weapons, decoration or clothes. 
During the civilization development gold became also a potent symbol. In the Bible, in 
the Iliad and Odyssey poems gold is associated to immortality and fecundity. In the 
Chinese tradition the gold and yellow were the colors that represented the Emperor of 
the Sky and even in the Incas old transcription gold traces symbolized the tears of the 
god Sun (from “Gold in the Ancient World” by John Hiller). [63,64] 
Starting in 5th century B.C. in Greece under Philipp II of Macedon, gold was employed 
in coinage of currency and this remained its main role through many centuries. Still 
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nowadays, the gold price has a relative stable value independently by wars, bourse 
depressions or financial crisis (see figure 1.6). 
 
 
Figure 1.6: left) gold price fluctuation over the last 50 years; right) the federal reserve bank USA; source 
Wikipedia common 
 
Alchemy considered gold as the noblest of all the elements and one of the mystical 
powers of the philosopher stone was to convert other metals to gold. The atomic 
number of gold is 79 and in the periodic table is placed beside mercury. Mercury is 
found liquid in nature and its chemical transformation it was considered to have the 
capacity to transcend different states and parallel to overcome the border between 
earth and heaven as well as the one between life and death. Gold was thought to be 
the end step of mercury transformations. [65] 
Gold has been considered catalytically inactive for a long time with the exception of 
some sporadic studies that were in any case not showing advantages in comparison 
with other catalysts. Surprisingly within the second half of the 20 th century gold 
industrial chemistry increased drastically. The activity of gold is mostly based on the 
size of the gold catalytic particles. The traditional preparation method for catalysts was 
the “impregnation method” which produced, in the case of gold, particles too large or 
bulky, impeding a good chemi-sorbtion of the reactant compounds. [66] Haruta and co-
workers firstly started to work on the particles size. In 1980s they established new 
preparative methods called “deposition precipitation” and “co-precipitation” that enabled to 
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produce gold nano-particles of 2-4 nm of diameter (with the impregnation precipitation 
method they were > 10 nm). Together with this finding they discovered that with such 
particles gold molecules are able to selective catalyze the oxidation of carbon monoxide 
(CO) at drastic low temperature (-76°C) as well as epoxidation.[67] In 1973 Bond and co-
workers published a milestone study that reported the hydrogenation of olefins over 
gold catalyst.[68] They demonstrated that even at not extreme temperatures (127-217°C) 
an efficient and chemo-selective mono-hydrogenation of alkene and alkyne was possible. 
They found that the catalytic capacity was influenced not just by the particle size of gold 
but also by the supporting material, changing from γ-Al2O3 to SiO2 support (see scheme 
1.1). 
 
 
 
Scheme 1.1: chemo-selective alchyl mono-hydrogenation performed by Bond and co-workers (scheme taken 
from reference 66) 
 
Stimulated by these discoveries, in the following years many research groups investigated 
gold catalytic properties and extended the application field to different carbonic structures 
(both aliphatic and aromatic) as even to functional groups. Gold has been found capable 
to catalyze hydrogenation reactions of α,β-unsaturated aldheyds, alcohols and polyols 
and C-H bond activation. Especially for nucleophilic attack Hutchings and co-workers 
described the hydrochlorination of ethyne to vinyl chloride, demonstrating gold(III) to be 
the most potent catalyst for such reactions.[66,69] Since 1990s, gold started to play an 
important role also in homogeneous catalysis. Especially, at the begin of the 21th century 
  
Page - 17 - 
 
Introduction Riccardo Rubbiani, PhD thesis 
effective generation of gold homogeneous catalysts have been synthesized by Corma and 
co-workers (e. g. Au-Me-duphos) or by Hosomi and co-workers (ClAuPPh3) enabling 
complexes functional groups as alkenes, ketones, alkynes, alkyl halides, tertiary alcohols, 
aldehyds and carbamates to be processed.[70,71] 
Gold has been also involved in healing remedies since 2500 B.C. It was probably the 
product of the simple deduction that something so rare and precious must also have 
extraordinary healing properties. Phoenicians, pharaohs as well as Incas population 
reported in their texts about gold preparations. Gold as medicament was also reported 
in “De Materia Medica” edited by Pedanius Dioscorides in the first century B.C. In the 
alchemy gold played also a central role such as important medicine (see figure 1.7). 
Tinctura Aurii, Oleum Aurii or Essentia Aurii were gold based remedies for cutaneous 
as well as per os application.[72,73] 
 
Figure 1.7: alchemic representation of the gold working process with the 7 steps of metal elaboration, 
the patched alchemist and the rabbit as a guide (picture from ref. 74) 
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Although gold based therapies (also called aurotherapy or chrysotherapy in the case 
of rheumatoid arthritis) have been known since the ancient times, the real mechanisms 
of action are still not fully understood. Elemental gold is an inert material and just its 
salts or radioisotopes could have been involved in aurotherapy. Gold can be found in 
all oxidation states (between –I to +IV) but just two forms are better suitable for 
medicinal applications: gold(I) and gold(III). [33] Gold(I) is a soft Lewis acid with affinity 
for soft ligands (like thiolates) and presents a d10 close shell configuration enabling it 
to assume the trigonal three-coordination, tetrahedral four-coordination and the most 
important (for medicinal purposes) linear planar two-coordination. Gold(III) is harder 
than gold(I) and presents a d8 close shell configuration with a classical square planar 
tetra coordination and analogies with platinum. [33,75] 
Similarly to its catalytic properties, because of their instability medicinal research on 
gold drugs was quite rare until the last centuries. Parallel to the innovations in 
catalysis, a real new gold rush started also in medicinal chemistry. The first scientific 
studies about medicinal gold have been published at the end of the 19 th century.[32] 
Gold compounds provided evidences to have an effect as anti-bacterial agents. In 
1920 they were tested for tubercolosis treatment but did not show any relevant 
activity.[76] In 1935 Forestier studied their salts as possible anti-inflammatory drugs and 
demonstrated a disease regression due to the action of the gold(I) salts.[32] Afterwards, 
we have to wait almost 40 years to see another medicinal gold study. 
At the end of the 20th century some derivatives of gold(I) started to be involved in anti-
rheumatic therapy. Aurothiomalate, Aurothioglucose and Auranofin are registered 
marks.[76,77] Nowadays chrysotherapy is an established strategy to cure rheumatoid 
arthritis, with 50% to 70% chance of disease suppression and 20% of complete 
remission.[64] Despite the mode of action is still not understood, some dominant 
hypothesis have been postulated. The curative potential of gold complexes is mainly 
the result of the action of the different metabolized gold salts (Au(III), Au(I), Au0). 
Au(III) can oxidize proteins and be reduced to Au(I). Gold(I) acts as chelating agent 
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forming a stable bond between cysteine residues. It inhibits key steps of the 
inflammatory answer such as the T-cell mediated antigen recognition, oxidative burst 
in the synovial fluid of the inflamed joints, the leukocytes migration and adhesion. [64,78] 
Some data reported the formation of Au0 from Au(I) and postulated it to be responsible 
of the activity. Overall, the action of gold salts proved to be strictly linked to the 
immune-modulatory answer, inhibiting the protein kinase C and the protein tyrosine 
phosphatase, suppressing relevant cytokines (tumor necrosis factor α, interleukin-6) 
and lowering the maturation and circulation of lymphocites. [64,78] Other evidences 
assessed that gold drugs should be able to block COX-2 expression and prostaglandin 
production by destabilizing COX-2 mRNA.[79] 
Research on gold based therapy has been applied to all the branches of medicine. In 
1996 Shapiro and Masci investigated the effect of Auranofin on a HIV patient who was 
also affected by psoriatic arthritis.[80] Her skin lesions and arthritis resolved after Auranofin 
treatment and she has remained free of opportunistic infections during the following 24 
months. Her CD4+ count during oral gold therapy showed a significant increase in CD4+ 
cells. Many research groups presented evidence of a reverse transcriptase inhibition by 
gold complexes. The main gold anticancer and anti-rheumatic drugs were tested and 
showed to have a therapeutic value against HIV.[80-82] 
Since the discoveries of the influence of gold chloroquine derivates on Plasmodium 
Falciparum (PF) made by Navarro in the late 1990s many research groups started to 
investigate the anti-malarial and anti-parasitic properties of gold complexes. [73,74,226] 
The inhibition β-hematin formation, that provokes a mysfunction in heme aggregation, or 
the inhibition of falcipain 2 kinase, providing vital monomers (e.g. aminoacids) and the 
intercalation with DNA (against the malaria pigment formation) produced a essential 
reduction of the PF proliferation in vitro and in vivo.[83-86] The gold derivative resulted to be 
effective also on two chloroquine resistant strains of PF.[86] The successes achieved 
against malaria stimulated the researchers to investigate more in detail the effects of gold 
complexes as anti-parasitic agents. Gold(III) demonstrated to be potent inhibitor of 
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Leishmaniasis, with LD50 in the nano-molar range.
[83,86] The trypanosomiasis family 
presented some metabolic analogies with cancer cells, especially for the anticancer drug 
response with inhibition concentration in the low micro-molar range, comparable with 
established drugs.[86] Gold(I) complexes have been recently also tested as anti-
schistosomiasis agents. These parasites possess a thioredoxin reductase / glutathione 
reductase system, essential for the worm life.[83,86] Established drugs such as Auranofin 
and Aurothiomalate have been investigated and demonstrated to inhibit the extracted 
enzyme in the low nano-molar range provoking the worm death. 
The interesting activity of a silver complex (Ag-sulphadiazine[87]) as anti-microbic 
stimulated many research groups to apply bioinorganic chemistry for the development of 
new anti-bacterial agents. Gold derivatives with ibuprofen or carbene ligands have been 
synthesized and demonstrated to be active towards some bacteria (e.g. E. Coli, S. 
Aereus).[88,89] Recently Cui and co-workers proposed two possible mechanism of action 
for gold as anti-bacterial agent. Gold complexes alter the membrane potential interfering 
with the ATP production. Concurrently, they inhibit the subunit of ribosome from binding 
tRNA.[90] 
In 1985 Mirabelli and co-workers studied the anticancer properties of Auranofin and 
opened a new interesting horizon for gold based therapy.[77] Also for the anticancer effect 
the mode of action is still a debate point but a main target for gold complexes inside the 
cell has been found. Thioredoxin reductase (TrxR) is a key enzyme over-expressed in 
tumor cells that present in the active site a selenocysteine / cysteine pair.[91-96] Gold 
complexes reacted selectivity with the selenium, building a covalent adduct and inhibiting 
the enzyme activity as proved by biochemical as well as mass spectrometry 
investigations.[97-99] The inhibition of TrxR leads to an onset in cell homeostasis, reactive 
oxygen species production and apoptosis induction.[97] Gold(I) and gold(III) compounds 
resulted to be the most potent inhibitors for this key enzyme. Especially for this 
therapeutic category, the activity and selectivity of gold seems to be in close relation 
with the specificity and properties of the ligand. A good drug design will lead to an 
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effective structure activity relationship and more predictable results. Following this 
trend many possible ligands have been synthesized and tested (see figure 1.8).[100] 
 
 
Figure 1.8: representative gold complexes 
 
The main group of gold based anticancer agents is represented by the phosphines. 
Their ligands have been already diffusely used in catalysts because of their good 
coordination capacity. Gold(I) phosphine derivatives have been studied by many 
research groups and demonstrated outstanding biological properties and represent the 
most common example of gold(I) complexes. [101-104] They inhibit potently and 
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selectively the target enzyme TrxR possessing also a good profile towards other 
components of the antioxidant network (glutathione reductase, glutathione 
peroxidase), inhibit the 26S proteasome activity, block angiogenesis, induce apoptosis 
and have strong antiproliferative effects. [101-106] The variation of the second ligand at 
the gold center (e.g. naphtalimide, alkyn, thiol) influenced deeply the stability as well 
as the overall pharmacodynamic. It is important to mention that belonging to this class 
are the two most potent TrxR inhibitors nowadays discovered: auranofin and gold 
phosphol inhibitor (GoPI).[107] Until 2008 few studies also reported the activity of gold(I) 
carbene complexes.[108-111] In 2006 Berners-Price and co-workers published a 
milestone report on the interaction of this species with the TrxR system, the influence 
on mitochondria and the selectivity of a gold N-heterocyclic carbene (NHC) towards 
cancer cells.[110,112] Gold(III) class of compounds has been also investigated. [113,114] 
Examples of bioactive gold(III) complexes are represented by porphyrins, 
phenantroline or in general halides or nitrogen bonded derivates. [115-117] The biological 
data proved a strong interaction with the mitochondria membrane potential, induction 
of mitochondrial membrane pores, reactive oxygen species stimulation, interaction 
with DNA and apoptosis induction.[116,118] Recently gold(III) dithiocarbamate complexes 
resulted to be good TrxR inhibitors and trigger apoptosis through mitogen activated 
protein kinase ERK mediated pathway. [119] 
Others interesting target enzymes have been recently discovered.[120,121] Casini and co-
workers tested the activity of some different gold complexes on PARP-1, a key enzyme 
involved in the protection of DNA and in combinatorial therapies. They demonstrated that 
gold derivatives are more effective than the traditional organic inhibitor (3-
aminobenzamide). A gold complex (Auphen) showed also a potent activity inhibition of the 
aquaglyceroporin-3 with IC50 value in the submicromolar range.
[121,122] Recently the strong 
inhibition by Auranofin of the enzyme glutathione-S-transferase has also been proved.[123] 
Very limited in vivo data are available for gold compounds. A partial success was obtained 
in the treatment of mice inoculated with lymphocytic P388 leukemia cells with Auranofin. 
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The therapy resulted in a dose dependent increase in survival up to a maximum of 22 
days (more than 200 %). However the data could just be partially reproduced in another 
experiment with the same animal tumor model. Although less data are available for 
gold(III) species, very recent reports described the encouraging in vivo activity of gold(III) 
porphyrins and dithiocarbamates that respectively increase the survival rate of 
hepatocarcinoma up to 42 days (against 30 days for the control) and inhibition of tumor 
growth in invasive breast adenocarcinoma in nude mice and no toxicity was noticed up to 
29 days.[75] 
Although until nowadays no clinical trials are running for gold complexes the above 
reported data stand for the great potential of this class of therapeutics. Especially in the 
anticancer field always new promising drugs are required. Gold based therapy like in the 
past as nowadays demonstrated a great medicinal potential. 
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2. Aim of the project 
 
As reported in the introduction metal complexes and especially platinum derivates 
represent nowadays a first line treatment against cancer and are involved in therapy 
(alone or in combination with surgery, radiation or other chemotherapeutics) in more than 
50% of the cases. Despite the incredible success of platinum therapy, two main concerns 
about the use of cisplatin, carboplatin and oxaliplatin remain. First of all, platinum based 
drugs provoke severe side effects, sometimes ending up in death cases. Secondly, 
already after few treatments the cancer develops resistance to these drugs, defeating the 
therapeutic value but preserving the hard side effects for the patients. 
The bioinorganic chemistry arsenal offers many solutions to correct these problems and to 
obtain efficient and selective anticancer agents. Among the different metals tested in the 
last decades, gold presents some interesting features. Gold has been involved in therapy 
since ancient times. Nowadays gold complexes are benchmark products against 
rheumatoid arthritis. Gold based therapy does not produce severe side effects during 
short time treatment (examples of them are just cutaneous rash, proteinuria or 
diarrhoea).[124] The main target of gold compounds is not DNA but proteins (like TrxR, GR, 
GPx, GST, 26S proteasome, etc.) enabling a broad range of medical targets and modes 
of action. 
Aim of this PhD thesis was to synthesize, characterize and biologically evaluate a series 
of new gold complexes, suitable for anticancer therapy. The oxidation state I of gold was 
chosen because it enables a more stable complex coordination and it is borne by some of 
the most effective gold therapeutics. Carbene complexes of the Arduengo type (N-
heterocyclic carbene, NHC) have been selected to be the core ligand of the new 
molecules. The direct σ coordination of the carbene carbon with the gold(I) atom should 
provide stability and remarkable bioactivity due to previous reports. Opportune 
modification at the NHC core (e.g. side chains) or at the second ligand (e.g. chlorido, 
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phosphine) will result in an essential change of the physical-chemical properties of the 
molecules and will lead to different bioactivity. 
An intensive biological evaluation will assess the anticancer potential of the new gold(I) 
NHCs. Key point of the screening will be the interaction with the target enzyme TrxR. 
Since the complexes are expected to be good inhibitors, all the possible metabolic onsets 
provoked by their influence on TrxR will be observed (ROS stimulation, apoptosis 
induction, etc.). Selectivity will be established between TrxR and other enzymes belonging 
to the antioxidant network (e.g. GR, GPx). The carbene moiety is also expected to confer 
an overall good stability to the compounds. Therefore, the gold NHCs will undergo stability 
test in buffer as well as under relevant biological conditions (serum protein, small 
intracellular thiols). Anti-proliferative effects of the gold carbenes will be tested in different 
cancer cell lines as well as in resistant and healthy cell lines. The presence of gold will 
enable to trace the uptake of the compounds into the cell by a convenient and sensitive 
technique (atomic absorption spectroscopy, AAS). For a schematic representation of the 
target complexes see figure 2.1. 
The overall data output of the present PhD project will contribute to enforce and improve 
the medicinal application of gold complexes. 
 
 
Figure 2.1: drug design of target gold(I) NHC complexes 
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3 Synthesis 
 
3.1.1 Chemical consideration on series I 
A steadily increasing number of reports assessed the suitability of gold molecules for 
medicinal implications.[33,96,100,125,126] The main problem affecting the benchmark gold 
based drugs (Auranofin, Aurothiomalate and Aurothiosulfate) is the high metabolization 
inside of the body once administered.[127,128] The binding to thiol shuttles (serum proteins), 
inactivation by small molecules (glutathione, ascorbic acid) and loss of the ligands 
defeated trustable drug designs and the study of possible structure activity relationships. 
An efficient investigation of the properties of different functional groups will contribute to 
optimize the drug design and stimulate the synthesis of more effective substances. 
Metallic gold is an inert ductile material but its other oxidation states possess interesting 
chemical properties and biological profile. Au has a stable 18 electron configuration. The 
ionic chemical compounds of gold are soft Lewis acids and are present in nature almost in 
all the oxidation states between +I and +IV but specific medicinal interest lie in gold(I) and 
gold(III). Gold(I) can assume a trigonal three-coordination, tetrahedral four-coordination 
or linear planar two-coordination configuration geometry while gold(III) has just a classical 
square planar tetra coordination configuration geometry.[33,75] Gold(III) salts (e.g. AuCl4) 
presented also a high metabolization under biological conditions and are easily reduced to 
gold(I). Recently, gold(III) thiocarbamates demonstrated outstanding biological 
properties.[115,116,119,129,130] 
Since the discovery of the anticancer properties of Auranofin, gold(I) complexes started to 
be intensively investigated. Especially, Auranofin became the lead structure and activity 
comparison parameter for anticancer aurotherapy. The easy substitution of the 
thioglucosidic rest and the redox instability of the phosphine ligand direct the attention of 
the researchers to find other new stable coordinative solutions. The hypothesized mode of 
action of gold complexes involved a direct interaction between the metal center and 
cysteine or selenocysteine containing enzymes.[97,100,131-133] To trigger bioactivity, the 
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presence of gold in the molecule as well as a good leaving group is required. Since many 
of the most efficient gold complexes are phosphine derivatives, a detailed analysis of the 
phosphine ligand chemical properties and metal interactions would clarify the role of that 
residue and would allow a rational improvement with other ligand solutions. 
A phosphorus atom containing three different alkyl residues (PR3, phosphine ligand) 
possesses favorable coordinative properties.[134,135] The electron repulsion between the 
alkyl rests and the phosphorus decreases in presence of a metal coordination. This is due 
to the sequestration of the P lone pair engaged in the P-M bonding. This push forward and 
backward compensation effect stabilizes the length of the P-C bonds. The same electron 
lone pair attributes to the phosphorus atom Lewis base properties and, thus, affinity for 
Lewis acids (like gold). Phosphorus establishes a convenient σ coordination with the 
metal atom which locates also (though without the formation of a particular strong bond) 
electron density from the p and d metal orbitals to the phosphorus symmetrical p and s 
antibonding orbitals, giving the formation of a backbonding (see figure 3.1).[134,135] 
 
 
Figure 3.1: phosphine – metal interaction: left) σ binding orbitals and P electron lone pairs interactions, right) 
σ P and metal d bonding orbitals and d metal and p P antibonding orbitals interaction 
 
The electron donor capacity of a single atom or a specific chemical environment could be 
described using the Tolman electronic parameter (TEP, ν).[134,135] TEP indicates the 
frequency or vibrational mobility of the carbonyl residue (νCO(A1)) of a complex containing 
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the electron donor ligand (in this case a phosphine ligand) binding to a nickel tricarbonyl 
moiety, measured with infrared spectroscopy. The higher the freedom degree of CO 
groups (see blue part in figure 3.2, with e- representing the electrons), the weaker will be 
the CO triple bond, the higher the donor character of the ligand at the Ni atom.[136] 
 
    
Figure 3.2: schematic representation of the CO vibration influenced by the ligand electron donor properties  
 
The implication of a strong donor ligand according with νCO(A1) could be a convenient 
starting point for the drug design of new stable metal complexes. TEP could be also 
implicated in the characterization of another emerging class of compounds with interesting 
properties: the carbene compounds. 
A carbene is a molecule containing a central carbon with a valence II and an unshared 
electron pair.[133,137] They are classified in 2 categories depending on the electronic 
configuration: singlet or triplet. Singlet carbenes possess a spin-paired moment with a sp2 
hybrid orbital configuration, a total spin of zero (Ћ) and represent the excited state of the 
carbene structures. Triplet carbenes present a paramagnetic character, two unpaired 
electrons with a total spin of one (Ћ) and can adopt either sp or sp2 hybridization. 
Unsubstituted hydrocarbon molecules assume often a triplet carbene with sp2 hybrid 
configuration that represent the energy ground state of the compounds. Generally, triplet 
carbenes are more stable than singlet ones. However, the presence of geminal donor, like 
hetero-atoms, that delocalizes electrons in the empty p orbital of the carbene carbon 
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offers a compensation effect on the molecule and enables the singlet carbene to become 
the new energy ground state. There are no reported data about a similar effect for triplet 
carbenes. Overall, unstabilized carbenes possess a very short half-life.[133,137-139] 
Carbene carbon could also be categorized for their intrinsic reactivity when they are 
coordinated to a metal. Fischer carbenes are described like electrophilic carbenoids due 
to the impoverishing effect of the bonded metal possessing an electron withdrawing 
ligand. Schrock carbenes are described like nucleophilic carbenoids due to the enriching 
effect of the bonded metal possessing an electron donating ligand. A third category is 
represented by the persistent carbenes that show a relative long half-life, stability and low 
reactivity. The N-heterocyclic carbene (NHC or Arduengo´s carbene) belong to that group 
and they found in the last decade broad use in catalysis as ancillary ligands (see figure 
3.3).[140,141] 
 
  
Figure 3.3: carbene classification: left) spin configuration, right) reactivity coordinated to a metal  
 
The presence of two nitrogens and the aromatic ring (imidazole ring) enforces furtherly the 
half-life of the NHC through a M+ / M+ stabilization effect of the α-groups which 
compensate the p orbitals electrons lack and simplify the π conjugations (of the N) and 
molecule stabilization.[98] 
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Based on these properties it results clear to understand the strong TEP similarity between 
NHC and phosphine ligands. Furthermore, the class of the NHC resulted in a lower 
νCO(A1) and thus in a stronger metal electron donor capacity (see figure 3.4).
[135,136] 
 
 
 
Figure 3.4: graphic representation of the TEP of some NHCs and phosphine ligands performed with an 
Ir(CO)3 complex; figure taken from reference 136 
 
3.1.2 Drug design of series I 
Considering the extended analogies between phosphine and NHC ligands, an Arduengo 
carbene seemed a suitable organic scaffold for the synthesis of the new target 
molecules.[142,143] Since the starting concept of the project was to synthesize stable 
complexes that would allow proper structure activity relationship (SAR), gold(I) has been 
preferred over gold(III). One of the most potent thioredoxin reductase inhibitor has been 
chosen as lead structure. The gold phosphol inhibitor (GoPI, see chapter 4) has the gold 
center atom binding to tertiary phosphorus and outstanding biological properties (see 
figure 3.5).[107] 
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Figure 3.5: drug design and analogies between gold phosphol inhibitor and the new carbene gold(I) 
complexes 
 
As core structure of the molecules we chose the benzimidazol-2-ylidene ligand (green 
dotted line in figure 3.5). The benzimidazol-2-ylidene is similar to the GoPI condensed ring 
system. Furthermore, the imidazole group possesses intrinsic biological properties 
(antiprotozoal, antibacterial) and could contribute to the overall activity of the 
substances.[144] 
The position and chemical properties of the two nitrogens (blue circle) are similar to those 
present in GoPI. They represented a typical Arduengo NHC and together with their 
position in a core structure conferred to the complexes a strong electron donor capacity, 
similarity to the phosphine bond (blue electron cloud) and a remarkable stability.[133] 
The lipophilic residues (yellow spheres), that in the leading structure are two pyridin rests, 
will be replaced by a series of lipophilic substituents. The increase in hindrance would 
afford a first drug design and the influence on the bioactivity of the complexes will be 
monitored. 
The gold center atom is carrying the activity and the chlorido ligand represents the leaving 
group of the molecule (both Au and Cl red marked). 
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3.1.3 Synthesis of series I[145] 
The new gold(I) NHC complexes of the benzimidazol-2-ylidene type were prepared 
according to a convenient established procedure starting from benzimidazole (see 
scheme 3.1 A).[146,147] Alkylation of the aromatic nitrogens was achieved by heating under 
reflux condition (~100°-120°C) treating the benzimidazole with an excess (1 : 3) of the 
respective alkyl halogenide in the presence of a mild base under vigorous stirring with 
acetonitrile as solvent. The reaction time was dependent on the structure of the residues. 
Good results were obtained for 6 - 10 h reactions. K2CO3 deprotonated the hydrogen in 
position N3, forming bicarbonate, that precipitated in the reaction mixture and was then 
filtered off. The obtained benzimidazolium halides were recrystallized in ethylacetate / 
dichloromethane. All the yields were above 75%. 
 
 
Scheme 3.1: synthesis of the benzimidazol-2-ylidene gold(I) chloride complexes 
 
To obtain the target gold complexes, benzimidazolium halides were reacted with Ag2O in 
dichloromethane at room temperature under vigorous stirring. The reaction led to the 
formation of a light instable silver-NHC intermediate (see scheme 3.1 A and B)[148] after at 
least 2 h. The first step of the complex formation reaction was followed by evident color 
change of the mixture and by TLC. Once the silver intermediate was achieved, chlorido 
dimethylsulfide gold(I) was added. The following reaction (also named trans-metallation) 
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led to the formation of the target gold(I) NHCs and precipitation of silver halogens. The 
compounds were finally purified by filtration over Celite-281 with a 45.3 µm particles 
diameter using dichloromethane as eluent. The gold complexes were characterized by 1H 
NMR, electron ionization mass spectrometry (EI-MS), and elemental analysis with a 
deviation from the theoretic value lower than 0.4 %. Complex 2a was also characterized 
by 13C NMR. The complexes presented an interesting substituent-dependent color. For 
small residues (methyl, ethyl) the color resulted intense or pale yellow (respectively), while 
large and lipophilic substituent gave a white coloration. All the yields were between 25 % 
and 55 %. 
 
 
 
Figure 3.6: 
1
H NMR spectrum in DMSO-d6 of compound 2 
 
Characteristic spectroscopic features of the benzimidazolium halides formation included 
the disappearing of the proton signal at N-H at 12.4 ppm of the benzimidazole core in the 
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1H NMR spectra and the strong downfield shift of the proton at the C2 carbon from 8.21 
ppm to 9 – 10 ppm (example provided in figure 3.6). 
Also the aromatic signals presented an interesting behavior. In the 1H NMR of the 
benzimidazole the protons at the C4 and C5 gave a broad signal at 7.59 ppm and a double 
duplet at 7.19 ppm respectively. The aromatic proton signals of the benzimidazolium 
halides have been revealed between 7.0 and 7.5 ppm and gave a characteristic two 
double-duplet signals. 
 
 
Figure 3.7: 
13
C NMR in DMSO-d6 of compound 2 
 
Characteristic spectroscopic features of the gold(I) NHC complexes formation included the 
disappearing of the proton signal at C2 of compounds 1 - 4 in the 1H NMR spectra 
(expected at 9 - 10 ppm) and a strong downfield shift of the C2 carbon signal from 141 
ppm (for benzimidazolium halide) to 177 ppm (for the gold NHCs) in 13C NMR spectra 
(see figure 3.7 and 3.8 for an example). The aromatic signals resulted in a double-duplet 
with the two signals shifting towards each other. EI-MS coupled with gas chromatography 
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as injection method confirmed the presence of the molecular ion peak and the M+-Cl as 
one of the main fragments. 
 
 
Figure 3.8: 
1
H NMR spectrum in CDCl3 of compound 2a 
 
 
Figure 3.9: 
13
C NMR spectrum in CDCl3 of compound 2a 
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3.2.1 Chemical consideration on series II 
The variation of the side chains at the nitrogen atom of the benzimidazole core 
represented one of the possible modifications to induce a proper biological activity. The 
increase in steric hindrance of bulky alkyl chains resulted in an increased lipophilicity of 
the gold complexes. However, the modification did not lead to significant modulation of the 
bioactivity pointing out the minor influence of the side chains in the overall 
pharmacodynamic profile (for more information see chapters 6 and 8). 
Since the gold atom demonstrated to carry the activity, substantial variation in its 
electronic environment or ligand dissociation energies could be expected to mirror a deep 
impact in the biological target interactions. The NHC structure showed useful chemical 
features coupled with bioactivity. Thus, a modification at the second ligand of the gold 
center atom (the chlorido ligand) could be rationally investigated. 
While the gold center atom established a stable interaction with the NHC system through 
a strong σ coordination and π backbonding, the electronic configuration of the chloride 
group did not allow broad electron shell interactions. The introduction of a ligand 
possessing a major level of orbitals could influence the molecule properties, increasing 
the complex stability, weakening the carbene-gold coordination and having a deep impact 
on the overall biological profile. Furthermore, the possible involvement of a neutral ligand 
would allow the formation of positively charged complexes. The gold atom enables the 
molecule to set electrons on the third electronic shell, reaching the 18 electron 
configuration. The formal aligned positive charge would be surrounded by a great number 
of negatively charged electrons that could be delocalized on the whole structure due to 
the extended orbital interactions. Nevertheless, the introduction of a cationic species on a 
broad lipophilic system could attribute to the complexes a feature known as delocalized 
lipophilic cation (DLC) with relevant biological importance.[149] 
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3.2.2 Drug design of series II 
Based on the results obtained with the first series (complexes 1a – 4a) of gold(I) NHC 
complexes, it was of interest to develop a new series of complexes positively charged and 
with a broad lipophilic system and compare their chemistry and bioactivity. 
The coordination of other strong electron donors will increase the overall stability of the 
gold complexes. An increment in bond energy and stability will defeat possible cellular 
inactivation reactions and decrease undesirable drug efflux. 
Many reports attested promising results concerning the biological potential of DLC 
substances.[110,112,149] While lipophilic structures penetrate through cellular membranes 
mainly by simple diffusion, DLCs possess an improved accumulation capacity. One of the 
main systems developed by the cell to regulate the nutrients and ion traffic between the 
outer and inner layer of the double phospholipidic strand is the electrochemical gradient 
(see chapter 9). Since the efflux of ions plays an important role for homeostasis and inter 
– intracellular communication, potassium, sodium and chloride ions level are highly 
controlled. The high concentration of Cl- kept in the cytosol will provoke a migration of 
these anions to the peripheral part of the cell to compensate the osmotic gradient. This 
partial negative charge is balanced by an accumulation of potassium or sodium cations 
outside of the membrane. This configuration behaves like a simple capacitor and will 
determine the electrochemical gradient.[150] A lipophilic cationic compound, that would 
normally be taken up by simple diffusion, would be influenced by the field and 
synergistically increase its accumulation. Furthermore, it has been reported that there is a 
difference of 60 mV in the electrochemical field of healthy and cancer cells.[149] The 
difference is expected to confer selectivity to DLC molecules. Once penetrated into the 
cell, the substances will be directed to the peripheral parts of the cytosol and to the 
mitochondria. Consequently, the analogy between the two membranes could also 
stimulate a selective uptake into mitochondria (see figure 3.10). 
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Figure 3.10: lipophilic cations and uptake into the cell of the target complexes 2b and 2c 
 
Encouraged by data already present in literature and by our promising results, as first 
rational modification, the chlorido ligand has been replaced by another NHC 
moiety.[112,151,152] The complex so obtained will present a positive charge on a lipophilic 
system and a significant increase in bond stability between the residues and the gold 
central atom could be expected. 
Since the gold phosphine complexes have been largely investigated with good results, the 
coordination of a phosphine moiety to the gold(I) NHC core will be performed. 
The resulting complex will show similar chemical properties and will present a broader 
charge displacement due to the increased conjugation system and an incremented 
lipophilicity. Both the derivatives are expected to still present a good biological profile 
(enzyme inhibition, cytotoxicity) with an improved cellular membrane penetration and 
mitochondria selective delivery. 
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3.2.3 Synthesis of series II[153] 
The target complexes were obtained starting from 1,3-diethylbenzimidazolium iodide 
(compound 2, synthesis presented above). The C2 possesses a proton with a pka of 
~25.[154] This feature could be used to “increment” the reactivity of this position by simple 
deprotonation. For the preparation of the di-carbene derivative (complex 2b), the 
benzimidazolium halide was reacted with chlorido 1,3-diethyl-benzimidazol-2-ylidene 
gold(I) (complex 2a, synthesis presented above) at room temperature under vigorous 
stirring in dichloromethane : methanol (1 :1) and in presence of a mild base (K2CO3 
deprotonating at the C2 position) for 8 – 12 h (see scheme 3.2). The choice of a weak 
base incremented the time needed to complete the reaction but avoided undesirable 
cross-side reactions (for example between the base and the gold atom). The formed 
bicarbonate was then easily filtered off. 
For the synthesis of the triphenylphosphine derivative (complex 2c) the benzimidazolium 
halide was reacted with chlorido triphenylphosphine gold(I) (TPPG) at room temperature 
under vigorous stirring in dichloromethane and in presence of a K2CO3. 
 
 
 
Scheme 3.2: synthesis of the DLCs benzimidazol-2-ylidene gold(I) complexes 
 
The products were isolated and purified by solvent extraction (bidistilled water / 
dichloromethane) or by column chromatography (with dichloromethane as eluent). The 
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obtained molecules were characterized by 1H NMR, 13C NMR, 31P NMR (concerning 
complex 2c) and elemental analysis with an accepted deviation from the theoretic values 
≤ 0.4 %. Electron spray ionization or fast atom bombardment mass spectrometry were 
involved in the determination of the molecular ion and confirmed the presence of M+ and 
M+ - I-. 
Characteristic spectroscopic features of the complex formation included the disappearing 
of the proton signal at C2 of benzimidazolium halide in 1H NMR spectra and a strong shift 
of the C2 carbon signal from 141 ppm (compound 2) to 177 ppm (complex 2a) to 190 ppm 
(complex 2b and 2c) in 13C NMR spectra (see figure 3.11). 31P NMR measurements of 
complex 2c showed an upfield shift of approximately 2 ppm for the phosphorus signal 
when compared to TPPG (see figure 3.12). 
 
 
Figure 3.11: downfield shift of the C
2
 carbon signal in 
13
C NMR spectra in CDCl3 for complex 2a and 2b 
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Figure 3.12: phosphorus signal in 
31
P NMR spectrum in CDCl3 of complex 2c 
 
3.3.1 Chemical consideration on series III 
The presence of a positive charge on a broad lipophilic system resulted to be a key 
feature enabling a substantial uptake improvement and could lead to an efficient 
delivery of the compounds into mitochondria (see chapter 9). The strong coordinative 
properties of NHC or phosphine ligands had an essential influence on the complexes 
bioactivity from enzyme inhibition to the interaction with cellular metabolic processes. 
The results overall indicated that modification of the chemical properties of the ligands 
at the gold center atom altered the pharmacodynamic profile of the molecules (see 
chapters 8, 9 and 10). 
Other functional groups with an electron-donor / electron-acceptor character could be 
added to the NHC scaffold in order to evaluate their influence on the overall stability 
and bioactivity. 
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From another perspective, modification of the phosphine could put in relation the 
coordinative potential (following the TEP) and the steric hindrance (from methyl to 
isopropyl R substituent) with the bioactivity of the compounds.[135,136] 
In table 3.1 characteristic TEP values of substituted carbenes and phosphines 
presenting different rests are indicated. 
 
NHC TEP (v) 
 
PR3 TEP (v) 
 
 
 
 
 
 
2068 
  
 
 
 
2064 
 
 
 
 
2055 
  
 
 
 
2061 
 
 
 
2052 
  
 
 
 
2059 
    
PPh3 
 
2068 
 
Table 3.1: Tolman electronic parameter for different phosphine and carbene ligands (values taken from 
ref. 135 and 136) 
 
3.3.2 Drug design of series III 
Different TEPs stand for different chemical properties of the metal - ligand bond. The 
alteration of the bond energy and electronic configuration resulted in a variation of 
bioactivity. As represented in table 3.1 even internal molecule modifications like 
functional group insertion contribute to the overall chemistry of the gold – ligand 
interactions. To investigate such properties in detail a new series of gold(I) NHC 
complexes has been synthesized. The maintenance of the benzimidazol-2-ylidene 
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core as well as the lipophilic cationic structure represented a consequent choice to 
complete the ligand-dependent variations, SAR and biological profile studies. 
Two main modifications have been carried out: NHC functionalization and phosphine 
modification. The insertion of an electron donor (methoxy) group in position C6 has 
been performed. The enriching effect is expected to influence the kinetics of the gold 
atom towards biological targets. Two phosphines were coordinated to the methoxy-
NHC: triethylphosphine as examples of short chain (5e), and triphenylphosphine as 
example of bulky aromatic residue (5c). 
Moreover, the variation of the phosphine residue in relation with TEP and hindrance is 
expected to dominate the solubility as well as the cellular uptake of the molecules. 
Three phosphines have been chosen as second ligand and represent a gradual 
increment in hindrance, lipophilicity and decrease in TEP: trimethylphosphine (2d), 
triethylphosphine (2e) and triisopropylphosphine (2f). 
 
3.3.3 Synthesis of series III 
The target complexes were obtained starting from 1,3-diethylbenzimidazolium iodide 
(compound 2, synthesis presented above). Compound 2 was dissolved in 
dichloromethane in presence of a mild base (Na2CO3), the suspension heated at 50°C 
for 10 minutes under vigorous stirring, the opportune chlorido phosphine gold(I) added 
and reacted at room temperature for 60 h (see scheme 3.3). The formed sodium 
bicarbonate was filtered off and the obtained powder washed with dichloromethane 
and water, dried and recrystallized in dichloromethane / hexane or purified by column 
chromatography with dichloromethane : methanol (2.5 %). 
Characteristic features of the complexes formation included the disappearing of the C 2 
proton signal at 8 - 10 ppm (NHC signal) in 1H NMR and the shift of the C2 signal from 
141 ppm to 190 ppm in 13C NMR such as already observed for the previous series (1a 
- 4a, 2b and 2c). Electron spray ionization mass spectrometry (ESI-MS) confirmed the 
presence of the M+ - I-. The phosphine residues were confirmed by 31P NMR and the 
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iodide counter-anion by elemental analysis with a maximal accepted deviation from the 
theoretic value of carbon, hydrogen and nitrogen ≤ 0.4 %. 
 
 
 
Scheme 3.3: synthesis of the carbene / phosphine variation gold(I) complexes 
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4. Computational chemistry 
 
Computational studies with LigandScout 3.0 were performed by Prof. Dr. Gerhard Wolber, 
Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Strasse 2þ4, 14195 Berlin, 
Germany 
 
DFT calculations were performed by Dr. Malte Kokoschka in the group of Prof. Dr. William 
Sheldrick, Lehrstuhl für Analytische Chemie, Ruhr-Universität Bochum, 44780 Bochum, 
Germany 
 
4.1 Computational studies with LigandScout[145] 
In the last decades many highly promising results concerning the involvement of novel 
gold(I) species in medicine have been reported.[100,155,156] The data progressively shed 
more light on the issue of drug design. In 2006 Becker and co-workers synthesized a new 
gold(I) phosphol complex [1-phenyl-2,5-di(2-pyridyl)-phosphole]AuCl (GoPI), which 
showed one of the strongest TrxR inhibition potential and IC50 values in the low nanomolar 
range either against TrxR and GR.[155] A crystal structure of GoPI with human GR was 
published. This provided an experimental proof for the covalent binding of gold to relevant 
cysteine residues in GR and thereby opened also some options for a more rational design 
of bioactive gold species. 
For the drug design of new bioactive gold(I) NHC coordination compounds, the recently 
published crystal structure of human GR containing GoPI was used as a starting point. An 
initial overlay of human TrxR with human GR (see figure 4.1) had confirmed the close 
structural analogy of both protein structures, indicating that the observed binding sites of 
GoPI in GR could also be used to design potent inhibitors of TrxR. 
TrxR shares with GR many crucial characteristics. Both the enzymes are ubiquitous 
NADPH dependent flavoproteins with the same folding configuration (with a conformation 
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analogy > 75%) and are involved in the cell homeostasis. They belong to the disulfide 
reductases antioxidant network. Moreover, the active site of the enzymes is characterized 
by a highly specific and similar motif that differs just for one amino acid: GR has Cys-aa-
Cys (where aa represent 4 aminoacids) and in TrxR the second cysteine is replaced by a 
selenocysteine (Cys-aa-Sec).[157] 
 
Figure 4.1: left) TrxR crystal structure (figure obtained from ref. 158); right) overlay between TrxR (blue) and 
GR (green); experiments performed by Prof. Dr. Gerard Wolber at the Freie Universität Berlin 
 
The interaction of GoPI with the active site of glutathione reductase has been investigated 
and some striking features could be observed. The chlorido ligand represented the leaving 
group of the complex allowing the formation of a covalent bond between the gold center 
atom and the cysteine 63 in the enzyme active site (Cys63 has an enhanced Lewis base 
property due to the favored deprotonation assisted by the presence of a proximal 
hystidine). Interestingly, also the organic backbone of the molecule seemed to play an 
important role for the molecule-GR interaction and selectivity. The lipophilic residues of 
GoPI could interact with three hydrophobic residues in the proximity of the catalytic site: 
the isoleucine 175, the leucine 183 and 261 (see figure 4.2). 
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The study clearly demonstrated how the drug-enzyme interaction is influenced by the 
ligands of the complex. A rational drug design that will take in consideration such 
properties will lead to a strong improvement in activity and selectivity. 
 
 
Figure 4.2: left) electron cloud and chemical interactions of GoPI with GR; right) P-Au and Au-Cl bond 
distances of the GoPI; experiments perfomed by Prof. Dr. Gerard Wolber at the Freie Universität Berlin 
 
4.2 Density functional theory calculations 
Density functional theory (DFT) developed in the late of the 20th century raised to routine 
method to calculate ground state, electron density and binding length or conformations of 
organometallic molecules.[159-162] 
The many-body systems started to be considered for their electron density, as a measure 
of the ground state, depending just on three spatial coordinates (Hohenberg–Kohn 
theorem). By introducing the time variable it was possible to describe also the excited 
state. Inverting the external conditions, from interactive electron in a static environment to 
not-interacting electrons in a dynamic potential (Kohn-Sham theorem), refined the DFT 
calculation method. To determine the exchange and correlation interaction of the external 
potential the Thomas-Fermi model together with the local density approximation (LDA) 
has been involved.[159] 
During the past decade, density functional theory and Becke´s three parameter (Lee, 
Yang, Parr) hybrid functional (B3LYP) in particular have evolved to be the workhorse in 
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the field of molecular structure calculations. Key feature of B3LYP theory is the description 
of the system energy. Its exchange correlation (xc) energy formula is written below and 
represents a measurement of the electron density and of the electron-gradient of a multi-
electron system. 
 
   
          
       (  
         )     ( 
          )      (  
        
   ) 
a0 = 0.20, ax = 0.72, and ac = 0.81  
 
Equation 4.1: exchange correlation energy in DFT B3LYP function 
 
The three “a” parameter are an external correction derived from a Becke´s original fitting. 
The GGA energy parameters represented the generalized gradient. In the B3LYP the 
exchange energy is calculated as the combination of Becke´s parameter and exact 
Hartree-Fock energy. They minimized the many-body problem simplifying the Û term of 
the Schrödinger equation (electron-electron interaction) attributing to the particle density a 
central role.[159] 
The low demand of density functional methods on computational resources is 
complemented by a high accuracy for many applications. Bond dissociation energies of 
systems containing transition metals, obtained with B3LYP were found to be of good 
quality.  
The results derived from the first series of synthesis stimulated the variation of the 
chemical properties of the molecules through ligand modification. Since that change has 
been supposed to have a deep impact on the complex profile, it was of interest to study 
the geometry and bond dissociation energy of the selected compounds. 
 
4.2.1 Molecules geometry[153] 
The geometrical configuration of the gold(I) NHC complexes has been investigated in 
order to get information about the spatial conformation and ligand hindrance. All the 
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calculations were performed using Gaussian 03 (Rev. E.01) employing density functional 
theory (B3LYP). Geometries and zero point corrections were calculated using the 
Stuttgart RSC 1997 ECP (SDD) basis set on Au and the 6-31G (d) basis set on all other 
atoms. An ultrafine grid had to be employed for PPh3-containing molecules to reach 
convergence. The calculations confirmed the expected linear planar coordination 
geometry of the complexes 2a – 2c (see figure 4.3). 
 
      
 
Figure 4.3: molecular representation of complexes 2a -  2c; experiments performed by Dr. Malte Kokoschka 
at the University of Bochum 
 
4.2.2 Bond dissociation energy 
Bond dissociation energies (BDEs) and geometry of the synthesized compounds have 
been investigated using density functional theory (B3LYP). 
For a set of a neutral and two cationic gold(I) complexes, results obtained with B3LYP 
were shown to be in agreement with post Hartree-Fock methods like CCSD (T) or second 
order Møller-Plesset (MP2) theory. Due to the nature of the resulting fragments the 
employment of a diffuse basis set and the inclusion of solvent effects were vital. Solvent 
effects were introduced via the polarizable continuum model (PCM), the basis set 
superposition error was reduced to less than 4% by using the diffuse basis set aug-cc-
pVDZ and corrected for by the counterpoise correction. The calculated BDE around the 
gold central atoms are summarized in table 4.1. The higher the BDE, the stronger will be 
the coordinative bond. 
2a 2b 2c 
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As expected, the carbene-gold bond presented a really high intrinsic stability with values 
always larger than 200 kJ / mol. The variation in the ligand induced a different electron 
density on the gold and consequently a different stability. The chlorido ligand of complex 
2a presented the lower BDE (concerning the Au-Cl bond), well according with its leaving 
group character. The dicarbene derivative (2b) showed an enhanced BDE over 225 kJ / 
mol resulting in being the more stable complex of the series (concerning the NHC-Au 
bond). Complex 2c demonstrated an interesting behavior. Although still having a high Au-
NHC BDE, the value is the lowest of the series. The PPH3 did not reach the stability of the 
carbene ligand but presented a higher BDE than the chlorido. The BDE is expected to 
dominate the reactivity of the compound. The higher the BDE, the more stable the bond 
and the lower would be the reactivity. The overall order of reactivity 2b < 2c < 2a is 
supposed to be reflected in the biological profile of the molecules. 
 
Complex 
NHC-Au-L 
 BDE (kJ/mol)  
NHC-Au  
BDE (kJ/mol) 
Au-L 
 2a (NHC-Au-Cl) 267.07 118.80 
 2b (NHC-Au-NHC) 225.39 225.39 
 2c (NHC-Au-PPh3) 207.59 158.48 
 
Table 4.1: bond dissociation energy calculation of the gold(I) NHC complexes 2a, 2b and 2c; experiments 
performed by Dr. Malte Kokoschka at the University of Bochum 
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5. Thiol interaction and stability 
 
5.1 General 
As described in the introduction, despite the good results achieved by metal complexes in 
medicinal chemistry a large number of promising drugs have been dismissed due to high 
metabolization problems. 
For example in aurotherapy, gold compounds demonstrated a significant interaction with 
small molecules present in serum or in the cell. Even before to penetrate the plasma 
membranes Auranofin is hydrolyzed at the acetyl groups and the whole thioglucosidic rest 
is replaced in a ligand exchange reaction forming thiol-shuttles with serum proteins (e.g. 
albumin, transferrin).[127] Once that Auranofin is taken up into the cell some reports proved 
the occurrence of a non enzymatic reaction between cytosolic small molecules 
(glutathione Glu, ascorbic acid) and the phosphine ligand leading to oxidation at the 
phosphorus atom (see figure 5.1).[163] 
 
 
 
Figure 5.1: schematic representation of the Auranofin metabolization 
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Although its biological potential, the evidences are attesting that Auranofin is not the real 
therapeutic agent but is just a pro-drug of gold(I). This consideration has a deep impact on 
pharmaceutical chemistry and defeats rational drug design based on the organic 
backbone of Auranofin. Since the model showed to be unreliable for efficient structure 
activity relationships, new stable substances are strongly required. 
The target gold(I) NHC carbene demonstrated already a considerably theoretical stability 
of the Au-NHC bond, enabling valuable drug design considerations (see chapter 4). 
 
5.2 Glutathione interaction study 
For inactivation of the anticancer drug cisplatin and many other metal based drugs, thiols 
such as the tripeptide Glu (γ-glutamyl-cysteinyl-glycine) play an important role. Glu 
depletion induces cancer cell sensitizing to xenobiotics, increase of reactive oxygen 
species (ROS) concentration and mitochondria permeability alteration, leading to 
apoptosis.[164] Glu binds with dangerous cellular molecules or xenobiotics and facilitates 
their extrusion through an ATP-dependent efflux channel system. P-glycoprotein families 
like the ATP binding cassette (ABC) or the multidrug resistance protein (MRP) are 
involved in Glu adducts or reduced Glu (GSSG) disposal process.[165,166] Compounds 
avoiding glutathione inactivation and extrusion (e.g. through an increase in internal bond 
energy) are required for a more effective therapy. 
The gold(I) phosphine lead compound Auranofin is biologically processed and 
metabolized in thiol ligand exchange processes. As metal NHC complexes supposedly 
represent biologically stable coordination compounds, it was of interest to study their 
interaction with glutathione under physiological conditions in comparison to relevant 
gold(I) phosphine complexes. 
 
5.2.1 Photometric assay[145] 
To investigate the possible interactions between Glu and the gold(I) NHC complexes, 5,5-
dithiobis-(2-nitrobenzoic acid) (DTNB, also known as the Ellmans reagent) has been 
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involved. DTNB can be used to quantify the thiol content of biological samples based on a 
rapid and stoichiometric reaction which also allows to monitor the activity of NADPH 
metabolizing enzymes such as TrxR.[167,168] In contrast to enzymatic reduction assays 
where one equivalent of DTNB is reduced under formation of two equivalents of 2-nitro-5-
thiobenzoic acid (TNB), DTNB reacts with a thiol to a mixed disulfide and one equivalent 
of TNB, which can finally be measured photometrically (see scheme 5.1). The binding of 
gold complexes at the cysteine thiol of reduced glutathione (or a metal mediated oxidation 
of the tripeptide) would lower the available amount of free thiol able to react with DTNB. 
This assay thus provides an efficient tool to screen the stability of gold complexes against 
inactivation by glutathione. 
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Scheme 5.1: a) DTNB enzymatic reaction; b) DTNB – glutathione reaction; c) metal complexes interference 
with the DTNB - glutathione reaction 
 
To run off the experiments an excess of the respective gold complex (1 : 2 ratio) has been 
incubated with reduced glutathione at 37 °C for 20 and 60 min. Chlorido 
(dimethylsulfide)gold(I) was used as a gold positive control. CuCl2, Hg-acetate (group 1), 
Auranofin and chlorido triphenylphosphine gold(I) (TPPG) (group 2) were involved as 
other comparative positive controls. As expected, all the standards of group 1 led to an 
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almost complete reduction of TNB product formation under the chosen conditions (see 
figure 5.2 - 5.4 for chlorido (dimethylsulfide)gold(I), figure 5.4 for CuCl2, Auranofin and Hg-
acetate). Instead lowering the TNB concentration, group 2 significantly increased the TNB 
level over 100% (see figure 5.4). 
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Figure 5.2: interactions of the gold(I) NHC complexes 1a – 4a with glutathione, incubation time 20 minutes, 
where std represents C2H6AuClS 
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Figure 5.3: interactions of the gold(I) NHC complexes 1a – 4a with glutathione, incubation time 60 minutes, 
where std represents C2H6AuClS 
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Figure 5.4: interactions of the gold(I) NHC complexes 2a – 2c and various positive controls with glutathione, 
incubation time 60 minutes; std = C2H6AuClS, TPPG = chlorido triphenylphosphine gold(I) 
 
Quite astonishingly, the gold(I) NHC species 1a - 4a, and 2b did not influence the reaction 
significantly and can thus be considered as sufficiently stable against thiols under 
biologically relevant conditions, a property highly desirable in the drug development of 
novel metal coordination compounds (see figure 5.2 - 5.4). Only 1a showed a minor 
inhibition of approximately 10% after 60 min. This might be attributed to the lower steric 
hindrance of an attack at the gold center by the less bulky methyl side chains. In fact, 
ligand replacement processes upon reaction with cysteine over an extended period of 
time have been reported for gold(I) NHC derivatives.[112] 
Unexpectedly, gold(I) phosphine complexes (e.g. Auranofin, TPPG or complex 2c) led to 
an increase in TNB release during the reaction. Due to stoichiometric reasons, an 
exceeding of 100% is not possible and therefore the occurrence of an additional breaking 
/ reduction of the DTNB disulfide bond had to be taken into account. For Auranofin, it had 
been reported that after an initial formation of an albumin-auranofin adduct, in which the 
thiocarbohydrate was replaced by a cysteine of albumin, the phosphine neutral ligand 
dissociated off the gold atom and was oxidized non enzymatically to the respective 
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phosphine oxide. Thus, an analogous “activation” by glutathione and subsequent 
oxidation of the phosphine moiety might in turn lead to the reduction of DTNB, resulting in 
the observed “overshot” of TNB. The formation of several intermediates related to a 
breakage of the DTNB disulfide bond (as well as coordinative bonds) in experiments on 
chlorido triphenylphosphine gold(I) (TPPG) could be expected. 
 
5.2.2 NMR study of the interaction between TPPG and glutathione[145] 
In order to study the reaction of gold(I) phosphines with glutathione and DTNB in more 
detail, 31P-NMR spectra were taken and TPPG has been used as phosphine standard. 
TPPG and glutathione (1 : 1) have been incubated at 40 °C for 2 h and the different 
phosphorus-containing products were monitored. The 31P-NMR spectrum showed four 
signals corresponding to Cl-Au-PPh3, triphenylphosphineoxide and two other P-containing 
products (P-Au-R1 and P-Au-R2, see figure 5.5). 
 
 
Figure 5.5: 
31
P-NMR spectra of the reaction between glutathione and TPPG; R1, R2 and triphenylphosphine 
oxide (TPPO) are represented in scheme 5.2 
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The suggested reaction mechanism resulting from these observations is depicted in 
scheme 5.2. Supposedly an initially formed gold complex with glutathione and TPPG 
reacts with DTNB in two different ways. On the one hand cleavage of the gold sulfur bond 
leads to release of TNB, glutathione and TNB-Au-PPh3. On the other hand cleavage of the 
gold phosphor bond causes the formation of TNB, triphenylphosphine and glutathione-
gold-TNB. Both the glutathione and triphenylphosphine products can undergo further 
reactions (disulfide exchange or oxidation / reduction) with DTNB under release of further 
equivalents of TNB. Overall these mechanisms explain the observed increase of TNB 
formation in the stability experiments with gold(I) phosphines. 
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Scheme 5.2: suggested ongoing reactions for the glutathione gold(I) phosphine interactions; R1 and R2 are 
represented in the scheme by the Glu-Au-PPh3 and the TNB-Au-PPh3 adducts 
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5.3 Binding with serum albumin[153] 
While intracellular thiols such as glutathione take part in the inactivation and elimination of 
dangerous species, extracellular thiols have a main carrier function facilitating the uptake 
or helping in the clearance. 
Between the serum proteins, albumin is the most common one (representing 60% of the 
plasma proteins) and plays a central role for the osmotic regulation and oncotic pressure 
of interstitial fluids, blood vessels and connective tissues. Serum albumin is a monomeric 
65 kDa protein, involved in the transport of lipophilic molecules such as fatty acids and 
steroids.[170] It is also capable to bind and carry cofactors such as hemin. Serum albumin 
tertiary structure is characterized by 17 disulfide bridges that are representing a main 
feature for the overall protein role and reactivity.[171] Many studies reported that the two 
domains, acting as binding regions, are highly hydrophobic pockets. The main reactive 
site of serum albumin has been found in a free cysteine residue (Cys-34) present in the 
hydrophobic pocket. Cys34 possesses two proximal lysines (Lys-195 and Lys-199) and a 
conformation vicinal histidine (His-39), which are hindering the water diffusion in the 
pocket. Biological relevant thiols have a normal pka around 8 – 9 (e.g. glutathione has a 
pka 8.7).
[172] The extreme accessibility of the Cys-34 (located at the entrance of the 
domain) and the basic amino acid environment decrease the pka of the cysteinic sulphur 
to ~ 5. Such acidity is comparable to that expected for a selenocysteine (pka ~ 5.3). The 
hydrophobic environment and specific character of the Cys-34 create suitable conditions 
for the binding between albumin and metal drugs (see schematic representation in figure 
5.6).[172] 
It was shown that gold can be bound to the surface exposed Cys-34 of serum albumin 
and a thiol shuttle-model describing many thiol exchange processes has been 
proposed.[127] 
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Figure 5.6: albumin domains and Cys-34 – His39 configuration (red circle: location, green: carbon backbone, 
blue: nitrogen, yellow: sulphur); imagine taken from ref. 173 and worked out with Protein-Workshop 
 
Since the occurrence of binding with serum proteins reflects a first step metabolization of 
the complexes and could defeat structure activity relationship models, it was of interest to 
study the binding of 2a - 2c to bovine serum albumin by a precipitation method over a 
period of 24 h in order to evaluate the reactivity towards another biologically relevant thiol 
over an extended time frame (see figure 5.7). This data, implemented with the glutathione 
inactivation experiments, provide a good characterization of the interaction between 
biological thiols and the gold(I) NHC complexes. 
Auranofin was used as a reference. In good agreement with the published literature[163] 
Auranofin showed a fast reaction (after 1 h binding of gold was almost complete) with 73 
% of the available gold binding to the protein after 6 h. Complex 2a reacted somewhat 
slower but overall protein binding was very similar to that of Auranofin (66 % after 6 h). 
Interestingly, 2b showed a comparably low protein binding, which was still below 20 % 
after 6 h and did not exceed 50 % after 24 h. For 2c, initial protein binding was 40 – 60 % 
and increased to 87 % over time. Whereas for Auranofin and 2a stable values were 
reached within 1 - 2 h, binding continuously increased with the exposure time in the case 
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of 2b and 2c. This indicates that the expected ligand exchange processes between the 
cysteine residue of albumin and the gold center are slowed down for the latter two 
complexes. All together these results are in excellent agreement with the theoretical 
calculations (see chapter 4) and glutathione interaction. 
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Figure 5.7: binding between bovine serum albumin and gold(I) NHC complexes 2a, 2b and 2c; Auranofin as 
reference 
 
5.4 Stability in buffer solution 
In the cell Cisplatin allows a ligand exchange reaction replacing the chlorido ligands with 
water molecules forming an aqua complex.[174,175] The strong destabilization effect 
provoked by that metabolization challenged the research and concurred to the discovery 
of the nowadays commercialized platinum compounds carboplatin and oxaliplatin. 
Since the carbene demonstrated to be more stable than the phosphine ligand (see results 
presented above), it was of interest to study their behavior under physiological conditions. 
Stock solutions of the target complexes in acetonitrile were prepared, diluted in a 
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phosphate buffer solution, incubated at 37 °C and the ultra violet spectrum modification 
monitored over different time frames.  
Because the second series of gold(I) NHC (2b, 2c) focused on ligand alteration replacing 
the chloride leaving group, complexes 2a, 2b and 2c have been investigated for their 
stability in buffer solution (see figures 5.8, 5.9 and 5.10). 
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Figure 5.8: UV/Vis spectra of complex 2a in buffer solution pH 7.0 incubated at 37 °C and at different time 
frames  
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Figure 5.9: UV/Vis spectra of complex 2b in buffer solution pH 7.0 incubated at 37 °C and at different time 
frames  
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Figure 5.10: UV/Vis spectra of complex 2c in buffer solution pH 7.0 incubated at 37 °C and at different time 
frames 
 
The spectra do not show relevant changes in the UV/Vis profile within the first 2 - 4 h of 
incubation for 2a and 2b. A progressive decrease in absorbance has been noticed, 
especially for complex 2b and 2c that represent also the most hydrophobic of the series, 
and stands for the slow precipitation of the high concentrated complexes in buffer 
medium. After 6 h of incubation all the gold compounds presented changes the UV / Vis 
profile (more marked for 2a and 2b) suggesting that a ligand exchange reaction in buffer 
medium could take place. 
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6. Enzymatic studies 
 
6.1 Background 
The cell life is enabled by several biological processes that are not other than chemical 
reactions. Most of them require high activation energy in order to happen. Mammalian 
cells adopt two main related mechanisms to lower that energy: high internal temperature 
(37°C) and involvement of sub-cellular units called enzymes. An enzyme is a catalyst that 
enables not convenient reactions from one or more substrates to a product, not altering 
the equilibrium between substrates and products. The temperature, pH and specificity of a 
peptidic sequence called active site of the enzyme for the substrate reduce significantly 
the activation energy of the target process. The chemical reaction reaches quickly the 
equilibrium state (with an order of velocity millions fold greater than the uncatalyzed one) 
without consuming the enzyme.[176] 
Between the 17th and the 19th century researchers started to observe the digestion of 
meat in the stomach, the fermentation of starch in plants or sugars in yeast. They did not 
correlate those processes with the life or organization of the cell in itself nor with the death 
or cellular decay. The structure, role and properties of enzymes were progressively 
established by the work of Nobel laureates such as Eduard Büchner, Stanley Northrop 
and David Chilton Philipps.[177] 
Enzymes cover a large range of particules size from 62 amino acids to very large proteins 
constituted by many tertiary structures for an overall weight of many kDa. The modulation 
of the catalytic properties of an enzyme results in the specificity of the reaction which it 
catalyzes. Proteins use allosteric factors and cofactors to modulate that capacity. An 
allosteric factor is a molecule that binds in another place of the enzyme than the active 
site and increases or decreases the enzyme activity. A cofactor is a molecule that binds to 
the enzyme and provides important reactive elements (e.g. NADH, Fe center atom) 
without which the reaction could not take place. The active site itself is characterized by 
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an extreme stereo / regio and chemical specificity and in normal biological conditions has 
a small number of substrates. The spatial conformation and amino acids proximity are 
strictly related with the ΔG of the enzymatic reaction (see figure 6.1).[178] 
 
 
Figure 6.1: schematic representation of the active site reactions of an enzyme, chemical interaction favored 
by the proximity (e.g. serum albumin) and energetic curve of the enzymatic process; insert in the picture from 
Wikipedia commons, file: “Carbonic_anhydrase_reaction_in_tissue.svg” 
 
The kinetic of the enzyme reactions were simplified by Henri Michaelis Menten at begin of 
the 20th century. Although further evidences underline the role of the enzyme environment, 
Michaelis-Menten kinetics are still at the base of modern enzymology. The core of the 
theory divides enzymatic reactions in many steps: the first equilibrium where the enzyme 
(E + S) and substrate are not in relation, the formation of the enzyme-substrate complex 
(ES), the chemical reaction that converts substrate in products (EP) and the release of 
them (E + P).[178] It is possible to have a single substrate reaction or a multi substrate 
reaction kinetic. Enzyme catalytic properties or activity does not follow a linear trend but is 
influenced by the substrate concentration displaying saturation kinetics. The velocity of the 
reaction, that is a measure of the affinity of the enzyme towards a target substrate, 
increases with the substrate concentration to reach a maximum when ES = E. It 
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represents the constant vmax also described by the Michaelis-Menten such as the 
concentration of substrate needed to reach half of vmax (Km). The number of substrates 
that an active site can process over time is expressed as kcat (or turnover number, [S]/s
-1). 
The enzymatic specificity or efficacy towards a substrate can, thus, be expressed as 
kcat/Km. When the enzymatic specificity reaches its theoretical maximum (10
-8 – 10-9 M-1s-
1), every collision of the enzyme with its substrate leads to catalysis.[178] Enzymes with this 
property are called kinetically perfect and the only parameter associated to them is the 
diffusion rate of the molecules in the medium.[178] For a single substrate enzymatic 
reaction the catalytic velocity of an enzyme will follow the equation presented below, 
assuming that the ES complex change over time is not minimal and tensing to zero and 
that the enzyme concentration is not changing over time. 
 
                         
    [ ]
   [ ]
      where            
       
  
     and               [ ] 
 
Equation 6.1: Michaelis-Menten relation for single substrate kinetic 
 
Some reactions are achieved by the walk-through an intermediate state. The Michaelis-
Menten equation applied to single substrate intermediate catalysis is shown in equation 
6.2. 
 
        
[ ][ ]
  
  [ ]
      where          
     
    
     
     and           
    
     
 
 
Equation 6.2: Michaelis-Menten relation for single substrate and intermediate kinetic 
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In multiple substrate reactions more than one substrate are concurring in the same 
enzymatic catalysis. When one substrate is kept constant the whole process can be 
reduced to a single substrate velocity kinetic. Another category of reaction is constituted 
by the random order multiple substrate reactions. They can be ternary when two 
substrates bind together to allow the formation of two products or with a ping-pong 
mechanism, in which the aggregation of the first substrate allows the formation of the first 
product and consequently the second substrate enables the formation of the second 
product.[176,178] 
 
 
Equation 6.3: Michaelis-Menten relation for multiple substrates kinetic 
 
All the enzymatic reactions cannot be efficiently described by Michaelis-Menten kinetics. 
Especially in the case of allosteric modulation it is possible that the ES adduct facilitates 
the formation of product increasing or decreasing the affinity of the enzymatic active site 
to the substrate (e.g. heme group). The Hill equation is often used to described such 
reactions where   is the amount ligand that occupies the active sites of the enzyme, L free 
ligand, Kd the dissociation constant and n the Hill coefficient and described the affinity of 
ES for other S (see equation 6.4).[178] 
In such cases the Michaelis-Menten equation needs to be integrated with the chemical 
kinetic orders equation that is used to determine the disappearance of substrate, the 
production of product and is a useful tool to predict metabolic processes. 
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Equation 6.4: Hill equation 
 
6.2 Enzyme role in physiology and therapy 
Non catalyzed reactions are characterized by a high energy demand or long span time 
frame. Enzymes enable these pathways with a convenient energy / time ratio, permitting 
the life of both simple and complex organisms. They are involved in almost all the cellular 
processes (motility, replication, internal communication, energy proceeds, transport, 
digestion etc.). A fine tuning up of their regulation results in homeostasis and maintenance 
of metabolic pathway functionality.[176,178] 
Due to their enhanced reactivity, the active sites of the enzymes are an eligible target for 
specific inhibitors. The inhibition of the enzyme will result in a block of the process 
coordinated by the protein correlated often with severe consequences at cellular level. 
According to the Cleland categories, enzymatic inhibition can be divided in four types 
dependent on the alteration of vmax and Km (see figure 6.2).
[178] 
 
Figure 6.2: schematic representation of types of inhibition 
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In the competitive inhibition mode (the most diffuse one) substrate and inhibitor bind at the 
same site of the enzyme; in the uncompetitive inhibition mode the block of activity is 
reached when the inhibitor binds to the already preformed ES adduct; in the non 
competitive inhibition mode the inhibitor can bind to the free enzyme as well as to the ES 
complex but not in the active site; the mixed inhibition even if similar to the non 
competitive inhibition does not follow the Michaelis-Menten kinetic.[178] 
Inhibition can be reversible or irreversible. In the reversible inhibition the binding between 
enzyme and inhibitor can be a dipole-dipole interaction, Van der Waals forces or hydrogen 
bond. The adduct EI (where I is the inhibitor) can be replaced by the substrate depending 
on exposure and concentration. In the irreversible inhibition the binding between enzyme 
and inhibitor is made by a covalent bond, with a consequent block of the active site 
functionality. The relation between vmax or Km, inhibitor concentration and inhibition 
constant (Ki) is reported in the equation below.
[178] 
 
             
[  ]
[  ]   
    or related to Km                   
[  ]
[  ]   
 
 
Equation 6.5: Michaelis-Menten inhibition correlation 
 
Parallel to the Michaelis-Menten kinetics another important parameter is frequently used 
to describe the inhibition potential of a substance towards an enzyme: the inhibition 
concentration 50 (or half maximal inhibitory concentration, IC50). The IC50 value indicates 
which concentration of an inhibitor is required to reduce the enzyme activity of the 50%. 
The IC50 can be related to the Ki as a measure of affinity of the substrate through the 
Cheng-Prusoff equation.[179] 
   
    
  
[ ]
  
 
 
Equation 6.6: correlation between IC50 value and Ki 
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Recently, beside the established anti-tumor approach some cancer cell lines 
demonstrated to over-express or under-express specific enzymes involved in the survival 
process. Examples of this preservation mechanism are the PI3K-AKT cascade, 
glutaminase, thioredoxin reductase, p38-α or monocarboxylate transferase.[180,181] The 
inhibition of over-expressed cellular components as therapeutic strategy stimulated in the 
last years many research groups to synthesize new potent and selective molecules to 
block key processes and induce tumor regression. 
 
6.2 Thioredoxin reductase and the antioxidant network as anticancer targets 
There is a difference of ten times fold in concentration between the reactive oxygen 
species (ROS) production in healthy cells towards cancer cells provoked by the increased 
metabolism connected to the pathology (DNA replication, movement and metastasis, un-
differentiation).[61,182] To protect the biological structures from severe oxidative damage all 
the living organisms developed an intra-cellular system highly conserved among the 
species. The antioxidant network is a group of enzymes and relative substrates, working 
together to prevent, expel ROS and regenerate themselves.[180] Main enzymes belonging 
to this class are thioredoxin reductase (TrxR) and its substrate thioredoxin (Trx), 
glutathione reductase (GR) and its substrate glutathione (Glu), glutathione peroxidase 
(GPx), glutathione S-transferase (GST) and glutaredoxin reductase (GTR). The main ROS 
inactivation mechanism goes through a first Glu oxidation due to the high concentration of 
Glu in the cell (~10 mM). The ROS-Glu adduct will be afterwards expelled through specific 
protein channels or regenerate primarily through GR or GST.[164] Consequently also the 
concentrations of GR and GST are quite high. To regenerate the two enzymes less 
concentrated proteins have been involved: TrxR, GTR and GPx.[183] Interestingly, TrxR is 
strongly over-expressed in cancer cell. Its modulation and role elected TrxR as a possible 
efficient target in chemotherapy.[97,183,184-186] 
TrxR is a ubiquitous NADPH dependent flavoprotein belonging to the family of the 
disulfide reductases.[185,187] There are two big families of TrxR, dependent on the cellular 
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evolution. The small TrxR (sTrxR) is present in prokaryotes and consists of two monomers 
both with an enzymatic active site and formed by three α-helices and two loops for an 
overall ~35 kDa of weight. All the structure is characterized by a high freedom degree that 
confers to the enzyme flexibility. It shows the so-called thioredoxin motif Cys-aa-Cys 
(where aa stand for 4 aminoacids) in the active site that through the disulfide bridge 
catalyzes the reaction. The large TrxR (lTrxR) is present in eukaryotes and consists of 
one NAPDH domain, one FAD domain, two monomeric regions composed by two α-
helicies, one β-strand and in between an interface domain for an overall ~55 / 65 kDa of 
weight.[180] It possesses two catalytic sites respectively in the N-terminal and in the C-
terminal of the protein. While both the active sites present a thioredoxin motif they differ 
just for one amino acid: in the N-terminal the bridge is between two cysteines but in the C-
terminal one cysteine is replaced by a selenocysteine (see figure 6.3). The lTrxR present 
a quaternary structure more rigid than the sTrxR.[180] 
       
 
Figure 6.3: left) TrxR crystal structure worked out with proteinworkshop (taken from ref.188); right) particular 
of NADPH (blue) and FAD (green) binding site 
 
In mammalian cells there are three types of TrxR. TrxR type 1 is present in the cytosol 
and has a central role in the regulation of the homeostasis. It regenerates Trx, Glu and 
GR and assists in the inactivation of ROS or small dangerous molecules (see figure 6.4). 
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Figure 6.4: enzymatic mechanism of the Trx / TrxR system 
 
TrxR type 2 is present on the membrane of mitochondria and plays an important role in 
cell survival. It concurs in the mechanism for the release of cytochrome c, apoptosome 
formation and apoptosis induction. TrxR type 3 is not largely expressed such as the other 
two subtypes and its role is still unclear.[189] 
In the last decades the selective inhibition of TrxR arises as possible new effective 
anticancer strategy. Many reports are assessing that its inhibition produces a deep 
metabolic onset in cancer cells with an increment of ROS concentration, mitochondria 
dysfunction and cell death.[184,190,191] Gold complexes resulted to be the strongest TrxR 
inhibitors with IC50 in the low nanomolar range, 10 - 100 times fold more potent in 
comparison with organic compounds (e.g. PX12).[192] The selenocysteine present in the C-
terminal active site of the enzyme has a pka 5.3 (cysteine just 8.1) and better coordination 
potential due to its Lewis base properties. Gold is a soft Lewis acid and its strong affinity 
for cysteine and moreover for selenocysteine determine an excellent selectivity. The 
inhibition of TrxR, such as main target for gold based therapy, has been evaluated and 
compared to the GR inhibition that possesses more than 75% of structural affinity in the 
active site with TrxR.[180] 
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6.3 TrxR and GR in situ inhibition by gold(I) NHC complexes[145,153] 
The inhibition of the activity of the target enzyme TrxR and the structurally closely related 
GR by the NHC gold complexes 1a - 4a, 2b – 2f, 5c, 5e and the compounds 2 and 5 (as 
negative controls) as well as the gold(I) phosphine species Auranofin, chlorido 
triethylphosphine gold(I) (TEPG), and TPPG (as positive controls) was performed using 
the isolated enzymes. Whereas the non gold-containing compounds 2 and 5 were devoid 
of any activity against both enzymes, strong inhibitory effects against TrxR (IC50 values 
between 0.009 and 5.0 μM) and more moderate or no effects against GR (1.9 to > 100 
μM) could be noted for all gold(I) complexes (see table 6.1). 
 
 IC50 TrxR (µM) IC50 GR (µM) selectivity (x-fold) 
auranofin 0.009 ± 0.000 15 ± 0.1 1666 
TEPG 0.037 ± 0.005 7.9 ± 0.4 213 
TPPG 0.256 ± 0.002 4.2 ± 0.7 16 
2 >50µM >50µM n. a. 
5 >50µM >50µM n. a. 
1a 0.399 ± 0.040 30 ± 2.5 75 
2a 0.361 ± 0.040 8.7 ± 0.0 24 
3a 0.465 ± 0.006 9.3 ± 1.7 20 
4a 4.01 ± 1.0 94 ± 15 23 
2b 4.89 ± 1.15 > 100 > 20 
2c 0.66 ± 0.02 2.60 ± 0.55 3.9 
2d 0.034 ± 0.007 3.42 ± 1.62 101 
2e 0.031 ± 0.001 2.55 ± 0.12 82 
2f 0.113 ± 0.058 4.72 ± 0.53 42 
5c 1.949 ± 1.020 49.9 ± 1.55 26 
5e 0.019 ± 0.002 1.94 ± 0.24 102 
 
 
Table 6.1: TrxR and GR in situ inhibition by Auranofin, TEPG and TPPG as positive controls (green), different 
free ligands (2 and 5, gray) and gold(I) NHC complexes (light blue: first series, blue: second series, dark blue: 
third series) 
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Overall, these results clearly demonstrate that the gold(I) center is necessary for the 
inhibition of the enzymes and support the assumption of the preferential binding to the 
selenocysteine residue present in the active site of TrxR. One striking feature observed in 
these enzymatic studies is the strong selectivity for TrxR over GR (see figure 6.5 for an 
example), which had been previously described for various gold phosphine derivatives 
and was also found for the here reported series of gold(I) NHC complexes. 
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Figure 6.5: example of dose-response curves of the inhibition of TrxR and GR by complex 5e and selectivity 
comparison 
 
Moreover, the first series of complexes (1a – 4a) demonstrated a good activity in the 
submicromolar concentration range, with the exception of the diphenylmethyl derivate 4a, 
which exhibited a comparably low solubility in the used assay buffer that might explain its 
significantly lower activity. 
The modification of the side chains at the benzimidazole core resulted in a minimal or no 
influence on the enzyme inhibition. The alteration of the second ligand at the gold atom 
(chlorido, NHC or phosphine), analyzed in the second series (2b and 2c), produced 
interesting effects and changed the biological profile of the molecules. According with the 
theoretical data on BDEs (see chapter 4), the increase in the dissociation energy of 
selectivity 
  
Page - 74 - 
 
 
Enzymatic studies Riccardo Rubbiani, PhD Thesis 
complex 2b resulted in a decrease of reactivity towards TrxR and in a block of the activity 
towards GR, for which no inhibition could be determined up to the highest concentration 
used (100 µM). Complex 2c was a good compromise between the phosphine and carbene 
class, demonstrating an enzymatic inhibition profile similar to other tested gold(I) NHCs 
(1a – 4a) coupled with relative high BDE. 
In general, higher activity was noted for the investigated gold(I) phosphine positive control 
derivatives (auranofin, TEPG and TPPG), which also represent a kinetically more reactive 
class of gold(I) complexes. 
The coordination of the 1,3-diethylbenzimidazol-2-ylidene gold(I) rest with different 
phosphines (trimethyl, triethyl and triisopropyl) resulted in an outstanding activity with IC50 
values in the low nanomolar range and an improvement in the selectivity towards TrxR in 
comparison with the precedent series (1a – 4a, 2b and 2c). The activity was directly 
comparable to the hindrance and coordinative potential of the substituent (2d - 2f, 2c). Not 
bulky phosphine ligands inhibited the target enzyme TrxR more efficiently with an order of 
activity: 2c < 2f < 2e < 2d. The insertion of a methoxy group at the carbene core 
modulated the coordination at the NHC. The electron donor group increased the 
coordination potential of the carbene-metal bond, depressing the inhibitory activity of the 
triphenyl phosphine derivative 5c. This chemical modification was not affecting the activity 
towards GR, influencing consequently the selectivity of the compounds. Especially for 
complex 5e an exceptional activity and selectivity, in the range of the strongest gold base 
inhibitors, has been found. This profile is expected to be the result of the base activity of 
the triethylphosphine gold(I) moiety (see 2e enzyme inhibition profile) and increment in 
selectivity due to the NHC-methoxy residue. 
Overall, the SARs clearly demonstrated the importance of the gold(I) center to carry the 
activity as well as the ligands chemical properties to modulate it. While modifications at 
the side chains did not result in variation of the biological spectrum, the modulation of the 
chemistry of the ligands had a deep influence on the TrxR inhibition and selectivity. 
Gold(I) NHC phosphine complexes proved to be the most potent and selective molecules 
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of all the series. The insertion of an electron donor group as well as the minimization of 
the phosphine hindrance resulted in the most effective complex 5e that for biological 
profile is almost comparable to other really potent TrxR inhibitors. 
 
6.4 GPx in situ inhibition by gold(I) NHC complexes[153] 
The presence of a selenocysteine in the active site of the interface domain of TrxR 
represented the reactive point of the protein and the specific target for gold complexes. 
The chemical difference between selenocysteine and cysteine is supposed to be the 
reason for the strong selectivity of the complexes towards this enzyme of the antioxidant 
network. TrxR is not the only seleno-protein present in the cell. Glutathione peroxidase 
(GPx) is another seleno-protein involved in the cellular protection against ROS. In order to 
study the selectivity between seleno-proteins the interaction between the gold(I) NHC 
complexes towards GPx was investigated (see table 6.2).[193] 
 
 IC50 GPx (µM) selectivity (GPx / TrxR) 
2 > 100 --- 
2a 10.8 ± 0.95 30 fold 
2b > 100 >20-fold 
2c > 100 >150 fold 
 
Table 6.2: GPx inhibition by 2a, 2b and 2c and selectivity against TrxR 
 
Representative complexes with a chlorido, a carbene and a phosphine as second ligand 
have been chosen and tested for their GPx activity. The enzyme was only inhibited by 2a 
with an IC50 value approximately 30 fold higher than that observed with TrxR, which 
demonstrated that the compounds are not unspecific seleno-enzyme inhibitors. More 
interesting results showed 2b and 2c. Both the cationic compounds were not influencing 
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the activity of GPx at concentration up to 100 µM. The gold free ligand 2 was once more 
again inactive against GPx. 
 
6.5 Disulfide reductase inhibition in cell lysates by gold(I) NHC complexes[145] 
In order to evaluate the difference between the in situ / in vitro inhibition of the target 
enzymes, a cell lysates assay has been performed. HCT-116 coloncarcinoma cells 
were treated with different effective concentrations of complex 2a for 18 h at 37 °C 
with the 5 % of CO2. After the incubation the cells were pelletted, the membrane 
disrupted and the lysates collected. The disulfide reductases activity was determined 
according with the established condition for the in situ assay. The results indicated a 
clear effect of the gold complex on the reductases system with IC50 values one order 
larger in comparison with the in situ evaluation (see figure 6.6) but good comparable 
with the cytotoxic effects (see chapter 8).[194] 
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Figure 6.6: inhibition of disulfide reductases in HCT-116 cell lysates by 2a after 18 h incubation at different 
concentrations 
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The results, in accordance with the antiproliferative activity, indicated that the enzyme 
inhibition has a central role to explain the activity of the complexes. Because GR and 
GPx are regenerated by TrxR, the hypothesis that a selective inhibition of that  enzyme 
will produce a severe damage on the whole prevention system, having an impact on 
the cell homeostasis, is drastically enforced. [195] 
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7. Mass spectrometry investigations 
 
MS experiments on the interaction of chlorido triphenylphosphine gold(I) with glutathione 
as well as the interaction of the gold(I) NHC carbenes with the selenocysteine containing 
decamer peptide were performed by Dr. Maria Stefanopoulou in the group of Prof. Dr. 
William Sheldrick, Lehrstuhl für Analytische Chemie, Ruhr-Universität Bochum, 44780 
Bochum, Germany 
 
MS experiments on the interaction of gold(I) NHC carbenes with the TrxR-containing-motif 
undecamer peptide were performed by Dr. Chiara Gabbiani in the group of Prof. Dr. Luigi 
Messori, Facoltá di Chimica, Universitá degli studi di Firenze, Via della Lastruccia 13, 
50019 Sesto Fiorentino, Firenze, Italy 
 
7.1 Background, importance and applications 
Since the development of mass spectrometry (MS) by Goldstein in 1886 and Wien in 
1899, MS analysis started to play a key role not only as mere molecule detecting tool but 
also as important method to perform high quality biological investigations such as 
proteomics and metabolomics.[196] 
The principle at the base of MS analysis is the possibility for charged molecules to travel 
from an anode to channels of a perforated cathode in a low pressure medium. This flow 
can be deflected by the application of a magnetic field dependent on mass and charge of 
the molecules. The separation can be evaluated equating the Lorentz force law and the 
Second Newton law where m represents the mass, Q the charge, a the acceleration, E 
the electric field, v the velocity of the particle and B the magnetic field (see equation 7.1). 
 
(
 
 
)       
Equation 7.1: relation between mass, electric field, magnetic field and charge of the particle 
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A MS measurement consists of the ionization of the target compound, its vaporization in 
the MS ion source and the carrying of the ionized molecules by an inert gas such as 
helium into the mass spectrometer under vacuum condition (see figure 7.1). In the 
spectrometer the ion flow will be deflected by the magnet, the magnitude of this deviation 
analyzed by a detector in form of scan (m / Q) of the molecules and increased by an 
amplifier. 
 
Figure 7.1: schematic representation of a MS analysis. 
 
Ionization and MS-separation are key parameters to perform proper MS analysis. The 
molecules are deflected and detected according to their m / Q that is commonly replaced 
by the factor m / z where z = Q / e and relates to Q the dimensionless number of 
elementary charges e. A mass spectrometer can work in positive or negative modus. 
Different ionization methods are involved for different sample types. Electron ionization 
(EI) and chemical ionization (CI) are providing normally a strong ionization suitable for 
organic compounds and involved gas chromatography (GC) as injection method. Typical 
liquid or solid phase samples are ionized with electron spray ionization (ESI when 
charged) or matrix assisted laser desorption ionization (MALDI). Inductively coupled 
plasma (ICP) source ionization is provided by an electric current provoked by radio 
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frequency magnetic field with a surrounding plasma coil, in which electrons are put in. ICP 
is a suitable technique for cations in really low concentrations or to determine metal 
traces. Fast atomic bombardment (FAB) ionization is obtained by the bombardment of the 
compounds inserted in a non-volatile matrix with a high energy electron beam. It 
represents a sort of ionization providing charged M++H+ ions. Quadrupole mass 
spectrometers (triple, linear or toroidal) are composed of 4 parallel rods that through 
specific radio frequency stabilize or destabilize compounds with the selected m / z. They 
work as a sort of analytic filter and are mainly involved in metabolomic and proteomic 
analysis. Tandem MS (MS / MS) operates a double fragmentation of a molecule. The ratio 
between mother MS and daughters MS provides high detection accuracy. Recently 
another kind of MS technique with high accuracy and sensitivity has been developed: 
orbitrap MS. Orbitrap works like a quadrupole with, at the end of the atoms fragmentation 
pathway, a spindle shaped electrode that allows the ion fragments to oscillate, prolonging 
their detectable time. The oscillation frequency produces current-images that will be 
translated into spectra through Fourier transformation where f is the frequency, Q the ion 
charge, B the magnetic field and m the mass of the molecule. 
 
   
  
   
 
Equation 7.2: relation between the frequency of the oscillation and the mass of the tested compound 
 
MS analysis presents some advantages. High accuracy and sensitivity, the use of 
relatively low sample concentration, high reproducibility and the possibility to be coupled 
with other separation methods (e.g. GC, HPLC, electrophoresis or CE) resulted in a huge 
increase of application fields.[197,198] MS of big macromolecules as well as whole cell 
extracts make a new valuable tool to investigate biological processes available to the 
researchers.[199] One of the first investigations has been performed in 1958 when 
Andersson involved MS experiments to sequence the amino acidic more abundant peak 
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in a selected peptide.[200] Reproducibility and reliability of MS spectra have been used in 
pharmacokinetic studies to determine the rate of drug clearance in urine, the 
metabolization in liver or to quantify the accumulation of specific markers in tissue.[201] 
Specifically in the field of the proteomics, MS advantages resulted to be decisive.[202,203] 
Coupled with mild ionization techniques, two main methods are involved in protein 
characterization: top down and bottom up approaches. In the top down analysis whole 
proteins are ionized through MALDI or ESI and injected into a triple or linear quadrupole. 
In the bottom up technique proteins are previously lysed by proteolytic enzymes and 
analyzed by tandem MS according to a classical pattern called peptide mass fingerprint 
(PMF). 
 
7.2 MS investigations on the interaction between TPPG and glutathione [145] 
The inactivation by Glu seemed to play a key role in cell homeostasis. The gold(I) carbene 
complexes did not react with the tripeptide while gold(I) phosphine complexes (used as 
positive control) allowed the formation of significantly more than 100 % of the product TNB 
(see chapter 5). The data coming from the photometric assay and 31P NMR studies 
suggested a possible further break down / oxidation reaction at the phosphine moiety and 
the formation of a DTNB–Glu / gold adduct. Because the results were still partially 
shaded, further studies on the kinetics of that DTNB–Glu / gold complex reaction have 
been required. Some reports are describing the possible non-enzymatic oxidation that 
could occur to the phosphine residue of Auranofin.[169] MS / MS investigations on the 
formation of triphenylphosphine oxide from chlorido triphenylphosphine gold(I) (TPPG) 
incubated with glutathione and DTNB have been performed. Clear spectra of the reaction 
mixture with significant signals were obtained (see figure 7.2). The data demonstrated the 
binding of the TPPG with TNB (695.24 m / z) and of the gold atom with both glutathione 
and DTNB (799.09 m/z), especially in the positive mode. The formation of the above 
mentioned triphenylphosphine oxide have been also confirmed in both the positive and 
the negative mode (316.36 and 316.07 m / z respectively). Overall the results 
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demonstrated that the phosphine moiety could undergo oxidation, supporting and 
clarifying the results previously described on the Glu interaction with gold complexes and 
DTNB (see chapter 5). 
 
Figure 7.2: MS / MS spectra in positive (top) and negative (bottom) mode of ClAuPPh3 incubated for 60 
minutes with DTNB and glutathione at 40 °C; experiments performed by Dr Maria Stefanopoulou at the 
University of Bochum 
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7.3 Peptide interaction study 
 
7.3.1 Interaction with a seleno-containing peptide[153] 
To resemble the interaction with selenocysteine - containing enzymes a closely related 
selenocysteine - containing peptide (Ala-Gly-Sec-Val-Gly-Ala-Gly-Leu-Ile-Lys, 
AGUVGAGLIK) has been involved. Initial studies using chlorido triphenylphosphine gold(I) 
as a positive reference (data not shown) and the gold(I) NHCs 2a – 2c in full scan 
confirmed covalent binding of gold to the selenocysteine residue (see figure 7.3). 
 
 
 
Figure 7.3: full scan of complex 2a incubated for 48 h at 37 °C with the selenopeptide and localization of the 
covalent binding; experiments performed by Dr. Maria Stefanopoulou at the University of Bochum 
 
Exposure of the seleno-peptide to complexes 2a, 2b and 2c followed by MS ionization led 
in all the cases to molecular ions at m / z 1306 and 1134 corresponding to a gold  
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diethylbenzimidazol-2-ylidene fragment or a single gold ion being respectively attached to 
the peptide. MS / MS analysis of these molecular ions contained appropriate modified and 
unmodified series of b+ (fragments containing selenocysteine) and y+ (fragments 
containing cysteine) fragments ions that confirmed the selenocysteine residue as the 
major binding site (see figure 7.4 – 7.6). This indicated that covalent binding to selenium 
can indeed be expected to be the dominating mechanism of molecular interaction for the 
herein presented gold complexes. 
 
 
 
 
Figure 7.4: MS / MS spectra of complex 2a incubated for 48 h at 37 °C with the selenopeptide and localization 
of gold bonded fragment(*); experiments performed by Dr. Maria Stefanopoulou at the University of Bochum 
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Figure 7.5: MS / MS spectra of complex 2b incubated for 48 h at 37 °C with the selenopeptide and localization 
of the gold bonded fragment(*); experiments performed by Dr. Maria Stefanopoulou at the University of 
Bochum 
 
 
Figure 7.6: MS / MS spectra of complex 2c incubated for 48 h at 37 °C with the selenopeptide and localization 
of the gold bonded fragment(*); experiments performed by Dr. Maria Stefanopoulou at the University of 
Bochum 
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7.3.2 Interaction with a seleno-containing peptide 
The target enzyme TrxR possesses a characteristic amino acidic motif in its active site 
containing the selenocysteine. Thus, it was of interest to study the interaction of 
complexes 2a, 2b and 2c with a selenopeptide mimicking the active site of TrxR. The 
seleno-dodecapeptide was prepared by solid phase peptide synthesis, following an 
established method present in the literature, and purified by reverse phase HPLC before 
to be tested by ESI-MS / MS in negative mode.[98] Preliminary full scan analysis of the 
dodecapeptide confirmed the presence of a main peak at 1181.3 m / z, corresponding to 
the peptide M+ (data not shown). 
Subsequently, the peptide was incubated for 20 minutes at room temperature with the 
gold complexes 2a - 2c, in a 3:1 molar ratio. The resulting ESI-MS spectra are shown in 
figure 7.7. 
The obtained ESI-MS/MS spectra clearly showed the formation of different products 
matching the peptide-Au containing fragment for all the three gold carbene compounds 2a 
– 2c. Interestingly, for all the molecules the same MS fragment Au-NHC+ bonded to the 
peptide could be detected. This result confirmed that the second ligand (NHC-Au-L) at the 
gold atom was mainly the leaving group of the compound. However, it resulted clear that 
the degree of peptide metalation and adduct formation differed in all three cases with the 
order of reaction 2c < 2b < 2a. In fact, complex 2a caused extensive peptide metalation 
with significant molecular peaks found at 1992.9, 1749.2, 1553.2 and 1379.3 m / z. 
Complex 2b slightly metallated the dodecapetide while for complex 2c just a very tiny and 
nearly negligible interaction was detected. In experiments with the dodecapeptide and 
Auranofin (as posivite control) an extensive peptide metallation has been observed as it is 
seen shown in figure 7.8 
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Figure 7.7: MS study of 2a (top), 2b (middle) and 2c (bottom) incubated 20 minutes at room temperature with 
the seleno-dodecapeptide; experiments performed by Dr. Chiara Gabbiani at the University of Firenze 
 
Figure 7.8: MS study of the interaction between Auranofin and the selenopeptide (with the Auranofin-peptide 
pattern): experiments performed by Dr. Chiara Gabbiani at the University of Firenze 
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7.4 Proteomics 
Proteomics is the research branch which aims a detailed proteins study: their 
conformation, role and modification. Proteins are among the main bio-macromolecules 
present in the cell, having many roles, from the mere structural function to the most 
complicated regulators of metabolic pathways. Crucial feature of proteins is the spatial 
conformation obtained through internal bonds, Van der Waals forces and post-
translational modifications like phosphorylation, acetylation or ubiquitination. These 
chemical modifications are strongly related to the protein activity.[204,205] 
With the advent of Cisplatin, DNA became a main target for metal-based drug 
development. Intercalators, histone destabilizers, nucleotide analogues have been broadly 
investigated. Recently a different approach in cancer research caught on. In the last 
decades, tumor over-expressed enzymes started to play a central role as possible 
alternative therapeutics. Especially, gold complexes resulted phenomenal inhibitors of the 
disulfide reductases family with a high selectivity towards TrxR. 
Proteomics is an important tool to evaluate not only the protein-mediated signalling 
pathways but even to study the chemical interaction of xenobiotics with target proteins. 
Due to the complexity of cell suspension contents, proper techniques are required to 
extract, separate and analyze specific proteins. The combination of the separation 
potential of multidimensional chromatography and identification and sequencing accuracy 
of mass spectrometry is a convenient and efficient tool to perform proteomic analysis. 
Multidimensional protein identification technology (MudPIT) is the combination of these 
two technologies, associated to a database searching system.[206-208] 
The proteins separation is not performed by electrophoresis but by biphasic and triphasic 
microcapillary columns associated to a HPLC system and used as injection method. The 
direct interface of the source and the separation method provide a drastic implement in 
sensitivity, avoiding band broadening. The base of the chromographic separation takes 
advantage of the different hydrophilicity of the proteins. A proper cell lysis and 
solubilisation will give a protein mixture of charged (hydrophilic) and uncharged (lipophilic) 
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peptides. This mixture is separated depending on the affinity of the peptide to the pre-
column / column. After a washing procedure, differential eluation will be used to bring the 
different peptidic fractions to the MS / MS system. The MS spectra are analyzed and 
compared to online bibliography from a protein database server (see figure 7.9). 
 
 
Figure 7.9: schematic representation of MudPIT working flow 
 
MudPIT analysis has been performed for the selected gold complex 2b. For comparative 
purposes, the incubation time was chosen to be 3 h (as well as for the uptake studies 
presented in chapter 9 and microarray experiments in chapter 10) and the concentration 
was set at 3 µM (as well as for the uptake studies and BIONAS data presented in chapter 
10). A great number of peptides have been evaluated and significant alterations of the 
expression of the proteins are listed in table 7.1. The data show a large standard 
deviation, but even if they are not suitable for scientific publication they represent really 
interesting preliminary results of a proteomic studies of cellular protein expression 
regulation stimulated by a gold(I) NHC complex (2b). 
A first sub-categorization of the proteins taken into consideration has been made. Four 
classes have been recognized: protein folding, phosphotransferase, DNA interaction and 
motility and transduction regulation (see figure 7.10). The protein folding process is 
responsible for the imprinting of the active protein shape. 
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The protein folding process is responsible for the imprinting of the active protein shape. 
The effect of 2b on this class is really interesting. All the proteins investigated present a 
general under-expression. 
 
Name of the Protein Function MuPIT result 
Retinal Dehydrogenase I oxidoreductase / Ras GTPase activator/ Vitamin A up-regulated 
Isoform C of Prelamin 
A/C 
apoptosis/ oxidative stress / cell migration up-regulated 
Protein Disulfide 
Isomerase 
cellredox homeostasis/ lipid & lipoprotein 
metabolic 
down-regulated 
Annexin A2 and isoform 2 heat-stress response/ angiogenesis down-regulated 
Histone  H1.2-5 nucleosome assembly up-regulated 
Heat shock cognate stress response/ regulation of transcription down-regulated 
X-ray complementing 
repair protein 6 
DNA repair  / transcription regulation up-regulated 
Elongation factor 2 protein biosynthesis up-regulated 
Protein disulfide 
isomerase A4 
cell redox homeostasis (3 thioredoxin domains) up-regulated 
Pyruvate kinase 
isoenzyme M1 M2 
glycolysis/ kinase/ transferase/ apoptosis down-regulated 
ATP synthase subunit 
alpha 
H
+
 transport/ respiratory electron transport chain down-regulated 
High mobility  group 
protein B2 
DNA damage/ DNA-RNA Pol. II transcription 
regulation 
up-regulated 
Calnexin post-translational protein modification/ protein 
folding 
down-regulated 
mTrifunctional enzyme α fatty acid metabolism/ lipid metabolism up-regulated 
nHeterogeneouesprotein 
M 
mRNA processing/mRNA splicing up-regulated 
Adenilate kinase and 
isoforms 
kinases/ transferases up-regulated 
cActin 1-2 cytoskeleton/ 'de novo' posttranslational protein 
folding 
down-regulated 
60S ribosome L10a mRNA translational elongation/  termination up-regulated 
neuroblast AHNAK nervous system development up-regulated 
Aspartyl/aspargyl β 
hydrolase and isoforms 
oxidoreductase down-regulated 
Neutral α glucosidase  AB protein folding/ post-translational protein 
modification 
down-regulated 
Plectin and isoforms cellular component disassembly involved in 
apoptosis 
up-regulated 
Myosin motility down-regulated 
 
Table 7.1: proteins with a significant change in expression, obtained from MCF-7 lysates treated with 3 µM of 
2b; experiments performed by Dr. Maria Stefanopoulou at the University of Bochum 
 
This could be explained by the good reactivity of the gold center atom that is able to bind 
free cysteines provoking consequently a strong misfolding of the structures. The 
phosphotransferase class is composed of a series of peptides in charge to transfer a 
phosphate moiety from a protein to another. This is one of the main mechanisms for the 
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translation of internal cellular signals. The translation of the signal induces protein 
biosynthesis, replication as well as apoptosis. 2b presented a different effect on the 
various proteins investigated with a marked under-expression tendency. The data are in 
good agreement with the microarray results presented in chapter 10. The DNA interaction 
class is formed by a group of peptides which interacts DNA or RNA and ribosomes, 
induce cell death or survival stimuli. All the proteins analyzed presented a marked over-
expression. This effect could be the symptom of a cellular answer which aims to 
compensate the stress provoked by 2b. Proteins controlling the motility and regulating the 
transduction have been categorized under a single class because of the extreme variable 
effect of the gold complex on them. Overall, a general under-expression has been noted 
probably provoked by the ongoing stress and proximal apoptosis that modifies the plasma 
membrane and alters RNA protein transduction. 
 
 
 
Figure 7.10: protein classes monitored via MudPIT analysis; experiments performed by Dr. Maria 
Stefanopoulou at the University of Bochum 
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8. Antiproliferative effects 
 
Experiments on resistant cell lines, DNA fragmentation and LDH release were performed 
by Liliane A. Onambele from the research group of Prof. Dr. Aram Prokop, department of 
Paedriatric Oncology, Childrens Hospital Cologne, Amsterdamer Strasse 59, 50735 
Cologne 
 
Experiments on the resistant healthy HFF cell line were performed by Dr. Hamed 
Alborzinia, apoptosis induction by Dr. Igor Kitanovic from the research group of Prof. Dr. 
Stefan Wölfl, Institut für Pharmazie und Molekulare Biotechnologie, Ruprecht-Karls-
Universität Heidelberg, Im Neuenheimer Feld 364, 69120 Heidelberg 
 
Experiments on the resistant healthy HEK-293 cell line for complex 2a cell line were 
performed by Dr. Yvonne Geldmacher from the research group of Prof. Dr. William S. 
Sheldrick, Lehrstuhl für Analytische Chemie, Ruhr-Universität Bochum, 44780 Bochum, 
Germany 
 
8.1 Introduction 
The life of a cell is enabled by a great number of metabolic processes. A complicated 
physiology provides nutrients and energy, regulates the stress answer and coordinates its 
replication. The alternation of all these phases constitutes the cell cycle that is mainly 
subdivided in a mitotic phase (M), the final step that leads to division and an inter-phase 
(I) in which the cell grows and prepares the replication step.[176] The inter-phase could be 
divided into growth (G) sub-phases. In the G1 phase the cell increases its metabolism, 
growing up until a maximum and then switches to the S phase in which the replication of 
DNA occurs. In the G2 phase the cell still marginally grows and all the mechanism needed 
for the mitosis are prepared.[176] Finally the cell enters in the M terminal phase and mitosis 
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occurs. A cell that naturally leaves the normal cell cycle and hold its mitotic process is 
named quiescient or senescient (G0 phase).
[176] 
There are several checkpoints during the cell cycle that control survival and replication (for 
example factors like p53 or p38 play a key role in both the G1-checkpoint and G2-
checkpoint). An alteration of the checkpoints or differentiation in cell cycle could induce 
carcinogenesis. Under normal conditions cell survival is highly controlled and regulated. 
Strong homeostatic mysregulation and cellular stress induce processes of programmed 
cell death (especially in eukaryotes). There are three main types of programmed cell 
death: apoptosis, paraptosis / autophagy and necrosis.[176,209-212] 
Apoptosis is a complicated metabolic multi-pathway that leads to cell death. It is 
composed by many factors, cascades and regulations. Almost 80 % of the apoptotic 
pathways converge to caspase 3 (Casp3) activation. Casp3 selectively cleaves Asp-aa-
Asp sequences (where “aa” represents other different amino acids) contained in various 
proteins especially those constituting the cytoskeleton. Apoptosis presents some 
characteristic features like morphological changes, membranes blebbing, chromatin 
condensation and DNA fragmentation. It is a mediated cell death that occurs in not harsh 
conditions. It could be divided in two big categories: intrinsic or extrinsic apoptosis.[213,214] 
The extrinsic apoptotic pathway is triggered by external factors like tumor necrotic factor 
(TNF) or Fas receptor interaction. They lead normally to the formation of adducts like TNF 
receptor-associated death domain (TRDD) or Fas / FasL (ligand) death inducing signaling 
complex (DISC) that activate caspase 8 and subsequently caspase 3. The intrinsic 
apoptosis is a mitochondria mediated pathway. It is provoked by different stimulation like 
oxidative stress, radiation, chemotherapy or internal communication pathways (p38, Hsp 
family). It works through the formation of apoptosome, release of Ca2+ cations into the 
cytosol, Bcl2 stimulation and activation of caspase 9 and caspase 3 (see figure 8.1).[215] 
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Figure 8.1: schematic representation of extrinsic (left) and intrinsic (right) apoptotic pathway 
 
During paraptosis or autophagy the cell degrades its own organelles through lysosomial 
auto-digestion. The process is induced by a strong protein damage and misfolding that 
leads to uncontrolled lysosomiomal activity. The lysosome grows up and starts to digest 
important structures such as cytoskeleton or nucleus. The cell swells up presenting a 
preliminary characteristic vacuolation phase with extended encompassing of all the 
organelles and cellular structures and leading to internal cell digestion (see figure 8.2).[216] 
 
 
Figure 8.2: schematic representation paraptosis / autophagy 
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Necrosis is provoked by a strong onset of the cell homeostasis. While apoptosis is a 
metabolic pathway and presents some positive characteristic for the cell environment, 
necrosis is characterized by a fatal non metabolic process provoked by a strong external 
(infection, poison, etc.) or internal cellular stress (ROS, lysosome membrane damage, 
etc.). The plasma and internal membranes (like those of the mitochondria or nucleus) start 
a process of disintegration. The cellular components are lysed and the major osmotic 
misbalance provoked by the strong water penetration through the membrane dissociation 
lets the cell swell up (see figure 8.3).[176,212] 
 
 
 
Figure 8.3: schematic representation of necrosis 
 
Between these three cell death mechanisms, apoptosis induction and regulation provide a 
key tool to control the growth and health of the overall cell. A deviation from the normal 
cell cycle has been proven to be one of the causes of tumor formation. Cancer cells 
mutate and down-regulate effectors of programmed cell death like proliferation suppressor 
factors and start uncontrolled and undifferentiated replication processes. The high 
metabolic rate of malignant cells makes DNA replication more susceptible to failures. To 
control the potential dangerous exposure of the cell to this high metabolism, a strict 
network of signal translation pathways as well as enzyme networks has been largely 
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developed. These over-expressed components (e.g. anti-oxidant network, DNA-
polymerases, kinases) are at the base of modern tumor therapy.[125] 
 
8.2 Proliferation evaluation assays 
In vitro antiproliferative effects provide a first basic screening to evaluate the possible 
anticancer properties of new drugs. A drug could have two different behaviors towards 
tumor: cytostatic and cytotoxic. Cytostatic is the property to block the replication of the cell 
without killing it directly. A substance with cytotoxic effect is able to provoke a strong onset 
in the metabolism that leads to cell death. A proper determination of the cytostatic / 
cytotoxic profile is required to start the characterization of new possible therapeutic 
agents. 
One of the main parameters to monitor cell status is the membrane integrity. Because of 
its protection and regulation role, membrane porosity is a useful criterion to assess cell 
functionality. For example crystal violet is a dye able to penetrate the intact cell 
membrane, staining nucleoproteins and enabling to discriminate between living and 
damaged cells (see figure 8.4).[217] An increment in membrane permeation will enable 
specific dye to penetrate and stain also other intracellular components that will not be 
reached in normal conditions (e.g. in figure 8.4). For example, propidium iodide is a 
fluorometric dye that is uptaken into the cell only when the plasma membrane presents 
discontinuity, directly related to the apoptotic or necrotic processes.[218] Membrane 
homeostasis is experimentally controlled also by constituent sequestration. Lactate 
dehydrogenase is sequestered from the outside to the inside of the cell and its reaction 
could be monitored. Specific protease reactions are prohibited outside of the cell or when 
the cell is compromised. The measure of their activity is a useful parameter to control cell 
viability.[219] Also ATP based assays have been developed.[220] Reducing reactions could 
be also involved to determine cell proliferation. 3-(4, 5-Dimethyl-2-thiazolyl)-2, 5-diphenyl-
2H-tetrazolium bromide (MTT) or resazurin are redox agents that are reduced by living 
cells to formazan (for MTT) or to fluorescent derivatives (for resazurin).[221] Recently, label-
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free techniques have been developed to monitor living cellular populations. The 
determination of impedance as a measure of the cell morphological changes started to be 
an established procedure.[240] Cells are seeded on a gold-film electrode and the variation 
of the potential is studied. 
 
 
Figure 8.4: examples of cellular dyes 
 
8.3 Effects on cell growth 
 
8.3.1 Crystal violet and MTT staining[145,153] 
The triggering of antiproliferative effects by the target new gold(I) carbene complexes was 
investigated in various tumor cell lines. A first screening of bioactivity has been conducted 
in two of the most common tumor cell lines with crystal violet assay: MCF-7 breast 
adenocarcinoma and HT-29 colon-carcinoma. 
Relevant activities could be noted for all the complexes in these cell lines. The observed 
IC50 values (in the range of 0.11 - 13.3 μM) were generally within the same order of 
magnitude as noted for gold(I) phosphine species (IC50 values in the range of 1 - 5 μM in 
the used assay).[102] These results are in good agreement with other reports on bioactive 
gold carbene species, which reached activities in the low micromolar range.[109,112] The 
inactivity (IC50 values >100 μM) of the free benzimidazolium halides 2 and 5 confirmed 
that the gold center was necessary to obtain bioactive species. 
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Interestingly, the substitution of the chlorido leaving group in 2a with the NHC and 
phosphine ligands in 2b and 2c led to an approximately 5 times fold increase in 
antiproliferative potency in MCF-7 cells as well as an approximately 15 fold increase in 
HT-29 cells. 
 
Substance IC50 HT-29 (µM) IC50 MCF-7 (µM) 
auranofin 2.6 ± 0.4 1.1 ± 0.3 
TEPG 5.3 ± 1.9 3.2 ± 1.3 
TPPG 4.2 ± 0.9 2.6 ± 0.1 
2 > 100  > 100  
5 > 100  > 100 
1a 13.3 ± 4.4  7.5 ± 0.6  
2a 6.4 ± 2.0  4.6 ± 0.0  
3a 11.8 ± 1.9  10.2 ± 0.1  
4a 12.3 ± 3.3  10.3 ± 0.7  
2b 0.44 ± 0.13 0.81 ± 0.13 
2c 0.40 ± 0.18 0.89 ± 0.40 
2d 1.46 ± 0.19 0.74 ± 0.49 
2e 8.85 ± 2.05 0.81 ± 0.07 
2f 5.98 ± 1.78 0.59 ± 0.23 
5c 6.23 ± 2.02 0.24 ± 0.01 
5e 3.88 ± 1.51 0.11 ± 0.01 
 
Table 8.1: antiproliferative effects of the new gold(I) carbene complexes on HT-29 human coloncarcinoma and 
MCF-7 human breast adenocarcinoma cell lines 
 
An increase of the activity correlated with the change of the phosphine ligand was 
observed. A significant reduction of the cytotoxicity has been observed for the decrease of 
hindrance of the phosphine ligand (e.g. complex 2c and complexes 2d – 2f). The data 
correlated well with already published information reporting the importance of lipophilic 
cations for the cellular uptake and the bioactivity. [112,149-151] A decrease in the 
phosphine lipophilicity will provoke a decrease in the cellular accumulation and weaker 
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anti-proliferative effects. An interesting preference of 2 – 35 times fold for MCF-7 
against HT-29 cancer cells line has been observed for the third series of complexes 
(2d - 5e). At this stage of the research an exhaustive explanation of the obtained 
selectivity cannot be explained. The role of lipophilic cations for the uptake and the 
selective delivery of the molecules (see chapter 9 and ref. 149) can play also a central 
role in explaining the obtained tendency. Also to be mentioned, MCF-7 display a larger 
size and estrogen receptors, differently to HT-29. But so far it was not possible to find 
a link between hormone-mediated cell answer and gold(I) NHC complexes. The 
insertion of an electron donor group on the carbene backbone deeply influenced the 
anticancer properties of the molecules that reached the lowest IC50 values (complex 
5c and 5e). Another feature could be also observed in the dose-response curve, 
comparing for example complex 2a and 2c. For curve values above 0, there is just a 
block in replication and proliferation, while for curve values below 0 the target 
molecule is able to effectively kills the cells (even the seeded as control, before the 
complex treatment). 2a (a neutral derivative) presented a cytostatic profile while 2c (a 
lipophilic cationic derivative) resulted more aggressive displaying cytotoxic character 
(see figure 8.5). 
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Figure 8.5: comparison between the antiproliferative properties (cytostatic / cytotoxic) of two chemically 
different gold(I) carbene complexes 
 
Since the promising results revealed a remarkable activity in the range of benchmark anti-
cancer compounds (e.g. tamoxifen, platinum derivatives[25,35]), it was of interest to study 
the activity of 1a – 4a towards other various cell lines. Other two cancers have been 
selected for further antiproliferative studies: HCT-116 colon-carcinoma and HEP-G2 
hepato-carcinoma. Similar results have been observed for the other two target cell lines 
(with the exception of lower activity of 4a in HCT-116 and HEP-G2 cells) (see table 8.2). 
The results clearly demonstrated the broad anticancer spectrum of the gold(I) NHCs. 
 
 
Substance IC50 HCT-116 (µM) IC50 HEP-G2 (µM) 
2 > 100 > 100 
1a 6.7 ± 0.6 4.9 ± 0.8 
2a 8.4 ± 2.2  11.2 ± 1.6 
3a 10.0 ± 0.4  14.9 ± 3.9 
4a 24.6 ± 2.8 60.7 ± 10.6 
 
Table 8.2: antiproliferative properties of 1a – 4a towards HCT-116 human coloncarcinoma and HEP-G2 
human hepatocarcinoma 
 
In order to evaluate a possible selective effect of the gold(I) carbene compounds towards 
cancer cells, HEK-293 human embryonic kidney cells and HFF human foreskin fibroblast 
cells were used as a reference. 
Selectivity towards cancer could not be confirmed for 1a - 4a and 2c as comparative 
experiments in non tumorigenic cell lines (HEK- 293 human embryonic kidney cells and / 
or HFF human foreskin fibroblasts) afforded similar activities (IC50 values in the range of 
7.6 - 32 μM). Interestingly, 2b showed a slight preference towards cancer cells in 
comparison with HEK-293, with selectivity between 3 - 8 times fold (see table 8.3). 
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Substance IC50 HEK-293 (µM) IC50 HFF (µM) 
2 > 100 > 100 
1a 10.8 ± 1.1 12.2* 
2a 10.3 ± 1.1  10.0* 
3a 9.6 ± 3.5 8.9* 
4a 32.0 ± 0.3 5.8* 
2b 3.13 ± 0.5 n.d. 
2c 0.41 ± 0.2 n.d. 
 
Table 8.3: antiproliferative properties of 1a – 4a, 2b and 2c towards HEK-293 immunized human embryonic 
kidney cells and HFF human foreskin fibroblast cells; *experiments performed by Dr. Hamed Alborzinia at the 
University of Heidelberg; ~ experiments performed by Dr. Yvonne Geldmacher at the University of Bochum 
 
8.4 Video microscopic imaging[153] 
The macro-morphology of MCF-7 cells was monitored in video microscopic imaging 
experiments. The cells were treated with an effective concentration (close to the IC50) of 
complex 2a (5.0 µM), 2b and 2c (both 1.0 µM) for 14 h and the changes in overall cell 
biomass are shown in figure 8.8 (pictures selected at 2, 6 and 10 h). 
While just a sporadic rounding, detaching dying of single cells has been observed for the 
chlorido derivative 2a (comparable with the untreated control), the cationic gold(I) NHCs 
(2b and 2c) induced a strong and fast reduction of cell layer. This was accompanied by an 
alteration of cell morphology and cell swelling starting after approximately 8 - 10 hours of 
incubation. Overall these data confirmed again that for 2a cell growth inhibition is mostly 
related to an inhibition of cell proliferation (cytostatic effect) whereas for the cationic 
species 2b and 2c also direct cytotoxic effects play a major role. 
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Figure 8.8: video imaging experiments of MCF-7 cancer cells treated with gold(I) NHC complexes for 14 h; 
from top to the bottom: control, 2a, 2b, and 2c; from left to right) 2 h, 6 h, 10 h; the white bar represents a 200 
µm scale 
 
8.3.2 LDH sequestration and DNA fragmentation[145] 
Short exposure (2 h) lactate dehydrogenase (LDH) release experiments (see figure 8.6) at 
higher concentrations (>10 μM) of 2a showed a relevant loss of cell vitality, which 
indicated that first effects took place within a rather short time frame. In overall correlation 
with its inactivity in the proliferation experiments (see Table 8.2), 2 did not influence cell 
viability in this assay up to the highest concentration investigated (100 μM). 
Control / 2 h Control / 6 h Control / 10 h
2a / 2 h
2b / 2 h
2c / 2 h 2c / 6 h 2c / 10 h
2b / 6 h 2b / 10 h
2a / 6 h 2a / 10 h
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Figure 8.6: LDH sequestration experiments on BJAB cancer cells treated with different concentration of 
complex 2a (top) and 2 (bottom) for 1 h; experiments performed by Liliane A. Onambele at the Children 
Hospital of Köln 
 
Additionally, DNA fragmentation experiments were performed with the selected complex 
2a as the DNA integrity is another important marker for apoptosis. 2a strongly increased 
DNA fragmentation after 72 h of exposure in a concentration dependent manner (see 
figure 8.7). The data are in overall good agreement with the proliferation inhibition assay. 
The organic ligand 2 did not influence the DNA integrity excepted for a really mild effect at 
100 µM, emphasizing the importance of the metal atom for the bioactivity. Analogous 
results have been observed in experiments with Jurkat cells. 
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Figure 8.7: Influence of 2a (top) on DNA fragmentation and viability in BJAB cells. 2 (bottom) showed only 
minor effects in both assays; experiments performed by Liliane A. Onambele at the University of Köln 
 
8.5 Apoptosis or necrosis induction studies[145,153] 
Experiments on the apoptosis and / or necrosis inducing activity of the new gold(I) 
carbene complexes were investigated in Jurkat leukemia cells using the annexin V / 
propidium iodide (PI) assay. During an onset capable to induce apoptosis, the negatively 
charged phophatidylserines present on the inner layer of the plasma membrane partially 
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migrate to the outer layer. The membrane, maintaining integrity, acquires symmetry and 
enables the binding with annexin V. When the membrane is completely compromised with 
relative necrosis induction, PI molecules are also allowed to penetrate into the cell. Both 
the dyes could be monitored through fluorescence-activated cell sorting technique (FACS 
analysis) and, dependent of the plasma membrane degradation degree, apoptosis and 
necrosis could be distinguished.[218] A selected complex per each different carbene class 
synthesized (2a as a chlorido, 2b as a dicarbene and 2c as a phosphine) underwent 
apoptosis / necrosis studies. 
2a influenced vital cells accompanied by a significant relative increase of necrotic cells 
and a low percentage of apoptotic cells in a concentration dependent manner. Complex 
2b induced apoptosis in concentrations above 1.0 μM with cells in the early and late 
stages of the apoptotic process. Similarly, 2c induced apoptosis in concentrations above 
0.5 μM, however, leading to drastically more pronounced effects with most of the cells 
reaching the late apoptotic stages (see figure 8.8). 
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Figure 8.8: apoptosis / necrosis studies performed with annexin V / PI method and FACS instrumentation: 
black column = viable cells, dark grey column = early apoptotic cells, light grey column = late apoptotic, white 
column = necrotic cells; experiments on 2a performed by Dr. Igor Kitanovic at the University of Heidelberg 
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8.6 Effect on resistant cell lines[145] 
Drug resistance phenomena have a major impact on current therapy regimens and cause 
frequent treatment failures. The major reasons are found with alterations in drug transport 
processes or the up / down regulation of relevant metabolizing enzymes or molecular 
targets, thus causing a complex multi-factorial event. Novel compounds with different 
chemical structures and biological properties in some cases can address these highly 
relevant issues.[222] 
To complete the antiproliferative properties evaluation of the target gold(I) NHC 
complexes the effects of 2a on the apoptosis induction in wild type (grey color) and 
doxorubicin, daunorubicin, and vincristin resistant BJAB and Nalm-6 leukemia cells (blue 
color) have been studied (see figures 8.9 – 8.11). Western blot studies confirmed the 
over-expression of P-glycoprotein, proving the acquired resistance mechanism (see figure 
8.12). The lower the apoptotic degree, the weaker is the effect of the complex on the cell 
line. The most marked effects of 2a were observed in daunorubicin resistant Nalm-6 cells, 
where 2a caused in the whole investigated concentration range (1.0 - 15.0 μM) the same 
extent of DNA fragmentation as in the respective wild type cells. In daunorubicine 
resistant Nalm-6 cells as well as in doxorubicine resistant 7CCA cells similar anti-
proliferative effects to those obtained in wild type cells were observed at concentrations 
above 7.5 μM of 2a. In the vincristin resistant cell types of BIBO and Nalm-6 cells, 
however, the resistance effects could only be partially reversed. 
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Figure 8.9: effect of complex 2a (DNA fragmentation) on wild type BJAB cells and doxorubicine resistant 
7CCA cells after 72 h incubation; experiments performed by Liliane A. Onambele at the Children Hospital of 
Köln 
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Figure 8.10: effect of complex 2a (DNA fragmentation) on wild type NALM-6 cells and daunorubicine resistant 
NALM-Dau-res cells after 72 h incubation; experiments performed by Liliane A. Onambele at the Children 
Hospital of Köln 
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Figure 8.11: effect of complex 2a (DNA fragmentation) on wild type BJAB (up-grey) and NALM-6 (down-grey) 
cells and vincristin resistant BIBO (up-blue) and NALM-Vin-res (down-blue) cells after 72 h incubation; 
experiments performed by Liliane A. Onambele at the University of Köln 
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Figure 8.12: western blot experiment confirming the expression of the P-GP complex and acquired resistance; 
experiments performed by Liliane A. Onambele at the Children Hospital of Köln 
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9. Biodistribution studies 
 
9.1 Introduction 
Cells need a controlled environment to survive and grow. During evolution and 
differentiation all living organisms developed a complex membranes system. The plasma 
membrane represents a feature shared by bacteria, fungi as well as plants or mammalian 
cells. It consists of an amphiphilic phospho-lipidic double strand presenting, at the 
peripheral part, hydrophilic phosphate heads and, on the internal part, the hydrophobic 
alkylic chains of fatty acids.[223] Membranes are forming a lipidic double layer 
conglomerate characterized by an impermeable barrier that separates two compartments: 
inside and outside.[223] Because of the efficiency of this separation, the micelle unit is 
plenty used in nature and forms the basis structure of all cells. To preserve this separation 
and coordinate the exchange of information and nutrients with the outside, the membrane 
needs to develop specific mechanisms to regulate molecule traffic. The cells elaborated a 
sophisticated system to regulate this exchange called membrane transport. It is based on 
selectively controlled internal concentration and permeability of some solutes through 
chemical properties or specific channels. The efflux of molecules can be concentration or 
electrochemical gradient dependent. If substances proceed in the direction of these two 
parameters then the permeation is facile and does not need energy. If it flows against the 
gradient than specific energy-dependent mechanisms are required. The electrochemical 
properties form a membrane potential, which is controlling internal processes (stress 
answer, communication) and favors the diffusion of cations through the membranes.[150] A 
membrane penetration that reduces the free energy of the system is named simple or 
passive diffusion through the phospholipids. This process is dependent on the size, 
charge, concentration and hydrophobicity of the solute. When energy is needed the cells 
developed a sophisticated channel system to control the transport. The phospholipidic bi-
layer is embedded with a lot of membrane proteins that through osmotic balance or ATP 
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involvement regulate the solutes efflux. The osmotic control favors the release or uptake 
of molecules through uniport, symport or antiport mechanisms, co-adjuvated by co-
transporters, solutes or just coupling a favorable reaction to a high-energy required 
reaction.[176,178] For example, ATP-dependent channels use the ATP  ADP conversion to 
overcome the energetic barrier of specific uptake (see figure 9.1). 
 
 
Figure 9.1: schematic representation of the cellular penetration mechanism 
 
While a small number of solutes penetrate through passive diffusion, the majority of 
essential elements needed by the cell are regulated by protein channels. 
A key principle that regulates membrane transport proteins is the exchange of free energy 
between two vicinal compartments. The Gibbs free energy variation (ΔG) of a system 
composed by two regions characterized by two different concentrations of the same 
analyte (C1 and C2) is regulated by the simplified equation 9.1. In it n represents the mole 
number (often calculated for 1 mole), R is the universal gas constant (R = 8.314 
J K−1 mol−1) and T is the absolute temperature. If C2 is lower than C1, ΔG will be negative 
and the whole process (e.g. analyte migration) will not require energy (till the equilibrium 
point C2 = C1). This is the principle at the base of passive diffusion. 
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Equation 9.1: Gibbs energy variation relate to the chemical equilibrium, of two compartment with 
concentration C1 and C2 
 
If the migration is thermodynamically prohibited, the system requires energy addition. This 
is the case of pump membrane transports. Pumps are normally ATPase dependent trans-
membrane proteins. The hydrolysis of ATP to ADP provides enough energy to overcome 
the contrary electrochemical or concentration gradient and transport specific solutes into 
the cell.[176] 
To enable an unfavorable process, a second transport can be coupled to the first one. The 
overall energy of the system will change following equation 9.2 where, in the case of an 
electrochemical gradient, ΔGex = zFΔP-1 where z is the number of elementary charges (or 
electrons) involved in the reaction, F is the Faraday constant (9.649*104 C mol−1) and ΔP 
the membrane potential according to the Nernst equation (assuming n = 1). 
 
        
  
  
       
 
Equation 9.2: two system-transport energy relation 
 
A negative ΔGex will affect the whole equilibrium of the system, encouraging the 
penetration of positive charged molecules. This is the principle at the base of the co-
transport channels. If the coupled transport flows in the same direction of the target solute 
then the channel will be a symporter, while in the contrary case the protein will be an 
antiporter. If the protein is directly binding the solute and regulating its cell access without 
the use of other molecules or ions then it is called uniporter.[176] 
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Since for the most therapeutic compounds the cellular uptake is a key step to trigger 
acitivity a detailed study of the molecule biodistribution is required to properly define the 
drug profile. 
 
9.2 Biodistribution 
Monitoring the pathway of a drug, from intake to the target, is a key point to define its 
medical suitability.[225] The nature of the drug (e.g. synthetic or plant extract) and the 
different biological environments encountered by the therapeutic before reaching its target 
represent a major problem with which researchers have to deal. The substance must be 
dissolved in a water based medium, penetrate from the blood to the connective tissue and 
interstitial liquid, then to the cellular barriers (like plasma membranes) and finally explicit 
its action.[39,225] During this pathway, compounds change from hydrophilic to hydrophobic 
conditions, different pH, different pressures and gradients. Many parameters play a role to 
overcome the body elimination and reach the target. The drug structure should provide a 
good solubility to dissolve in water, medium or blood. Lipophilicity will increase the passive 
diffusion through cellular membrane. Some reports indicated that the presence of 
characteristic structures (e.g. amino-acid sequence for mitochondria) could also induce a 
specific delivery.[226] In 1997 Christopher A. Lipinski enunciated the so called “rule of five” 
which should regulate the administration, distribution, metabolization and escretion 
conditions (ADME). A compound should respect at least three of those four parameters: to 
have at maximum 5 hydrogen-bond donors or 10 acceptors, a molecular weight of 500 g / 
mol or less and a maximum log P of 5.[227] 
A proper drug design should always take in consideration or even plan the compounds 
biodistribution and accumulation. Especially for metal complexes, a useful technique is 
available to quantify even small amounts of metal in biological samples: atomic absorption 
spectroscopy. 
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9.3 Atomic absorption spectroscopy 
Discovered in the 19th century by Bunsen and Kirchhoff and improved in the 20th century 
by Walsh, atomic absorption spectroscopy (AAS) is an analytical technique to qualify and 
quantify specific elements in a sample.[228-230] The principle at the base of the method is 
that a certain atom irradiated with a specific energy and wavelength stimulates the 
electrons of the outer shield to reach the excited state. The amount of energy required is 
characteristic for each electron transition and element. The absorbance is quantified 
following the Lambert-Beer law. Through the Lambert-Beer law it is possible to correlate 
the transmission of the light with its absorption coefficient. 
 
              where          
        and thus           
 
Equation 9.3: Lambert-Beer law 
 
The absorption coefficient is a measure of the cross-section of the cuvette analyzed and 
the molar absorbidity. Once measured the absorbance with photometer will be possible to 
determine the concentration of the substance, keeping constant the cross section 
parameter. Since each substance dissolved in constant concentration in a known medium 
gives a specific spectrum of absorbance, the variation of the spectroscopic profile will 
correspond to a compounds chemistry alteration. 
AAS measurements allow the determination of more than 70 elements of the periodic 
table.[228-230] 
The instrumentation is composed by an injector, an atomizer, a radiation source and a 
spectrometer (see figure 9.2). 
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Figure 9.2: schematic representation of AAS instrumentation and workflow 
 
There are two main injectors, dependent on the atomization type: simple pneumatic 
nebulizer injector or nebulizer-autosampler. Once that the probe is injected it needs to be 
atomized (reduced to its atoms) and analyzed. There are two main instrumentations: 
flames or electro-thermal atomizers. Flame atomizers consist of an O2-acetylene or N2O-
acetylene flame and reach 2300 – 2700 °C. The sample is aspirated to a spray chamber 
and conditioned through a fine filter, that allows just small particles (<10 µm), to the flame 
that is crossed by the radiation beam. Electro-thermal atomizers involved characteristic 
trails called graphite tubes. This technique allows the analysis of different kinds of 
samples (liquid or solid) with an increment in selectivity of 2 – 3 time folds in comparison 
with the flame atomizers.[231] The graphite tube is heated and the solvent or matrix is 
removed by drying and pyrolysis steps. Then, the atomization occurs and the elements 
are quantified. The radiation source is producing the excitation required for the analysis. It 
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can be a linear or a continuum source. The linear source (LS AAS) provides energy for a 
specific element transition. The typical LS AAS lamp is a hollow cathode lamp (e.g. 
deuterium) that contains at the cathode traces of the target atom with an optimal working 
range of 190 – 320 nm. Continuum source (CS AAS) covers the entire spectral range and 
must be coupled with a high resolution monochromator. A full spectrum view enables the 
evaluation of background effects with a range of 190 – 900 nm and an analytic window of 
2 nm. Because high radiation energy is needed, Xenon short arc lamps that can work in 
hot spot mode are required (for a resolution of 2 pm). The spectrometer is the final part of 
the instrumentation. It can be of two types: medium resolution and high resolution. The 
usual LS AAS detector is emitting a single narrow line and is capable to filter (through a 
monochromator) a band pass in a range of 0.2 – 2 nm. In CS AAS the detector is emitting 
a continuum beam to cover the whole spectrum and a high resolution monochromator (or 
double monochromator in the newest versions) is required. An important feature of the 
high resolution AAS is the possibility of a 3D – signal, which enables information also 
about the noise or matrix impurities. 
Although AAS presents a high sensitivity, notable problems of interference and calibration 
subsist. To solve those effects, all the measurements meet mathematical corrections. 
Both AAS methods (LS and CS) need a calibration curve to standardize and quantify the 
area under the curve (AUC) and determine the amount of sample. The main interference 
effect is produced by the interfering lines from the analysis background. While there are 
just few and narrow absorption lines for single atoms, absorption lines of molecules are 
more abundant. The overlap of atomic lines by molecular lines produces erroneous 
spectra quantification. The principal reason for this absorption error is just a partial 
pyrolysis and the quantification of matrix-element adducts. Another common problem is 
provoked by a particle able to irradiate, creating a false positive. LS AAS does not allow 
many background corrections. Mainly, standardization occurs through a sequential 
measurement of whole sample signal (sample + background) followed by a background 
signal. Background correction are operated also using a secondary lamp (deuterium 
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correction method) or applying a magnetic field at the atomizer (Zeeman correction 
method). Concrete methods to determine lines overlap are not possible. In CS AAS few 
pixel are used to determine absorption. The rest of the free-pixel is involved in background 
calculations that are mathematically performed by the software. The full scan of CS AAS 
allows the measurement of all the background spectra, their storing and correction 
through a least-square algorithm to evaluate different possible structure and even atom 
line overlap. 
 
9.4 Cellular uptake determination by AAS 
AAS analysis is characterized by high sensitivity and enables quantification of target 
atoms in the ng range. Many reports demonstrated the suitability of AAS to determine 
metallic elements content, especially in biological samples.[224,232] CS AAS can be involved 
in lysates analysis due to its discrimination capability between background (like matrix 
effect, molecular lines) and element quantification. 
Gold determination by AAS presents some advantages. ICP-MS is nowadays the most 
sensitive method to determine gold traces in a sample but has relevant analysis costs. 
AAS is a relative cheap technique that does not require complicated sample preparation. 
The limit of detection of gold is 2 ng / mL, still enough sensitive for biological 
determinations.[228,229] The peak shape of the gold line is sharp and defined (see figure 
9.3). 
 
 
Figure 9.3: example of a gold signal determined by AAS 
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The main absorption line of gold is at 242.8 nm and does not collide with other important 
lines present in biological sample (just a minor interference could come from vanadium). 
Moreover, many recent reports described efficient methods for the gold determination in 
cell lysates.[224,232] Consequently, AAS proved to be a valuable technique for the 
determination of the gold content in the cell after the treatment with the target gold(I) NHC 
complexes. 
To prepare the probes, MCF-7 cancer cells were incubated with an effective concentration 
of the gold complexes (referred to the cytotoxicity values, see chapter 8) of 3 µM. The 
experiments were conducted in a time dependent and comparative manner. After 
incubation the cells were trypsinized, the pellet collected and the lysis operated with a 
dounce homogenizator in a hypertonic solution or by freeze and thaw cycles. Protein 
quantification was performed according to the Bradford assay.[233] Aliquot of the sample for 
AAS analysis were finally prepared adding to the solution Triton X and HNO3. 
 
9.4.1 Gold uptake into whole cells: influence of the ligand type [153] 
As reported in the previous chapters, the chemical properties could deeply influence the 
biological profile of the molecules. Since the carbene represented a strong coordinative 
ligand conferring high coordination potential to the gold(I) complexes, it was of interest to 
study the variation of cellular uptake in relation with the second ligand (L = -Cl, -NHC, or 
PPH3) at the gold atom. 
Three compounds underwent time-dependent uptake study into the MCF-7 cancer cell 
line. Complex 2a is a rather lipophilic neutral compound that could easily penetrate 
through the plasma membrane by simple passive diffusion. Complex 2b and 2c are 
positively charged but also lipophilic species. For these, properties similar to that 
observed with delocalized lipophilic cations (DLC) could be expected. This includes an 
increased accumulation due to the coupled effect of concentration gradient (simple 
diffusion) and electro-chemical gradient (electric migration from the membrane outer-layer 
to the inner-layer). Consequently, the cellular uptake as well as the biodistribution of the 
  
Page - 119 - 
 
 
Biodistribution studies Riccardo Rubbiani, PhD Thesis 
complexes 2a – 2c has been evaluated by atomic absorption spectroscopy. Cell uptake 
studies with serum free and serum containing fetal calf serum (FCS) medium (for its 
interference properties, see chapter 5) have been performed in parallel (see figure 9.4 – 
9.6). In the experiments with serum free cell culture medium the gold uptake increased in 
the order 2a < 2b ≤ 2c and the complexes reached stable cellular levels within the first 2 - 
4 hours of incubation. The presumable DLC character notably increased the uptake of 2b 
and 2c, more markedly for the phosphine derivative that presents a higher reactivity (see 
BDEs, glutathione interaction and albumin binding studies in chapter 5). The presence of 
serum did not significantly affect the cellular uptake of 2b, which had shown a rather low 
affinity for binding albumin. For 2a and 2c, which had shown higher protein binding ability, 
the cellular gold levels in the presence of serum were decreased indicating that protein 
binding negatively influenced the uptake of these two gold complexes with a profile 
comparable to what was reported for Auranofin. This effect was more marked for 2c. 
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Figure 9.4: cellular uptake of complex 2a in MCF-7, performed in serum free or serum containing FCS 
medium 
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Figure 9.5: cellular uptake of complex 2b in MCF-7, performed in serum free or serum containing FCS 
medium 
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Figure 9.6: cellular uptake of complex 2c in MCF-7, performed in serum free or serum containing FCS 
medium 
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9.4.2 Gold uptake into isolated mitochondria and cytosol: influence of the ligand 
type [153] 
Due to the electrochemical gradient, an increment in cellular membrane penetration has 
been noticed, especially for the cationic compounds. Once taken up into the cell the 
complexes could be influenced by an analogous effect produced by the compartment 
membranes. It has been studied that for substances presenting the DLC character a 
migration effect to the peripheral zone of the cell (from the cytosol to the external 
membranes) could be expected.[150] This migration would drive the complexes in contact 
with the inner side of the plasma membrane or with the outer side of the organelle 
membranes. Recent studies described the strong effect of gold species on the 
mitochondria metabolism.[112,115] The lipophilic cation character and the presence of the 
gold atom could produce an increased or even selective delivery into this cell 
compartment. 
For these reasons, the uptake of 2a – 2c into mitochondria isolated from MCF-7 cells 
exposed to 3 µM of the complexes was evaluated (see figure 9.7). 
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Figure 9.7: left) cell model with highlighted electro-chemical gradient and mitochondria delivery; right) time 
dependent mitochondrial uptake of 3 µM 2a – 2c in the MCF-7 cancer cell line 
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To avoid effects of albumin or other serum components the experiments were done using 
serum free cell culture media. The gold levels increased in the order 2a ≤ 2b << 2c and 
similar to the overall uptake studies stable levels were obtained within the first four hours 
of exposure. The result indicated an exceptionally high mitochondrial uptake of 2c. In part 
this can be related to its high whole cellular uptake and its lipophilic cationic character. 
However, based on the results above a similar strong uptake of 2b could have been 
expected. The presence of a cation in a broad delocalized lipophilic system showed to be 
an important feature to improve membrane permeation. 
During the isolation procedure of the mitochondria additional cytosolic fractions were 
obtained and were also investigated for their gold content. The gold levels in these 
samples were comparably low (see figure 9.8), implicating that the uptake into the 
mitochondria may be a major pathway for the cellular biodistribution of the complexes. 
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Figure 9.8: time dependent cytosolic uptake of 3 µM 2a – 2c in the MCF-7 cancer cell line 
 
9.4.3 Gold uptake into whole cells: influence of the residues at the P atom 
Since complex 2c showed outstanding mitochondrial uptake properties coupled with a 
good TrxR inhibition (see chapter 6) a series of new gold(I) carbene phosphine complexes 
has been synthesized. The coordination of the different phosphine residues is expected to 
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have a different influence on the chemical properties and a deep affection on the cellular 
uptake. 
To establish the impact of the phosphine ligand on the molecule permeation through the 
cell membranes, the new compounds underwent cellular uptake investigations. MCF-7 
cells were treated with complexes 2d – 2f for a time span of 0 - 6 h at a concentration of 3 
µM and were compared with the data obtained with 2c. For all the molecules a similar 
profile to that observed for 2c could be expected. The compounds accumulated in the cell 
with the order 2d ≤ 2e < 2f << 2c, reaching a maximum value within 4 h of incubation, in 
good agreement with the previous results (see figure 9.9). The P-aromatic system of 
complex 2c was a key feature and enabled an uptake ~3 times fold greater than that 
obtained for the other phosphines (2d- 2f). 
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Figure 9.9: time dependent cellular uptake of 3 µM 2d – 2f in MCF-7 cancer cell line compared with the 
uptake of 2c 
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10. Cell metabolism studies 
 
Experiments on ROS induction by 2a were performed by Dr. Igor Kitanovic, Bionas 
measurements of 2a by Dr. Hamed Alborzinia, MMP, cytochrome c release and oxygen 
consumption by Suzan Can and ELISA microarray by Pavlo Holenya from the research 
group of Prof. Dr. Stefan Wölfl, Institut für Pharmazie und Molekulare Biotechnologie, 
Ruprecht-Karls-Universität Heidelberg, Im Neuenheimer Feld 364, 69120 Heidelberg 
 
10.1 Cell metabolic pathways 
The metabolism includes all those cellular activities that allow survival and growth. It is 
divided in two main processes: catabolism and anabolism.[176,178] Catabolism covers all the 
reactions that process organic material in order to provide energy. The most common 
catabolic reactions are basely redox, breaking down of organic macromolecules (e.g. 
glycogen lysis) or water and photoreactions. For example, glycolysis is one of the main 
catabolic processes that produce energy from carbohydrate molecules, pyruvate and then 
acetyl coenzyme A (AcetylCoA).[176,178] Fatty acids are processed in glycerol, proceeding 
into the glysolysis cycle, and their alkylic chains by oxidation. Amino acids are de-
aminated and, through oxidation, converted into metabolites of the citric acid cycle.[176,178] 
In eukaryotes all the catabolic processes lead to the formation of AcetylCoA, the starting 
point of the Krebbs cycle and mitochondrial oxidative phosphorylation. In the latter 
energetic process, electrons are moved from molecules to oxygen. The high proton 
concentration formed by the reaction is pumped out from the mitochondria, creating an 
electrochemical gradient that is coupled with a non favorite process to form adenosine-tri-
phosphate (ATP, the main energy molecule of the cell). Moreover, during the oxidative 
phosphorylation NAD+ / NADP+, a key molecule for all the metabolic processes and 
homeostasis regulation, is reconverted to NADH / NADPH due to the H+ production and 
gradient.[178] 
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Anabolism includes all those processes that form cellular components using the energy 
produced during the catabolism. It is divided in three main phases: monomer formation, 
monomer activation through ATP involvement and monomer assembly (see figure 10.1 for 
a schematic representation of the metabolism). 
Metabolic processes play also a key role in homeostasis regulation. Due to the variety of 
species and substances the cell cannot metabolize all the molecules. Some of them are 
harmful for the overall metabolism and could damage important structures or enzymes. 
The cell developed specific detoxification mechanisms to counteract the xenobiotic stress. 
Normally a first redox reaction is coupled with water coordination and termed with the 
modified substance extrusion through specific efflux channels. The cell itself produces 
dangerous species during its catabolic or anabolic processes. For example, a high rate of 
the cellular respiration stimulates the formation of reactive oxygen species (like peroxides 
or oxygen radicals). These molecules are able to induce severe oxidative damage. The 
cell answer involves a conjugated system called antioxidant network, formed by many 
enzymes, cofactors and substrates (see chapter 6).[234,235] 
The cell represents a dynamic system influenced by environmental conditions as well as 
by internal processes. To control and coordinate this complicated mechanism, a fine 
tuning of the metabolism is required. There are two main levels of metabolic regulation. 
The intrinsic metabolic regulation is provided by the cellular monitoring, inducing or 
inhibiting of cell components like enzymes, substrates or products dependently on their 
cellular concentration (feedback mechanism). The extrinsic metabolic regulation answers 
directly to external stimuli (molecules as well electric potential of physical stress) from the 
environment or other cells.[176] 
Especially targeted therapy in cancer research takes advantages of the deep 
understanding of cell metabolism. Some processes are drastically increased in cancer 
cells, resulting in an over-expression of enzymes that can become a selective target for 
chemotherapy. 
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Figure 10.1: catabolic and anabolic processes schematic representation 
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10.2 Evaluation of reactive oxygen species (ROS) production[145,153] 
ROS are largely products of the physiological mitochondrial cell metabolism and are 
negatively involved in cellular redox homeostasis. A high and uncontrolled concentration 
of ROS provokes DNA damage, lipoxidation of lipids with membrane lesions and proteins 
loss of functionality.[182] To control the cellular level of ROS and to avoid severe damage 
the cells developed an efficient enzymatic system called antioxidant network.[164,236-238] 
Belonging to this network are a series of enzymes and their substrates responsible for the 
detoxification and ROS extrusion. An alteration in its functionality allows a drastic increase 
of ROS concentration leading to cell death. Tumor cells present an increased metabolism 
and mitotic rate. The high energy demand of all the processes influences the ATP 
production in mitochondria and increments ROS concentration. Some reports indicate a 
significant difference of one order of magnitude between the internal ROS concentration 
of cancer cells in comparison with healthy ones.[61,239] This difference can be used to 
enhance the selectivity towards cancer cells or to sensitize and weaken their 
homeostasis. 
Gold based molecules demonstrated to strongly inhibit the enzymes of the antioxidant 
network and especially with a high selectivity towards TrxR (see chapter 6). Since the 
inhibition of the cellular antioxidant network system can trigger a severe oxidative stress, it 
was of interest to study the production and cellular ROS content in cells treated with the 
gold(I) NHC carbene complexes. For this purpose three compounds have been selected, 
representing three different chemical categories of gold complexes: the chlorido derivative 
2a, the dicarbene derivative 2b and the phosphine derivative 2c. 
In good agreement with the results of the proliferation assay, concentrations higher than 
2.5 μM of 2a, 1 – 2 µM of 2b and 2c strongly induced cellular ROS levels already after 24 
h of incubation (see figure 10.2). In contrast, compound 2 (not containing the gold atom) 
did not trigger ROS production. This pattern correlates also well with the above notion that 
the gold compounds selectively affected the activity of the redox relevant enzyme TrxR 
and GR, whereas 2 had no effect on enzymatic activities (see chapter 6). 
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Figure 10.2: ROS induction in Jurkat cells incubated for 24 h with different concentrations of complex 2a - 2c 
(DMF and 10 µM camptothecin, DMF and CMPT respectively) were used as negative and positive standard); 
experiments on 2a performed by Dr. Igor Kitanovic at the University of Heidelberg 
 
10.3 Metabolism alteration in living cell populations[145,153] 
In the last decades an increasing number of methods started to deal with “online” 
monitoring of an in vitro system. Techniques like fluorescence microscopy or multi-sensor 
arrays have been established and started to play a role as routine analysis in research. 
Between these methods, the multi-sensor techniques were recently deeply involved in 
anticancer research.[240,241] 
Bionas DiscoveryTM 2500 system is a scientific instrumentation that, through the 
involvement of up to 6 bio-modules and 6 sensors per bio-module, allows the tracking of 
several morphological and bio-energetical cellular pathways (see figure 10.3). The Bionas 
work flow is divided into three phases. In the adjustment phase medium free of substance 
flows on the chip to set the zero value. This first step is followed by a treatment phase in 
which the untreated medium is replaced with medium containing the compounds. At the 
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end, during a recovery the medium containing the substance is washed out by medium 
free of compounds.[240] 
 
 
 
Figure 10.3: Bionas Discovery
TM
 2500 instrumentation: left) chip containing the different sensors on which the 
cells are seeded, right) workstation composed by medium carousels, six biomodules and calculation system; 
pictures taken from the official webpage http://www.bionas-discovery.com 
 
For adherent cancer cells, the adhesion capacity and the membrane interaction between 
cells plays an important role in cell life. It allows nutrients and information exchange and 
confers a high resistance potential. A strong onset or apoptosis induction triggers a deep 
change in cell morphology as well as in cell-cell interactions. Since the gold(I) NHC 
complexes caused a metabolic onset (see chapters 6 and 8 and above) and induced 
apoptosis (see chapter 8), they underwent online analysis of impedance as a measure of 
cell morphology (see figure 10.4). The cells interact with the electric field produced by two 
sensors on the chip. Each variation of the field mirrors a variation of the shape or of the 
cell to cell contact. The impedance of the cells started to decrease in a concentration 
dependent manner after an exposure of approximately 7 h for all the gold compounds 
tested. The concentrations chose for the experiment were all close to the IC50 values of 
the complexes. The alteration of cell adhesion and cell-to-cell contacts were in good 
agreement with the uptake and anti-proliferative studies reported in chapter 8 and 9. 
Interestingly, the onset induced by the gold NHC complexes showed to be irreversible 
because no recovery has been observed after the treatment. Just a slight effect on 
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impedance could be noticed for compound 2, demonstrating the importance of the gold 
center to achieve bioactive species. 
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Figure 10.4: standard impedance modification in MCF-7 cancer cells treated with different concentrations of 
the compounds 2 and 2a (left), 2b and 2c (right); experiments on 2a performed by Dr. Hamed Alborzinia at the 
University of Heidelberg 
 
The inter- and intra- cellular acidification rate is a measure of the cell catabolism and 
especially of the central energetic process of glysolysis. A dysregulation of the pH 
environment of the cell can be monitored by the chip sensors and will reflect a deep 
cellular onset. While 2b and 2c showed a minor effect on the acidification rate for an 
exposure time of almost 8 h, 2a depressed drastically the process in a concentration 
dependent manner, which can be ascribed to the “dying” of the cells. The effect was not 
reversible once that the treated medium was replaced by medium free of substances and 
the cells washed for many hours. An initial increase in acidification is noticed within the 
first ≈ 4 h of treatment, suggesting an enhanced glycolysis to compensate for cellular 
stress. Once again 2 did not show to affect the analyzed parameter (see figure 10.5). 
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Figure 10.5: acidification rate of MCF-7 cancer cells treated with different concentrations of compounds 2 and 
2a (left), 2b and 2c (right) ; experiments on 2a performed by Dr. Hamed Alborzinia at the University of 
Heidelberg 
 
The respiration rate represents the major cell activity finalized to produce energy in form 
of ATP. In mammalian cells this process is in charge of the mitochondria that through the 
oxidative phosphorylation convert O2 in water, CO2 and ATP. During the experiment the 
cells seeded at the bottom of the chip were treated with cycles with flowing-medium rich or 
poor of oxygen. The variation in O2 concentration could be monitored by the Bionas 
sensors. 
The gold complexes showed a good uptake into the cell and a good delivery into 
mitochondria (especially for 2b and 2c) (see chapter 9). Consequently, the possible 
alteration of the respiration rate, as an index of mitochondria functionality, is a key 
parameter to describe the activity of the new gold(I) NHCs. All the complexes showed 
immediate effects (after just 1 - 3 h of incubation) reducing the oxygen consumption, and 
so probably stimulating the first glycolytic compensation effect in a concentration 
dependent manner. The aggressiveness of the gold compounds dysregulated intensively 
the respiration capacity not allowing any sort of recovery. As observed with the 
acidification rate and impedance, compound 2 did not affect also this parameter (see 
figure 10.6). 
 
  
Page - 132 - 
 
 
Cell metabolism studies Riccardo Rubbiani, PhD Thesis 
4 8 12 16 20 24 28 32 36
0
20
40
60
80
100
120
 2a 5.0 µM
 2a 7.5 µM
 2a 10 µM
 2 10 µM
 control
adjustment exposure recovery
s
ta
n
d
a
rd
 r
e
s
p
ir
a
ti
o
n
 r
a
te
 (
%
)
incubation time (h)
4 6 8 10 12 14 16 18
0
20
40
60
80
100
120
exposure recovery
s
ta
n
d
a
rd
 r
e
s
p
ir
a
ti
o
n
 r
a
te
 (
%
)
incubation time (h)
 2b, 1.0 µM
 2b, 2.5 µM
 2c, 1.0 µM
 2c, 2.5 µM
 control
adjustment
 
 
Figure 10.6: respiration rate of MCF-7 cancer cells treated with different concentrations of compounds 2 and 
2a (left), 2b and 2c (right) ; experiments on 2a performed by Dr. Hamed Alborzinia at the University of 
Heidelberg 
 
10.4 Influence on mitochondria metabolism[145,153] 
The membrane encoded organelles called mitochondria have a central role in mammalian 
cell life. They provide energy, in the form of ATP through oxidative phosphorylation, and 
regenerate NADH / NADPH.[178] They play also a central role in cell homeostasis 
regulating the Ca2+ concentration, through its release and reuptake. Moreover, under 
cellular stress mitochondria allow the release of cytochrome c contributing to the formation 
of the apoptosome and activation of programmed cell death pathways.[150,242,243] The main 
mitochondrial activity is oxidative phosphorylation. When their metabolism is compromised 
a block of the respiration functionality is observed. The gold(I) NHC complexes 
demonstrated a good potential in altering the mitochondria homeostasis. They showed a 
good uptake into mitochondria, selective inhibition of TrxR and a strong influence on the 
respiration rate of the overall cell (see chapters 6 and 9). Thus, it was of interest to study 
the influence of the gold compounds on isolated mitochondria. 
For this purpose, an assay measuring the oxygen consumption of isolated, functionally 
active mitochondria was applied. As expected, strong effects were observed in a 
concentration-dependent manner for all the three gold complexes (2a – 2c). 2a presented 
a remarkable activity, lowering the oxygen consumption in a concentration of 5.0 µM, 
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(close to the IC50 of the antiproliferative experiments, see chapter 8). The lipophilic cationic 
substances 2b and 2c presented a significantly stronger activity lowering respiration in 
concentrations as low as 0.1 μM and completely blocked respiration at 1.0 μM. The 
overall order of activity was 2a < 2c < 2b (see figure 10.7). 
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Figure 10.7: Respiration of freshly isolated mouse liver mitochondria. Mitochondrial activity leads to a 
decrease in oxygen saturation, which decreases over time (control). Inhibition of mitochondrial activity blocks 
oxygen consumption, resulting in continuous high oxygen concentration (rotenone, an inhibitor of respiratory 
chain complex I, positive control); decoupling of respiration by carbonyl cyanide 3- chlorophenylhydrazone 
(CCCP, positive control) leads to increased oxygen consumption. The gold complexes leads to a 
concentration-dependent inhibition of mitochondrial respiration while treatment with 2 shows no effect 
compared to the untreated control; buffer: positive control containing the organic solvent (DMF) but no 
compound, “respiration buffer”: experiment without mitochondria; experiments performed by Suzan Can at the 
University of Heidelberg 
 
The regulation of Ca2+ signaling and its release play a central role in the homeostasis of 
mitochondria and cells. The mitochondrial membrane potential (MMP) produced during 
oxidative phosphorylation largely contributes to its control and re-uptake. 
Hyperpolarization of the membrane leads to Ca2+ re-uptake while depolarization 
stimulates its release. A modification in the electrical properties of the membrane can 
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provoke an alteration in mitochondrial membrane permeability, the release of small 
mitochondria-derived activator of caspases (SMACs), the formation of the mitochondrial 
apoptosis-induced channel (MAC) and permeability transition pores (PTP), triggering 
programmed cell death.[150,242] Complexes 2a – 2c influenced the MMP in different ways 
(see figure 10.8). Complexes 2a and 2c induced after short incubation a strong 
hyperpolarization and after 8 h a small depolarization that can lead to Ca2+ release and 
possible activation of apoptotic processes. The effect was more pronounced for 2a. In 
contrast to that, complex 2b triggered an immediate and strong depolarization, which is in 
accordance with its exceptionally strong effects on mitochondrial respiration (see figure 
10.7). 
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Figure 10.8: mitochondria membrane potential alteration provoked by the gold complexes: decoupling of 
respiration by carbonyl cyanide 3- chlorophenylhydrazone (CCCP dashed green line, positive control) leads to 
membrane depolarization, “DMF”: buffer containing the organic solvent but no compound, “NT”: not treated 
(experiment without solvent or compounds); experiments performed by Suzan Can at the University of 
Heidelberg 
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A strong onset of mitochondria homeostasis can also induce the release of cytochrome c 
as another possible apoptosis intermediate. Consequently, released cytochrome c levels 
were studied by Western blot experiments with mitochondria exposed to effective 
concentrations of 2a – 2c. However, the results do not indicate a contribution of the 
mentioned pathway, as no detectable levels of cytochrome c were present in the 
supernatants of the mitochondrial suspensions (with the exception of a marginally positive 
signal with 10 μM of 2a (see figure 10.9). 
 
 
 
Figure 10.9: cytochrome c release of freshly isolated mouse mitochondria exposed to the gold complexes 2a 
– 2c. Mitochondria were treated with concentrations of 2a – 2c that had demonstrated a substantial 
impairment of respiratory effects. In all cases cytochrome c could be detected in the mitochondrial pellets but 
not in the respective supernatants. COX IV and truncated BH3 interacting domain death agonist (tBID) were 
used as positive controls; experiments performed by Suzan Can at the University of Heidelberg 
 
10.5 Influence on protein kinases pathways 
The regulation of serine-threonine protein kinases is a one of the main translational 
systems of the cell (e.g. mitogen activated protein kinase pathway, MAPK).[244] It is a 
signaling cascade that conveys information to effectors, translates signals and regulates 
the cellular answers phosphorylating or double-phosphorylating cytoplasmic components 
and nuclear transcription factors (see figure 10.10).[245] A cancer cell is characterized by a 
high metabolic degree that has to provide energy for mitosis and to react quickly against 
external and internal dangerous stimuli (e.g. reactive oxygen species ROS, inflammatory 
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stress). Monitoring these signaling systems provides useful information to understand 
better the cellular answer to anticancer drugs. Moreover, compounds that selectively 
interact especially with the MAPK cascade or related systems proved to be valuable as 
therapeutic agents in the control of malignant diseases.[246-248] 
 
 
 
Figure 10.10: schematic representation of signal translation 
 
Since the gold carbene complexes presented a different biological profile (e.g. enzyme 
inhibition, anti-mitochondrial effects), it was of interest to select some of them and screen 
their influence on the MAPK as well as on other important related signaling pathways (e.g. 
PI3K).[249] The signal pathways have been investigated with protein microarray 
technique.[250] With this method is possible to analyze simultaneously the expression of a 
wide number of proteins as well as their phosphorylation. A first antibody, specific for the 
phosphorylated or unphosphorylated target protein, is fixed directly on specific coated 
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slides used for the detection. The proteins are tagged with specific antigens, added to the 
slide where the specific sequence is recognized and the protein blotted on the antibody. 
Some following washing steps eliminate the non blot proteins from the slide and enable 
the effective treatment of the target protein with the secondary antibody. The detection is 
performed with a confocal high resolution microscope or scanner and analysis of the 
signal pattern by different multivariate statistical techniques. 
A protein enzyme-linked immunosorbent assay microarray (ELISA-microarray, see 
reference 251) investigation has been performed on breast adenocarcinoma cancer cells 
(MCF-7) treated with different concentrations of 2b and 2c at different time frames. The 
tested proteins belonged to the MAPK cascade, to the PI3K signaling pathway or work in 
concert with them and can be divided in three groups: movement and adhesion regulating, 
energy regulating and stress regulating. 
 
10.5.1 Movement and adhesion 
Two proteins have been monitored concentration and time dependently: proto-oncogene 
tyrosine-protein kinase (Src) and focal adhesion associated protein kinase (FAK) (see 
figure 10.11). FAK and Src are controlling the MAPKs mediated adhesion and migration 
capacity that in cancer cells regulates the metastasis.[252,253] 
Src is a protein which plays an important role in movement and proliferation and is 
correlated with the increase of invasiveness in cancer cells. Both gold(I) complexes did 
not show interactions with the exception of a small over-expression tendency of 2b after 6 
h of incubation.  
FAK is responsible for cell adhesion and migration. It plays also a role in the nucleus 
ERK-dependent cascade (see below) promoting cell survival. 2b promoted the under-
expression of FAK in a time and concentration dependent manner and presented a 
stronger interaction than 2c. The down-regulationphosphorylation of this protein can be 
associated to block of protein biosynthesis and alteration in the proliferation.[252] 
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Figure 10.11: microarray phosphorylation results of movement and adhesion regulating proteins in MCF-7 
cells incubated with 2b and 2c at different time frame and different concentrations; experiments performed by 
Pavlo Holenya at the University of Heidelberg 
 
10.5.2 Energy and proliferation 
Three proteins belonging to the cellular energy regulating signal pathway were monitored: 
5` adenosine monophosphate-activated protein kinase (AMPK), mammalian target of 
rapamycin (mTOR) and glycogen synthase kinase 3β (GSK-3β) (see figure 10.12).[254-256] 
AMPK plays a key role in cell energy homeostasis. It controls the fatty acid and 
cholesterol biosynthesis and glycogen oxidation. Stimulated by an increase of AMP, it is 
able to switch the cell from ATP consuming to ATP producing metabolism. The 
compounds depressed the phosphorylation of the target protein at concentrations below 
the IC50 values (related to the antiproliferative experiments, see chapter 8). At 
concentrations above the IC50 2c did not show any influence and 2b kept a mild 
depression of its phosphorylation. The dysregulation of the energy compensation 
mechanism is associated with a perturbation in the cell cycle. These events are rapidly 
initiated and are referred to as short-term regulatory processes. They can be observed 
just for treatment concentrations that do not produce severe cell damage, explaining the 
minor effects noticed for high concentration.[254] 
GSK-3β is a serine-threonine protein kinase with inhibiting function. It influences the 
activity of mTOR, the glycogen synthase pathway (together with AMPK) and it is 
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implicated in the cell response from damaged DNA. It regulates also the mitochondrial 
ERK fraction that prevents the protein transition pore (PTP) formation in mitochondria and 
apoptosis induction.[255] 2b and 2c influenced the level of phosphorylated GSK-3β after 12 
h of incubation. Noteworthly, 2b lowered drastically in a long-time incubation experiments 
the amount of pGSK-3β at a concentration of 2.0 µM. 
mTOR is a key protein that integrates the upstream signals (e.g. AMPK) and translates 
them into the nucleus to promote protein biosynthesis and proliferation.[256] 2b and 2c did 
not interact with the mTOR functionality with the exception of a marked enzyme 
phosphorylation after 6 h incubation with 2b (concentration dependent). 
 
 
 
 
Figure 10.12: microarray phosphorylation results of energy and lipid oxidation regulating proteins in MCF-7 
cells incubated with 2b and 2c at different time frame and different concentrations; experiments performed by 
Pavlo Holenya at the University of Heidelberg 
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10.5.3 Stress answer 
Four proteins involved in the homeostatic cellular response and programmed cell death 
regulation have been investigated: MAPK-ERK-kinase (MEK1/2) and extracellular signal 
regulated kinase (ERK1, ERK2) for the survival and proliferation mechanism (see figure 
10.13), heat shock protein 27 (Hsp27) and p38α mitogen protein activated kinase for the 
cellular stress answer (see figure 10.14).[246,257-259] 
ERK (type 1 and 2) is activated by inflammatory stress or pleiotropic effectors. Its 
activation plays an important role in the control of gene expression involved in the cell 
division cycle, apoptosis, cell differentiation, and cell migration. The mitochondrial form 
prevents cancer cells from death altering the PTP formation. 2b did not present relevant 
interaction on ERK-1 and ERK-2 with the exception of a mild increment in the 
phosphorylated forms with the highest concentration after 6 h of incubation. 2c influenced 
the two ERK investigated similarly. While at 0.5 µM it did not show relevant activity, for 
dose above the IC50 value already after 1 h of incubation the protein is drastically 
phosphorylated (more than 10 times fold). The results suggested that the cell tried to 
compensate the dangerous stimulus but this response has been defeated by the cytoxic 
action of the complex. The effect of the gold(I) NHC complexes on the MEK-ERK kinases 
are shown in figure 10.13. 
MEK1/2 kinase is a key protein with a central role in the MAPK pathway. It is activated by 
growth factors, Ca2+ level perturbation or inflammatory stress and mediates the activation 
of the ERK cascade leading to survival and proliferation response.[257] At 0.5 µM the 
gold(I) complexes stimulated its phosphorylation in a time dependent manner with effects 
more pronounced for 2b. At 2.0 µM 2c presented almost the same profile as for the low 
concentration used. 2b induced a strong increase in phosphorylation (≈275% of the 
control), followed by a time dependent decrease (≈10% of control).  
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Figure 10.13: microarray phosphorylation results of translational mechanism regulating proteins in MCF-7 
cells incubated with 2b and 2c at different time frame and different concentrations; experiments performed by 
Pavlo Holenya at the University of Heidelberg 
 
Hsp27 provides thermotolerance in vivo, cytoprotection and supports the cell survival 
under stress conditions. It also modulates the ROS production raising glutathione levels. 
Hsp27 interacts also with the outer layer of the mitochondrial membrane interfering with 
the apoptosome, inhibiting the release of cytochrome c, SMACs production and 
procaspase / caspase-3 cascade activation.[246] High phosphorylated protein levels are in 
inverse relation with cell proliferation, metastasis and resistance to chemotherapy. Cellular 
levels of phosphorylated Hsp27 were not modified by a 0.5 µM treatment with the gold(I) 
complexes. Just an increment of the pHsp27 has been observed after 12 h incubation. 
However, the compounds presented interesting effects at high dosage. 2b, at high 
concentration and after 6 h treatment, drastically increased the pHsp27 (~10 times fold 
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more than control) that was mainly reduced after 12 h. 2c induced an increment in the 
phosphorylation of target protein gradually in a time dependent manner reaching also 
extreme high values (~8 times fold more than control). The results suggested a failure in 
the compensation mechanism of Hsp27 relatively to 2b (antimitochondrial effects) and 
remarked the extreme stress induction caused by 2c (TrxR inhibition, ROS stimulation 
and apoptosis induction). 
p38α is the mayor regulator for inflammatory response. It is activated by many cellular 
stress factors including heat shock proteins, high osmotic stress, pro-inflammatory 
cytokines (such as IL-1 and TNF-α), DNA damage and ROS.[258] It is an essential effector 
of the programmed cell death pathway activation. It modulates Hsp27, GSK-3β, enhances 
the activity of ERK and down-regulates the proapoptotic protein Fas and Bax. Inhibition of 
p38α produces hyper-activation of proliferative stimuli. The gold(I) complexes presented a 
very different influence on the protein phosphorylation. Cells treated with 2b showed a 
drastic decrease of pp38α even after 1 h of incubation. In contrast 2c did not trigger strong 
effects. 
 
 
 
Figure 10.14: microarray phosphorylation results of cellular stress answer regulating proteins in MCF-7 cells 
incubated with 2b and 2c at different time frame and different concentrations; experiments performed by Pavlo 
Holenya at the University of Heidelberg 
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10.6 TrxR cellular expression 
The control of the expression of specific enzymes enables the cells to react against 
internal as well as external stress. Elevated ROS levels induce the biosynthesis of the 
components of the antioxidant network (see chapter 6). TrxR has a key role in 
preventing ROS damage regenerating Trx, GR and glutathione peroxidase (GPx) or 
acting directly inactivating dangerous small molecules. Due to its vital function TrxR is 
over-expressed in cancer cells. [262,263] A strong internal onset can increase the need of 
the enzymes involved in the cellular protection and stimulate their further over-
expression. The gold(I) NHCs demonstrated strong inhibitory activity towards TrxR. 
Thus, it was of interest to observe the modulation of the levels of TrxR by cancer cells. 
To monitor the proteins expression a technique called western blot is commonly used. 
Western blot is an immune-technique that through an electrophoretic separation 
enables the labeling of specific proteins and their detection. The cell lysate is firstly 
heated in order to denaturate the proteic fraction and loaded on an acrylamide gel. 
The proteins are electrophoretically separated and transferred on a spongy membrane 
to which is applied a first antibody that will recognize specific sequences of the target 
protein. After some washing steps the membrane is treated with a second antibody 
that recognizes the first antibody and is detectable through specific staining or 
chemiluminescence activation. In figure 10.15 a schematic representation of SDS-
PAGE / western blot procedure is depicted. 
Since the gold(I) phosphine derivatives are selective and strong TrxR inhibitors, it was 
of interest to study the expression of the target enzyme in cell lysates. MCF-7 cancer 
cells were treated with 3 µM concentration of selected gold(I) complexes and the TrxR 
expression was evaluated in a comparative manner by western blot analysis (see 
figure 10.16 and 10.17). 
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Figure 10.15: flow diagram of western blot experiment procedure 
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The electrophoresis showed the presence of marked bands in the range of 55-75 kDa, 
probably corresponding to the molecular weight of GR (55 kDa) and TrxR (55 - 65 
kDa). 
The western blot analysis indicated an influence of the compounds on the induction of 
TrxR. Interestingly, the control and complex 2f presented expression analogies while 
complex 2d and 2e induced a clear strong over-expression of the target enzyme. The 
results are in good agreement with the inhibition studies on the isolated enzyme (see 
chapter 6) that assessed the order of enzyme inhibition 2d = 2e > 2f. The results 
suggested a strong connection between the chemical properties (TEP, hindrance, 
lipophilicity, see chapter 3) of the phosphine moiety, the influence on TrxR and 
consequently the mode of action of the gold complexes.  
 
 
 
Figure 10.16: western blot analysis on MCF-7 cells treated 3 µM of complex 2d, 2e and 2f for 3 h at 
37°C / 5% CO2; TrxR2 analysis: semi-dry blot of the substances on a nitrocellose membrane, marked 
with monoclonal mouse anti-TrxR2 antibody / anti-mouse 2° antibody phosphatase and visualized with a 
CCD camera in chemiluminescence mode; Control = lysate of untreated cells 
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11. Synopsis 
 
A first series of chlorido N,N-disubstituted benzimidazol-2-ylidene gold(I) (1a – 4a) was 
successfully synthesized and analytically characterized (see figure 11.1). The drug design 
was based on the combination of NHC coordination potential and structural analogy with a 
potent bioactive gold complex (GoPI). 
 
 
 
Figure 11.1: gold(I) NHC complexes of the first series 
 
Key feature at the base of the drug design was the improvement of the stability of the gold 
compounds due to the carbene coordinative potential (in comparison with the more labile 
phosphine ligand, e.g. Auranofin) that enables trustable structure activity relationship 
(SAR) studies. Investigations on possible ligand exchange reactions at the carbene 
moiety under relevant biological conditions (high concentration of glutathione) confirmed 
the stability of the Au-NHC bond. Chlorido phosphine gold(I) derivatives (Auranofin, TEPG 
and TPPG), used as positive controls, displayed a characteristic two-step metabolization 
in presence of glutathione. It was indicated with NMR and MS ad hoc studies on TPPG 
that the first reaction, with the exchange of the chlorido ligand, is followed by a non 
enzymatic oxidation of the phosphine moiety. The results clearly attested the suitability of 
the gold(I) NHC complexes to perform reliable SARs in contrast with class of gold(I) 
phosphine complexes. 
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Studies on the inhibition of TrxR revealed a strong interaction between the complexes and 
the target enzyme. All the compounds strongly inhibited the activity of TrxR in situ in 
concentrations in the submicromolar range. The gold free N,N-diethyl-benzimidazolium 
iodide (2) did not show any activity up to the highest concentration tested (100 µM) 
attesting the importance of the gold atom to carry the activity. Studies on the inhibition of 
GR resulted in the minor interaction of 1a – 4a (in comparison with TrxR) with its active 
site containing a disulfide bridge (with IC50 values 20 - 75 fold higher than that for TrxR). 
The data clearly supported the hypothesis to inhibit selectively TrxR and its 
selenocysteine – cysteine pair, with a profile comparable to other gold(I) phosphine 
complexes (TEPG, TPPG), as described in the aim of the project (chapter 2). 
Unfortunately, the modification at the side chains of the benzimidazole core did not result 
in a difference in their activity. 
In vitro anti-proliferative experiments showed an interesting cytostatic potential of the new 
molecules. The complexes were effective against different cancer cell lines (breast 
cancer, coloncarcinoma, hepatocarcinoma), displaying IC50 values in the low micromolar 
range (4.6 – 14.9, with the exception of 4a probably due to solubility problems) well 
comparable with established anticancer drugs present on the market (e.g. Cisplatin). 
Unfortunately 1a – 4a did not demonstrate any selectivity in experiments with healthy and 
immortalized cell lines (HEK-293, HFF respectively). As observed in the enzymatic 
studies, the presence of the gold atom was a key feature to achieve activity (compound 2 
was not active up to 100 µM). 
Complex 2a was chosen for a more detailed biological investigation. As expected, the 
interaction with the components of the antioxidant network (TrxR, GR) induced a drastic 
increase in ROS already after 24 h treatment with 2a in a concentration dependent 
manner. At the same time frame, annexinV / PI experiments confirmed a high population 
of early and late apoptotic cells. For short time treatment (already after 2 - 3 h of 
incubation) an irreversible decrease in respiration rate was observed in living cell 
populations. The cells tried in vain to compensate the onset enhancing glycolysis as 
  
Page - 148 - 
 
 
Synopsis Riccardo Rubbiani, PhD Thesis 
demonstrated by BIONAS experiments on acidification rate. The failure of the cell 
compensative mechanisms and its homeostasis impairment was confirmed by the release 
of LDH, loss of DNA integrity and alteration of membrane functionality. Finally, 
experiments on doxorubicine, daunorubicine and vincristine resistant cell lines showed 
partial or significant overcoming of the resistance. Interestingly, all the biological effects 
were achieved with treatment concentration close to the IC50 value (for antiproliferative 
effects) of 2a. 
The hindrance and lipophilicity of the alkyl substituents at the nitrogens of the 
benzimidazole core, present in the first series, did not affect the overall activity of 1a – 4a. 
As a consequent and rational development of the project, it was of interest to study the 
alteration of the chemical environment of the gold center by replacing the chlorido ligand 
(second series of gold(I) NHCs). Two different ligands were chosen: a second NHC and a 
phosphine. The increase in coordination potential due to the backbonding and the overall 
positive charge of the designed molecules were expected to deeply influence the 
bioactivity. The two new gold(I) complexes were successfully synthesized and 
investigated in a comparative manner with the previous intensively tested 2a (see figure 
11.2). 
 
 
 
Figure 11.2: gold(I) NHC complexes of the second series 
 
DFT calculations for the binding between NHC-Au and the second ligand (-Cl, -NHC, -
PPh3) revealed different BDEs with an order of stability 2a < 2c < 2b. The complexes 
  
Page - 149 - 
 
 
Synopsis Riccardo Rubbiani, PhD Thesis 
presented a good stability profile in glutathione inactivation experiments with just a partial 
lability of 2c (due probably to oxidation of the phosphine residue). All the compounds 
showed an alteration in the UV profile after 2 – 4 h incubation in buffer solution, 
suggesting that a ligand exchange reaction in buffer medium could take place. Because 
many reports proved the binding of Auranofin with serum proteins and its impact on the 
complex pharmacodynamic, the interaction of 2a - 2c with bovine serum albumin has 
been investigated. Interestingly, the gold(I) NHC complexes demonstrated a different 
profile in close relation with the results obtained from the DFT calculations and presented 
the order of reactivity 2a > 2c >> 2b. Especially 2b showed just a really slight binding (< 
20%) up to 6 h while 2a and 2c after 2 h showed already 50 – 60% of the gold binding to 
BSA. 
In addition to the stability profile, also the TrxR inhibitory capacity was affected by the 
modification of the coordination sphere of the ligand. Complex 2a and 2c showed 
comparable effects with IC50 values in the submicromolar range. The TrxR inhibition of 2b 
soared to 4.89 µM. The high BDE of the Au-NHC bond in 2b depressed also the TrxR 
inhibition, for which a covalent binding modus between the gold atom and the 
selenocysteine is needed. 
MS investigation confirmed for all the complexes the formation of a covalent bond 
between the gold center and representative peptides. The incubation of the gold NHC 
complexes with a decamer peptide containing a selenocysteine and a peptide mimicking 
the active site of TrxR revealed as the main binding modus the formation of a NHC-Au-
Se-peptide or peptide-Sec-Au adducts. 
In accordance with their BDEs, the new complexes differently interacted with GR. 2c 
presented an inhibition profile and selectivity similar to 2a. It was not possible to determine 
an IC50 value for 2b (up to 100 µM, the highest concentration tested) against GR, which 
resulted to be the most selective compound synthesized. 
Since the presence of a selenocysteine showed to be a key feature for the selectivity of 
the gold(I) NHCs, the inhibition of 2a – 2c on GPx as another selenocysteine containing 
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enzyme involved in the antioxidant network has been investigated. Interestingly only 
complex 2a (presenting a lower BDE and higher activity in experiments with BSA) 
inhibited GPx, in the same range of concentration as GR. For complex 2b and 2c no 
inhibition was determined up to 100 µM. The data clearly demonstrated the importance of 
the ligands to achieve an overall selective inhibition of TrxR. 
Anti-proliferative studies in two different cancer cell lines assessed a ~ 5 - 10 times fold 
increase in activity for 2b and 2c, in comparison with the first series (1a – 4a), with IC50 
values in the submicromolar range. Interestingly, complex 2b demonstrated also a 
preference towards cancer cells in comparison with immortalized HEK-293 (3 - 8 times 
fold). Video microscopic imaging of MCF-7 cells treated with the gold(I) NHC complexes 
underlined a spread cell swelling for complex 2b and 2c while complex 2a showed just a 
sporadic reduction of biomass in comparison with the untreated control. These results 
were confirmed by irreversible effects on cell morphology observed with BIONAS 
instrumentation. All the results stand for the difference in anti-proliferative profile of the 
complexes: 2a showed cytostatic properties, 2b and 2c were more aggressive than the 
chloride derivative (2a) demonstrating a cytotoxic profile. 
The different antiproliferative properties between the complexes were related to the 
different chemical character of the molecules. The coordination of a neutral ligand, like a 
NHC or PPh3, to the gold(I) benzimidazol-2-ylidene core produced a cationic substance 
with a broad lipophilic system. Many reports assessed the capacity of lipophilic cations to 
better penetrate the cellular membranes (due to the enhancement effect caused by the 
inner / outer electrochemical gradient) than neutral substances and even to accumulate in 
specific compartments like mitochondria. Biodistribution studies were conducted in a 
HRCS–AAS. The experiments were performed with serum containing or serum free 
medium, in order to evaluate the impact of serum proteins for the uptake of the 
complexes. In experiments without FCS the gold complexes were taken up into the cell 
with an order 2a < 2b << 2c reaching a maximum already after 6 h. Experiments led with 
FCS clearly demonstrated the negative impact of the serum proteins interaction with the 
  
Page - 151 - 
 
 
Synopsis Riccardo Rubbiani, PhD Thesis 
complexes. With the exception of 2b, the gold uptake of 2a and 2c was reduced with 
stronger effect for the latter one. The uptake order, for experiment with serum free 
medium, was 2a < 2c < 2b indicating the key role of the chemical stability in good 
agreement with the BDEs and BSA interaction studies. As mentioned above, lipophilic 
cations can accumulate in organelles like mitochondria. Consequently, to complete the 
biodistribution profile the delivery of 2a – 2c into mitochondria was investigated. The order 
of accumulation was 2a < 2b << 2c with the complexes reaching a maximum already after 
4 – 6 h and highlighted the outstanding mitochondrial uptake of 2c. 
The uptake and lipophilic cationic character were at the base of the strong 
antimitochondrial profile shown by 2c and especially by 2b. The respiration rate of living 
cell population as well as oxygen consumption of isolated mitochondria was drastically 
reduced after short time incubation (less than 2 h). In particular 2b already at 0.1 µM 
totally depressed the oxygen consumption. This effect has been confirmed by 
experiments on the mitochondrial membrane potential. While 2a and 2c interacted at high 
concentration with the MMP, 2b already after short incubation time and low concentration 
drastically depolarized the mitochondrial membrane with increments of membrane 
permeability. 
Apoptosis was confirmed by annexinV / PI assay. Especially 2c showed a drastic increase 
(over 90%) of late apoptotic cells at concentration close to its IC50 value (relative to the 
antiproliferative studies). Experiments on cytochrome c release resulted negative, 
suggesting that the programmed cell death mechanism was cytochrome c - independent. 
Moreover, also microarray analysis on the key signaling pathways (e.g. MAPK, PI3K) 
remarked the possible different mode of action of 2b and 2c. The latter presented a 
classical TrxR inhibition profile with activation of stress compensatory mechanisms 
(Hsp27, MEK1/2 – ERK cascade) but insufficient to restore homeostasis. 2b showed a 
generalized influence on the different protein kinases, probably affecting the whole signal 
translation as confirmed by the proteomic studies. An extraordinary insight revealed the 
strong decrease in phosphorylation for the protein p38α by 2b. 
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The study on the second series of gold(I) NHC complexes (2a – 2c) clearly demonstrated 
how the pharmacodynamic pattern mainly was the consequence of several pathways 
related to the inhibition of TrxR but also the product of distinct effects against 
mitochondrial biochemistry as well as signaling pathway interaction not necessarily related 
to TrxR inhibition. The choice of a ligand instead of another deeply affected all the 
bioactivity as shown by the difference between neutral (2a) or cationic (2b and 2c) 
complexes or even between cationic molecules with different coordination potential (2b / 
2c). 
The combination of a NHC and a phosphine in 2c proved to be a good compromise 
between good TrxR inhibition, metabolic onset induction and cellular uptake. Moreover, 
the gold(I) phosphine class represents the most investigated category of anticancer gold 
complexes. Since chemical variation of the gold ligands resulted in biodistribution and 
bioactivity modulation, it was of interest to synthesize a third series of gold(I) NHCs with 
different phosphine residues. The criterium behind the rational drug design was to 
modulate the coordination potential maintaining a lipophilic cationic system and the 
flexibility of the phosphines (e.g. possible ligand exchange reaction). According with the 
TEP as a parameter of the strength of the Au-P bond (and consequently influencing even 
the Au-NHC bond), a third series of gold(I) NHC phosphine complexes was successfully 
synthesized and characterized (see figure 11.3). 
 
 
Figure 11.3: gold(I) NHC complexes of the third series (part I, phosphine variation) 
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All the new gold(I) NHC phosphines strongly inhibited the target enzyme TrxR with an 
improvement in reactivity of ~3 – 10 times fold in comparison with the previous series. 
Interestingly, the same increment could not be observed for the GR inhibition, resulting in 
a strong increase of selectivity (~80-100 times fold for 2d and 2e, ~40 time fold for 2f to ~4  
times fold for 2c). It was also possible to notice a representative size – inhibition 
correlation: the smaller the phosphine ligand, the better the TrxR inhibition (from ~30 nM 
for 2d and 2e, 113 nM of 2f to 660 nM of 2c). Unexpectedly, the data demonstrated the 
importance of the ligand to achieve not just a strong inhibition but even a remarkable 
selectivity for TrxR. 
The remarkable activity of the new complexes towards TrxR influenced the whole 
homeostasis and regulation of the target enzyme. Preliminary western blot experiments 
on the expression of TrxR suggested a marked over-expression of the enzyme for 
treatment with 2d and 2e (with lower IC50 values, related to the enzyme inhibition studies) 
while for 2f the intensity of the band was comparable to the control. 
Anti-proliferative experiments assessed IC50 values for all the complexes in the high 
nanomolar range, in good correlation with the second series (2b – 2c). The incoherence 
between the enzyme inhibition and the cytotoxic experiments was explained with the 
cellular uptake. Biodistribution experiments demonstrated how the phosphine hindrance 
and its lipophilicity influenced the accumulation. The smaller the phosphine ligand was the 
lower was the uptake into the cells. 
Finally, it was of interest to study the influence of the donor properties of the carbene core 
through its modification. The addition of an electron-donor group at position 5 of the 
benzimidazol-2-ylidene scaffold affected the coordination potential of the NHC ligand to 
the gold atom. Triethylphopshine and triphenylphosphine were chosen as examples of a 
small residue at the phosphorus or a hindered P-ligand and the new complexes were 
successfully synthesized and characterized (see figure 11.4). 
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Figure 11.4: gold(I) NHC complexes of the third series (carbene variation) 
 
The alteration of the donor properties of the carbene deeply influenced the TrxR inhibition. 
For the triethylphosphine derivative (5e) the modification at the benzimidazol-2-ylidene 
scaffold slightly improved to ~2 times fold the already outstanding activity of its 
unsubstituted phosphine derivative (31 nM for 2e and 19 nM for 5e). Also the selectivity 
for TrxR increased from ~80 times fold of the analogous 2e to ~100 times fold for 5e, 
making it the most potent TrxR inhibitor of all the series. The electron donor effect in the 
triphenyl phosphine derivative 5c did not significantly affect the inhibitory potential of the 
molecule in comparison with its unsubstituted analogous 2c. However, similarly to 5e the 
selectivity of the compound was increased from ~4 times fold for 2c to ~26 times fold for 
5c. 
All the modified NHC gold complexes demonstrated valuable antiprolifertive properties 
against HT-29 and especially MCF-7 cancer cell lines with IC50 values in the micromolar / 
submicromolar range. Cytotoxic activities followed the enzymatic trend, reaching the most 
potent value of all the complexes series synthesized (0.11 µM against MCF-7 for 5e). The 
data strongly suggested that an electron donor moiety on the NHC backbone influences 
deeply the bioactivity, increases the enzyme inhibition and the selectivity towards TrxR as 
well as the antiproliferative properties. 
Summarizing all, the here presented PhD thesis dealt with the therapeutical potential of 
gold(I) carbene complexes. The synthesis and full characterization of different compounds 
was successfully performed. A rational modus operandi stimulated all the further drug 
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designs. An intensive biological investigation highlighted the great potential of gold NHCs 
as anticancer agents. Features like TrxR inhibition, apoptosis induction, ROS stimulation, 
mitochondria metabolism interactions, uptake and anti-proliferative properties were 
successfully related to the chemical properties. The gold center carried the activity and it 
is at the base of the whole pharmacodynamic behavior of the complexes. Nevertheless, 
its chemical environment modulated the bioactivity profile. All the bioinvestigations 
presented here concurred to disclose the action mechanism of gold based therapeutics. It 
could be concluded that gold(I) NHC complexes represent a very interesting class of 
compounds and a possible alternative treatment to the classical platinum based therapy. 
Further, this study provided important evidence on their easy functionalization that 
enabled to investigate different SARs resulting in different bioactivity and stimulated the 
scientific research in the still niche-field of bioinorganic chemistry. 
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12. Materials and Methods 
 
12.1 General 
 
All the reagents and the solvents for synthetic purposes were used as received from 
Sigma Aldrich, Acros Organic, Fluka ChemPur, Invitrogen, Acrys or other suppliers. 
Reagents, standards and compounds were weighted on a Sartorius CPA225D. 1H-NMR, 
13C-NMR and 31P-NMR were recorded on a Bruker DRX-400 AS NMR System, MS 
spectra were recorded on a Finnigan MAT 4515 (Thermo Electron Corp.). Elemental 
analysis was performed with a Flash EA112, Thermo Quest Italia (for all compounds 
undergoing biological evaluation the experimental values differed less than 0.5% from the 
calculated ones.). UV measurements were performed on a Specord 200 (Analytik Jena). 
pH was assessed with a SevenEasy pH-meter (Mettler-Toledo). Sterilization was obtained 
in a LTA 2x3x4 autoclave (Zyrbus Technologies). Proper solubilization of lysates or 
complexes was achived through a Vortex Genie2 (ScientificIndustries) or an Ultrasonic 
Cleaner (VWR). 
MCF-7 breast adenocarcinoma, HT-29 colon carcinoma, HCT-116 coloncarcinoma, HEP-
G2 hepato carcinoma and HEK-293 human embryonic kidney healthy cells were 
maintained in DMEM High Glucose (PAA laboratories GmbH), supplemented with 50 mg / 
L gentamycin (US-Biological) and 10% (V/V) fetal calf serum (FCS, Biochrom AG) prior to 
use. Jurkat cells were cultured in RPMI 1640 supplemented with 10% (V/V) FCS. Purity of 
≥ 95% of all synthesized compounds was confirmed by elemental analysis. All the cells 
were cultured in a Binder Incubator (Binder) or in a HeraCell240i CO2 incubator 
(ThermoScientific). Experiments on cell under sterile conditions were led under a 
HeraSafeKS (ThermoScientific). Short and unsterile incubations were performed in a 
Vortemp56 (Labnet) or in a Inculine (VWR). 
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Cells were counted with a on C-Chip Neubauer Improve counting chamber (Biochrom AG) 
an optical microscope (Motic®) and videoimaging files recorded with EVOSxl microscope 
(AMG). Two plate shakers were used: a linear Titramax 1000 (Heidolph) and an orbital 
shaker PS-M3D (Grant-Bio). 
Electrophoretic runs were performed on a MP-300V (Biozym) in a standard mini-
electrophoresis chamber (BioStep). Western Blot analysises were led with iBlot semidry 
blotting system (Invitrogen) and the visualized with a CCD camera (Fusion Fx7, PeqLab). 
All the photometric experiments (enzyme inhibitions, antiproliferative assay, protein 
quantification through Bradford method) were performed in a microplate reader (Victor x4, 
PerkinElmer). 
Pellets for lysates or AAS analysis were obtained with two centrifuges: CompactStarCS4 
(VWR) and CT15RE HIMAC (VWR). AAS analyses were performed in a high resolution 
continuum source electrothermal atomic absorption spectrometer (ContrAA 700, Analytik 
Jena). 
 
12.2 Synthesis 
 
12.2.1 General Procedure for Synthesis of the Benzimidazolium Halide Salts 
Benzimidazole (1.0 mmol), 5-methoxybenzimidazole (1.0 mmol), the respective alkyl 
halogenide (3.0 mmol) and K2CO3 or Na2CO3 (1.0 mmol) were heated under reflux 
conditions in acetonitrile or toluene for 8 - 24 h. The solvent of the resulting suspension 
was removed under reduced pressure, and the residue was resuspended in 
dichloromethane and filtered to remove the formed potassium or sodium halogenide. The 
filtrate was evaporated under reduced pressure, the residue was resuspended in 
tetrahydrofuran or ethylacetate to remove the excess of halogenide and filtered to give the 
pure product. 
  
Page - 158 - 
 
 
Material and methods Riccardo Rubbiani, PhD Thesis 
 
 
Figure 12.1: position number at the benzimidazole scaffold for the 1,3-dialkylbenzimidazolium halides 
 
1,3-Dimethylbenzimidazolium iodide (1) 
Benzimidazole (0.118 g, 1.0 mmol) was dissolved in acetonitrile and reacted with methyl 
iodide (0.187 mL, 3.0 mmol) under reflux condition for 8 h in presence of K2CO3 (0.138 g, 
1.0 mmol); yield: 0.238 g (0.8 mmol, 87%); white powder; mp 217 °C; 1H NMR (DMSO-
d6): (ppm) 4.08 (s, 6H, CH3), 7.71 (dd, 2H, 
4J = 3.2 Hz, 3J = 6.3 Hz, ArH4/7), 8.02 (dd, 2H, 
4J = 3.2 Hz, 3J = 6.3 Hz, ArH5/6), 9.64 (s, 1H, NHC); elemental analysis for C9H11N2I (% 
calculated/found): C (39.44/39.04), H (4.05/4.54), N (10.22/10.00). 
 
 
 
1,3-Diethylbenzimidazolium iodide (2) 
Benzimidazole (0.118 g, 1.0 mmol) was dissolved in acetonitrile and reacted with ethyl 
iodide (0.241 mL, 3.0 mmol) under reflux condition for 8 h in presence of K2CO3 (0.138 g, 
1.0 mmol); yield: 0.272 g (0.9 mmol, 90%); white powder; mp 240 °C; 1H NMR (DMSO-
d6): (ppm) 1.55 (t, 6H, J = 9.7 Hz, CH3), 4.52 (q, 4H, J = 9.7 Hz, CH2), 7.68 (dd, 2H, 
4J = 
4.2 Hz, 3J = 8.4 Hz, ArH4/7), 8.10 (dd, 2H, 
4J = 4.2 Hz, 3J = 8.4 Hz, ArH5/6), 9.8 (s, 1H, 
NHC); 13C NMR (DMSO-d6): (ppm) 14.1 (CH3) 42.0 (CH2) 113 (ArC3a/7a) 126 (ArC4) 130 
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(ArC5) 141 (NHC); elemental analysis for C11H15N2I (% calculated/found): C (43.73/43.80), 
H (5.00/5.02), N (9.27/9.13). 
 
 
1,3-Dibenzylbenzimidazolium bromide (3) 
Benzimidazole (0.118 g, 1.0 mmol) was dissolved in acetonitrile and reacted with benzyl 
bromide (0.357 mL, 3.0 mmol) under reflux condition for 8 h in presence of K2CO3 (0.138 
g, 1.0 mmol); yield: 0.323 g (0.8 mmol, 76%); white powder; mp 150 °C; 1H NMR (DMSO-
d6): (ppm) 5.81 (s, 4H, CH2), 7.46 (m, 10H, ArH), 7.64 (dd, 2H, 
4J = 3.1 Hz, 3J = 6.3 Hz, 
ArH4/7), 7.98 (dd, 2H, 
4J = 3.2 Hz, 3J = 6.3 Hz, ArH5/6), 10.12 (s, 1H, NHC); elemental 
analysis for C21H19N2Br (% calculated/found): C (66.30/65.41),H(5.26/5.20),N (7.36/6.79).  
 
 
 
1,3-Bis-(diphenylmethyl)benzimidazolium chloride (4) 
Benzimidazole (0.118 g, 1.0 mmol) was dissolved in acetonitrile and reacted with 
diphenyl-methyl chloride (0.608 g, 3.0 mmol) under reflux condition for 8 h in presence of 
K2CO3 (0.138 g, 1.0 mmol); yield: 0.462 g (0.8 mmol, 80%); white powder; mp 254 °C; 
1H 
NMR (CDCl3): (ppm) 7.45 (m, 24H, ArH), 7.82 (s, 2H, CH), 10.68 (s, 1H, NHC); elemental 
analysis for C33H27N2Cl (% calculated/found): C (81.48/80.99), H (5.55/5.54), N 
(5.76/5.60). 
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1,3-Diethyl-5-methoxy-benzylimidazolium iodide (5)  
5-Methoxy-benzimidazole (0.74 g, 5.0 mmol) was dissolved in toluene and reacted with 
ethyl iodide (1.2 ml, 15.0 mmol) in presence of Na2CO3 (0.53 g, 5.0 mmol) for 24 h in 
reflux under vigorous stirring. The solvent of the resulting suspension was removed under 
reduced pressure, and the residue was resuspended in dichloromethane and filtered to 
remove the sodium bicarbonate. The filtrate was evaporated under reduced pressure, the 
residue was resuspended in tetrahydrofuran and filtered to give the pure product. Yield: 
1.23 g (3.7 mmol, 74%) brown powder; 1H NMR (DMSO-d6): (ppm) 1.54 (m, 6H, CH3), 
3.92 (s, 3H, OCH3), 4.48 (m, 4H, CH2), 7.28 (dd, 1H, 
3J = 9.1 Hz, 4J = 2.4 Hz, ArH6), 7.61 
(d, 1H, 4J = 2.4 Hz, ArH4), 7.97 (d, 1H, 
3J = 9.1 Hz, ArH7), 9.68 (s, 1H, ArH2); 
13C NMR 
(DMSO-d6): (ppm) 14.2 (CH3), 42.0 (CH2), 56.3 (OCH3), 96.0 (ArC), 114.4 (ArC), 116.4 
(ArC), 125.2 (ArC), 132.1 (ArC), 140.6 (ArC2), 158.6 (ArC5); elemental analysis for 
C10H13N2O·I (% calculated/found): C (43.39/43.55) H (5.16/5.20) N (8.43/8.41). 
 
 
 
12.2.2 General Procedure for Synthesis of the Gold NHC Complexes  
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Series I 
To achieve the chloride derivatives (1a – 4a) the respective benzimidazolium salts (1.0 
mmol) were treated with Ag2O (0.5 mmol) under vigorous stirring in dichloromethane for 5 
- 8 h. After the color change, dimethylsulfidegold(I) (1.0 mmol) was added and the 
reaction was stirred for another 10 h. The obtained suspension was filtered over Celite 
(281 nm), and the solvent was evaporated under reduced pressure to give the pure 
products. 
 
 
 
Figure 12.2: position number at the benzimidazole scaffold for the 1,3-dialkylbenzimidazol-2-ylidene gold(I) 
complexes 
 
Chlorido-(1,3-dimethylbenzimidazol-2-ylidene)gold(I) (1a) 
Dimethyl-benzimidazolium iodide (0.274 g, 1.0 mmol) was dissolved in dichloromethane 
and reacted with Ag2O (0.116 g, 0.5 mmol) 5 h in reflux under vigorous stirring in the dark 
till color change then C2H6AuClS (0.295 g, 1.0 mmol) was added and the reaction 
additionally stirred for another 10 h. The product was purified under Celite column; yield: 
0.095 g (0.3 mmol, 25%) yellow powder. 1H NMR (CDCl3): (ppm) 3.99 (s, 6H, CH3), 7.46 
(m, 4H, ArH); MS (EI): 378 [M+H]+; elemental analysis for C9H10AuClN2 (% 
calculated/found): C (28.55/28.56), H (2.60/2.69), N (7.40/6.98). 
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Chlorido-(1,3-diethylbenzimidazol-2-ylidene)gold(I) (2a) 
1,3-Diethyl-benzimidazolium iodide (0.302 g, 1.0 mmol) was dissolved in dichloromethane 
and reacted with Ag2O (0.116 g, 0.5 mmol) 5 h in reflux under vigorous stirring in the dark 
till color change then C2H6AuClS (0.295 g, 1.0 mmol) was added and the reaction 
additionally stirred for another 10 h. The product was purified under Celite column; yield: 
0.122 g (0.3 mmol, 30%) pale-yellow powder. 1H NMR (CDCl3): (ppm) 1.55 (t, 6H, J = 5.9 
Hz, CH3), 4.54 (q, 4H, J = 9.8 Hz, CH2), 7.46 (m, 4H, ArH); 
13C NMR (CDCl3): (ppm) 15.4 
(CH3), 43.9 (CH2), 111 (ArC8), 124 (ArC4), 132 (ArC5), 177 (NHC); MS(EI) 406 [M+H]
+; 
elemental analysis for C11H14AuClN2 (% calculated/found): C (32.49/32.03), H (3.47/3.38), 
N (6.89/6.91). 
 
 
Chlorido-(1,3-dibenzylbenzimidazol-2-ylidene)gold(I) (3a) 
1,3-Dibenzyl-benzimidazolium bromide (0.379 g, 1.0 mmol) was dissolved in 
dichloromethane and reacted with Ag2O (0.116 g, 0.5 mmol) 5 h in reflux under vigorous 
stirring in the dark till color change then C2H6AuClS (0.295 g, 1.0 mmol) was added and 
the reaction additionally stirred for another 10 h. The product was purified under Celite 
column; yield: 0.265 g (0.5 mmol, 50%) white powder; 1H NMR (CDCl3): (ppm) 5.76 (s, 
4H, CH2), 7.35 (m, 14H, ArH). MS (EI): 530 [M-H]
+; elemental analysis for C21H18AuClN2 
(% calculated/found): C (47.52/47.72), H (3.42/3.58), N (5.28/5.25). 
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Chlorido-[1,3-bis-(diphenylmethyl)benzimidazol-2-ylidene]gold-(I) (4a) 
1,3-Bis-diphenylmethyl-benzimidazolium chloride (0.487 g, 1.0 mmol) was dissolved in 
dichloromethane and reacted with Ag2O (0.116 g, 0.5 mmol) 5 h in reflux under vigorous 
stirring in the dark till color change then C2H6AuClS (0.295 g, 1.0 mmol) was added and 
the reaction additionally stirred for another 10 h. The product was purified under Celite 
column; yield: 0.375 g (0.6 mmol, 55%); white powder; 1H NMR (CDCl3): (ppm) 7.05 (dd, 
2H, 4J = 3.5 Hz, 3J = 6.5 Hz, ArH4/7), 7.36 (m, 22H, ArH), 7.89 (s, 2H, CH); MS (EI) 682 
[M+H]+; elemental analysis for C33H26AuClN2 (% calculated/found): C (58.03/57.75), H 
(3.84/3.87), N (4.10/3.87). 
 
 
Series II 
To achieve the dicarbene derivative (2b) the opportune salts (1.0 mmol) was dissolved in 
dichloromethane methanol (1 : 1) in presence of a K2CO3 (1.0 mmol) and reacted with the 
relative gold(I) chloride complex (2a) under vigorous stirring till the disappearing of the 
color and stirred for other 12 h. The solution was filtered to remove the K2CO3, evaporate 
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under reduced pressure and purified through column chromatography (silica column, 
eluent dichloromethane / methanol 97.5 / 2.5 %). 
 
[Bis-(1,3-diethylbenzylimidazol-2-ylidene)]gold(I) iodide (2b) 
Diethylbenzimidazolium iodide (0.151 g, 0.5 mmol) was dissolved in dichloromethane 
methanol (1 : 1) in presence of K2CO3 (0.069 g, 0.5 mmol), reacted with complex 2a 
(0.203 g, 0.5 mmol) till color change and stirred for another 12 h. The carbonate was 
filtered off and the solvent removed under reduced pressure. The formed product was 
isolated by column chromatography (eluent: dichloromethane / methanol 97.5 / 2.5); yield: 
0.202 g (0.3 mmol, 43%) white powder; 1H NMR (CDCl3): (ppm) 1.69 (t, 12H, J = 9.7 Hz, 
CH3), 4.72 (q, 8H, J = 9.7 Hz, CH2), 7.46 (dd, 4H, 
4J = 4.4 Hz, 3J = 8.2 Hz, ArH4/7), 7.58 
(dd, 4H, 4J = 4.4 Hz, 3J = 8.2 Hz, ArH5/6), 
13C NMR (CDCl3): (ppm) 16.0 (CH3), 44.2 (CH2), 
111.6 (ArC3a/7a), 124.6 (ArC4), 133.1 (ArC5), 190.3 (NHC); MS(EI): 498 [M-NHC]
+, 
MS(ESI): 672 [M]+, 545 [M-I]-, elemental analysis for C22H28AuN4I (%calculated/found): C 
(39.18/39.08) H (4.48/4.22) N (8.31/8.06). 
 
 
[Triphenylphosphine-(1,3-diethylbenzylimidazol-2-ylidene)]gold(I) iodide (2c) 
Diethylbenzimidazolium iodide (0.151 g, 0.5 mmol) was dissolved in dichloromethane 
methanol (1 : 1) in presence of K2CO3 (0.069 g, 0.5 mmol), reacted with complex triphenyl 
phosphine gold(I) chloride (0.275 g, 0.5 mmol) till color change and stirred for another 8 - 
10 h. The carbonate was filtered off and the solvent removed under reduced pressure. 
The substance was purified through liquid / liquid extraction with dichloromethane / water 
and the organic solvent was afterwards evaporated to give the pure product; yield: 0.228 g 
(0.3 mmol, 58%) white powder; 1H NMR (CDCl3): (ppm) 1.68 (t, 6H, 
3J = 9.7 Hz, CH3), 
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4.71 (q, 4H, 3J = 9.7 Hz, CH2), 7.52 (m, 19H, ArH), 
13C NMR (CDCl3): (ppm) 16.0 (CH3), 
44.2 (CH2), 111.6 (ArC8), 124.7 (ArC4), 128.8 (PArC1), 128.9 (PArC2), 130.6 (ArC5), 134.0 
(PArC3), 134.1 (PArC4), 190.2 (NHC), 
31P NMR: (ppm) 32.5; MS (EI): 586 [M-NHC] +, 498 
[M-PPh3]
+, MS (FAB): 760 [M]+; elemental analysis for C29H29AuN2PI (% calculated/found): 
C (45.75/46.24) H (3.97/3.83) N (3.68/3.56). 
 
 
Series III 
To achieve the gold phosphine complexes (2c – 2f, 5c, 5e) the opportune 
benzimizadolium salt was dissolved in dichloromethane methanol (1 : 1) in presence of a 
Na2CO3 (1.0 mmol), heated at 50 °C for 15 minutes and then reacted with the relative tri-
alkyl-phosphine gold(I) chloride (1.0 mmol) under vigorous stirring for 8 - 60 h. The 
solution was filtered to remove the K2CO3, evaporated under reduced pressure and 
purified through column chromatography (silica column, eluent dichloromethane / 
methanol 97.5 / 2.5 %) or washed with bidistilled water, redissolved in dichloromethane, 
treated with Na2SO4 for 2 h and the solvent evaporate under reduced pressure. 
 
[Trimethylphosphine-(1,3-diethylbenzylimidazol-2-ylidene)]gold(I) iodide (2d)  
1,3-Diethylbenzimidazolium iodide (0.060 g, 0.2 mmol) was dissolved in dichloromethane 
in presence of Na2CO3 (0.021 g, 0.2 mmol), heated 10 minutes at 50°C and reacted with 
trimethylphosphine gold(I) chloride (0.062 g, 0.2 mmol) under vigorous stirring for 60 h. 
The Na2CO3 was filtered off and the complex was purified through liquid / liquid extraction 
with dichloromethane / water, the organic solvent was afterwards evaporated and 
recrystallized in dichloromethane / hexane to give the pure product; yield: 0.057 g (0.1 
mmol, 49%) white powder; 1H NMR (CDCl3): (ppm) 1.67 (br, 15H, PCH3 / CH3), 4.71 (q, 
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4H, J = 7.32 Hz, CH2), 7.48 (dd, 2H, 
4J = 3.1 Hz, 3J = 6.2 Hz, ArH4/7), 7.60 (dd, 2H, 
4J = 
3.1 Hz, 3J = 6.2 Hz, ArH5/6); 
13C NMR (CDCl3): (ppm) 16.0 (PCH3 / CH3), 44.2 (CH2), 111.6 
(ArC3a/7a), 124.8 (ArC5/6), 133.0 (ArC4/7), 189.9 (NHC); 
31P NMR (CDCl3): (ppm) 39.3; MS 
(ESI): 574 [M-I]+; m.p. 196°C; elemental analysis for C14H23AuN2P·I (% calculated/found): 
C (29.28/29.66) H (4.04/4.06) N (4.88/5.00). 
 
 
[Triethylphosphine-(1,3-diethylbenzylimidazol-2-ylidene)]gold(I) iodide (2e)  
1,3-Diethylbenzimidazolium iodide (0.060 g, 0.2 mmol) was dissolved in dichloromethane 
in presence of Na2CO3 (0.021 g, 0.2 mmol), heated 10 minutes at 50°C and reacted with 
triethylphosphine gold(I) chloride (0.070 g, 0.2 mmol) under vigorous stirring for 60 h. The 
Na2CO3 was filtered off and the complex was purified through liquid / liquid extraction with 
dichloromethane / water, the organic solvent was afterwards evaporated and 
recrystallized in dichloromethane / hexane to give the pure product; yield: 0.073 g (0.1 
mmol, 59%); white powder; 1H NMR (CDCl3): (ppm) 1.21 (br, 9H, PCH3), 1.65 (t, 6H, J = 
7.36 Hz, CH3), 1.87 (br, 6H, PCH2), 4.72 (q, 4H, J = 7.32 Hz, CH2), 7.48 (dd, 2H, 
4J = 3.1 
Hz, 3J = 6.2 Hz, ArH4/7), 7.57 (dd, 2H, 
4J = 3.1 Hz, 3J = 6.2 Hz, ArH5/6); 
13C NMR (CDCl3): 
(ppm) 8.9 (PCH3), 15.6 (CH3), 17.8 (PCH2), 44.2 (CH2), 111.6 (ArC3a/7a), 124.7 (ArC4), 
133.1 (ArC5), 190.3 (NHC); 
31P NMR (CDCl3): (ppm) 39.4; MS (EI): 489 [M-I]
+; m.p. 215°C; 
elemental analysis for C17H29AuN2P·I (% calculated/found): C (33.13/33.44) H (4.74/4.61) 
N (4.55/4.29). 
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[Triisopropylphosphine-(1,3-diethylbenzylimidazol-2-ylidene)]gold(I) iodide (2f)  
1,3-Diethylbenzimidazolium iodide (0.060 g, 0.2 mmol) was dissolved in dichloromethane 
in presence of Na2CO3 (0.021 g, 0.2 mmol), heated 10 minutes at 50°C and reacted with 
triisopropylphosphine gold(I) chloride (0.078 g, 0.2 mmol) under vigorous stirring for 60 h. 
The Na2CO3 was filtered off and the complex was purified through liquid / liquid extraction 
with dichloromethane / water, the organic solvent was afterwards evaporated and 
recrystalized in dichloromethane / hexane to give the pure product; yield: 0.071 g (0.1 
mmol, 54%) white powder; 1H NMR (CDCl3): (ppm) 1.34 (br, 18H, PCH3), 1.67 (t, 6H, J = 
7.36 Hz, CH3), 2.62 (br, 3H, PCH), 4.71 (q, 4H, J = 7.32 Hz, CH2), 7.49 (dd, 2H,
 4J = 3.1 
Hz 3J = 6.2 Hz, ArH4/7), 7.59 (dd, 2H,
 4J = 3.1 Hz 3J = 6.2 Hz, ArH5/6);
 13C NMR (CDCl3): 
(ppm) 16.0 (CH3), 20.3 (PCH3), 20.6 (PCH), 44.2 (CH2), 111.6 (ArC3a/7a), 124.7 (ArC4), 
133.0 (ArC5), 192.6 (NHC); 
31P NMR (CDCl3): (ppm) 66.0; MS (ESI): 531 [M-I]
+; m.p. 
174°C; elemental analysis for C20H35AuN2P·I (% calculated/found): C (36.49/36.66) H 
(5.36/5.42) N (4.26/4.48). 
 
 
[Triethylphosphine-(1,3-diethyl-5-methoxy-benzylimidazol-2-ylidene)]gold(I) iodide (5e)  
1,3-Diethyl-5-methoxy-benzimidazolium iodide (0.066 g, 0.2 mmol) was dissolved in 
dichloromethane in presence of Na2CO3 (0.021 g, 0.2 mmol), heated 10 minutes at 50°C 
and reacted with triethylphosphine gold(I) chloride (0.070 g, 0.2 mmol) under vigorous 
stirring for 60 h. The Na2CO3 was filtered off and the complex was purified through liquid / 
liquid extraction with dichloromethane / water, the organic solvent was afterwards 
evaporated and recrystalized in dichloromethane / hexane to give the pure product; 
yield: 0.098 g (0.2 mmol, 76%) brown powder; 1H NMR (CDCl3): (ppm) 1.21 (br, 9H, 
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PCH3), 1.64 (m, 6H, CH3), 1.99 (br, 6H, PCH2), 3.95 (s, 3H, OCH3), 4.63 (q, 4H, J = 7.32 
Hz, CH2), 7.08 (dd, 1H, 
4J = 3.1 Hz, 3J = 6.2 Hz, ArH5), 7.09 (d, 1H, 
3J = 2.36 Hz, ArH4), 
7.46 (d, 1H, 3J = 9.08 Hz, ArH7); 
13C NMR (CDCl3): (ppm) 8.9 (PCH3), 16.0 (d, CH3), 17.8 
(PCH2), 44.2 (d, CH2), 56.4 (OCH3), 95.1 (ArC6), 112.2 (ArC), 114.1 (ArC), 127.4 (ArC4), 
134.1 (ArC5), 158.1 (ArC7), 189.3 (NHC); 
31P NMR: (ppm) 39.4; MS (ESI): 519 [M+-I]+; 
m.p. 210°C; elemental analysis for C18H31AuN2OP·I (%calc./found): C (33.45/33.33) H 
(4.83/4.76) N (4.33/4.02). 
 
 
 
[Triphenylphosphine-(1,3-diethyl-5-methoxy-benzylimidazol-2-ylidene)]gold(I) iodide (5c)  
1,3-Diethyl-5-methoxy-benzimidazolium iodide (0.066 g, 0.2 mmol) was dissolved in 
dichloromethane in presence of Na2CO3 (0.021 g, 0.2 mmol), heated 10 minutes at 50°C 
and reacted with chloridotriphenylphosphane gold(I) (0.099 g, 0.2 mmol) under vigorous 
stirring for 60 h. The solution was filtered to remove the Na2CO3, evaporated under 
reduced pressure and purified through column chromatography (silica column, eluent 
dichloromethane / methanol 97.5 / 2.5 %). Yield: 0.093 g (0.11 mmol, 59%) brown 
powder; 1H NMR (CDCl3): (ppm) 1.64 (m, 6H, CH3), 3.95 (s, 3H, OCH3), 4.60 (q, 2H, 
3J = 
7.3 Hz, CH2), 4.66 (q, 2H, 
3J = 7.3 Hz, CH2), 7.45 (m, 18H, ArH); 
13C NMR (CDCl3): (ppm) 
16.0 (CH3), 44.2 (CH2), 56.5 (OCH3), 95.1 (ArC), 112.2 (ArC), 114.2 (ArC), 127.3 (ArC), 
128.8 (d, PArC1’), 130.6 (d, PArC2’), 132.2 (d, PArC3’),133.9 (ArC), 134.1 (d, PArC4’), 158.1 
(ArC5), 190.2 (ArC2); 
31P NMR (CDCl3): (ppm) 32.9; MS (ESI): 663 [M-I]
+; m.p. 202°C; 
elemental analysis for C30H31AuN2OP·I (%calc./found): C (45.59/45.87) H (3.95/4.02) N 
(3.54/3.81). 
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12.3 Computational chemistry[145] 
 
Computational chemical studies on GoPI and TrxR active site were performed by Prof. Dr. 
Gerard Wolber, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Strasse 2þ4, 
14195 Berlin, Germany 
 
The X-ray structure of GR complexed with the GoPI residue 2-(2-phenyl-3-pyridin-2-yl-
4,5,6,7-tetrahydro-2H-isophosphoindol-1-yl)pyridine (PDB entry 1AAQ) was used and 
derived a 3D pharmacophore using the software LigandScout 3.0. LigandScout identified 
lipophilic contacts to Leu261, Leu183, and Ile175, which served as a basis for 
assumptions leading to the new compounds presented in this work. The 3D overlay of 
TrxR (2CFY) and GR (2AAQ) was performed using the molecular modeling package MOE 
(Molecular Operating Environment, version 2009.10, Chemical Computing Group, 
Montreal, Canada) and is based on a sequence alignment of the two proteins with a 
subsequent 3D overlay. 
 
12.4 DFT Calculations[153] 
 
DFT calculation were performed by Dr. Malte Kokoschka from the research group of Prof. 
Dr. William S. Sheldrick, Lehrstuhl für Analytische Chemie, Ruhr-Universität Bochum, 
44780 Bochum, Germany 
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All calculations were performed using Gaussian 03 (Rev. E.01). Density functional theory 
(B3LYP) has been employed for all geometry and energy calculations. Geometries and 
zero point corrections were calculated using the Stuttgart RSC 1997 ECP (SDD) basis set 
on Au and the 6-31G(d) basis set on all other atoms. An ultragrid had to be employed for 
PPh3 containing molecules to reach convergence. For the calculation of energies the 
diffuse basis sets aug-cc-pVDZ-PP on Au and aug-cc-pVDZ on all other atoms were used. 
The basis sets Stuttgart RSC 1997 ECP, aug-cc-pVDZ and aug-cc-pVDZ-PP have been 
obtained via the EMSL website Basis Set Exchange. The final energy values were 
corrected for the basis set superposition error using the counterpoise method according to 
Boys and Bernardi. To account for solvent effects the polarizable continuum model (IEF-
PCM) was employed with ε=78.39 for water.[159-162] All Illustrations of molecular structures 
obtained from ab-initio calculations were prepared using Chemcraft. 
 
12.5 Stability experiments 
 
12.5.1 Stability in buffer solution 
Stock solutions of 2a – 2c were prepared in acetonitrile and diluted with phosphate 
buffered saline (8.0 g NaCl, 1.0 g Na2HPO4, 0.15 NaH2PO4, 0.2 KCl, 0.2 KH2PO4, 
dissolved in 1.0 L) to a concentration of 100µM. The solutions were incubated at 37°C at 
different time frames and UV/Vis spectra were taken with a Specord 200 (AnalytikJena 
AG) spectrometer. 
 
12.5.2 Interaction between the gold complexes and glutathione[145,153] 
The metal complexes were prepared as stock solutions in dimethylformamide (DMF) and 
diluted with potassium phosphate buffer pH 7.0 to achieve a final concentration of 500 μM 
(DMF: 0.2% V/V). 25 μL of 250 μM aqueous solutions of reduced glutathione were added 
each to 25 μL of the respective potassium phosphate buffer solution (containing the 
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compounds or only the DMF vehicle as control) and 25 μL 100 mM aqueous EDTA 
solution pH 7.5 and the resulting solutions were incubated with moderate shaking in a 96-
well plate at 37 °C for 20 or 60 min. To each well, 200 μL of reaction mixture (1000 μL 
reaction mixture consisted of 620 μL potassium phosphate buffer pH 7.0, 80 μL 100 mM 
EDTA solution pH 7.5, and 300 μL distilled water) were added, and the reaction was 
started with the addition of 25 μL of a 20 mM ethanolic solution of DTNB. After proper 
mixing, the formation of 5-TNB was monitored in a microplate reader (Perkin-Elmer Victor 
X4) at 405 nm. For each tested compound, the non interference with the assay 
components was confirmed by a negative control experiment using a glutathione free 
solution. Results are presented as means of two independent experiments. 
 
12.5.3 31P-NMR experiments on TPPG interaction with glutathione and DTNB[145] 
0.03 g (0.1 mmol) of glutathione were dissolved in 10 mL of methanol and 0.1 g (0.2 
mmol) of triphenylphosphine gold(I) chloride (TPPG) dissolved in 5 mL dichloromethane : 
methanol (1 : 1) were added. The resulting solution was stirred at 40°C for two hours. 
Then 0.15 g (0.38 mmol) of DTNB dissolved in 15 mL of methanol were added and the 
solution was stirred vigorously for another hour. The solvent was evaporated and the 
yellow powder dried overnight. The powder was dissolved in aceton and two aliquots were 
prepared in NMR tubes: one containing the probe and one containing the probe with a 
mixture of triphenylphosphine oxide and TPPG (1:1, 0.3 mmol) as positive controls. 
 
12.5.4 Binding to albumin[153] 
The gold(I) complexes were prepared as stock solutions in dimethylformamide to achieve 
a final concentration of 3.0 mM. 440 mg of bovine serum albumin (BSA, Sigma Aldrich) 
were dissolved in 11.0 ml cell culture medium. 11 µL of the gold complex stock solutions 
were added to the BSA containing medium and incubated at 37°C in the dark under gentle 
shaking. After 0, 1, 2, 4, 6 and 24 h an 250 µL aliquot thereof was taken, treated with 500 
µL of cold (-20°C) ethanol and stored at -20°C for 2 h to allow precipitation of the protein 
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fraction. Afterwards the solution was centrifuged at 400 g for 5 minutes at 4°C, 400 µL of 
the supernatant were taken, treated with 40 µL HNO3 13% and the gold content was 
measured by atomic absorption spectroscopy (see table 12.1). The percentage of gold 
bonded to albumin was calculated thereof. Results are given as the means and error of 
repeated two independent experiments. 
 
Step Temp. (°C) Rate (°C) Hold (sec) 
Drying 80 10 40 
Drying 105 7 30 
Drying 120 15 20 
Drying 500 50 30 
Pyrolysis 700 200 20 
AZ zeroing 700 --- 5 
Atomization 1800 1500 6 
Cleaning 2400 500 7 
 
Table 12.1: graphite furnace program for the determination of gold traces in biological samples with AAS 
 
12.5.5 Atomic absorption spectroscopy[153] 
Gold contents were measured with a graphite furnace high resolution continuum source 
atomic absorption spectrometer (contraAA 700, Analytik Jena AG) at 242.795 nm 
according to a recently described method with minor modifications in the graphite furnace 
temperature program.[224,232] Matrix matched calibration with gold standard solutions 
(Fluka) was used as calibration mode. Probes were injected at a volume of 20 µL into 
graphite wall tubes. The mean absorbances of duplicate injections were used throughout 
the study.  
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12.6 Enzymatic experiments 
 
12.6.1 TrxR / GR Inhibition Assay[145,153] 
To determine the inhibition of TrxR and GR an established microplate reader based assay 
was performed with minor modifications.[168] For this purpose commercially available rat 
liver TrxR and baker yeast GR (both from Sigma-Aldrich) were used and diluted with 
distilled water to achieve a concentration of 2.0 U/mL. The compounds were freshly 
dissolved as stock solutions in DMF. To each 25 μL aliquots of the enzyme solution each 
25 μL of potassium phosphate buffer pH 7.0 containing the compounds in graded 
concentrations or vehicle (DMF) without compounds (control probe) were added and the 
resulting solutions (final concentration of DMF: max. 0.5% V/V) were incubated with 
moderate shaking for 75 minutes at 37°C in a 96 well plate. To each well 225 μL of 
reaction mixture (1000 μL reaction mixture consisted of 500 μL potassium phosphate 
buffer pH 7.0, 80 μL 100 mM EDTA solution pH 7.5, 20 μL BSA solution 0.05%, 100 μL of 
20 mM NADPH solution and 300μL of distilled water) were added and the reaction started 
by addition of 25 μL of an 20 mM ethanolic DTNB solution. After proper mixing, the 
formation of 5-TNB was monitored with a microplate reader (Perkin Elmer VictortmX4) at 
405 nm in 10 s intervals for 6 minutes. The increase in 5-TNB concentration over time 
followed a linear trend (r2 ≥ 0.99) and the enzymatic activities were calculated as the 
slopes (increase in absorbance per second) thereof. For each tested compound the non 
interference with the assay components was confirmed by a negative control experiment 
using an enzyme free solution. The IC50 values were calculated as the concentration of 
compound decreasing the enzymatic activity of the untreated control by 50% and are 
given as the means and error of 3 - 6 independent experiments. The whole inhibition 
assay work flow is showed in figure 12.3. 
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Figure 12.3: flow diagram of enzyme inhibition assay procedure 
 
12.6.2 GPx Inhibition Assay[153] 
To determine the inhibition of GPx an established microplate reader based assay was 
performed with minor modifications.[102,193] For this purpose commercially available fetal 
bovine erythrocytes GPx (Sigma-Aldrich) was used and diluted with distilled water to 
achieve a concentration of 100 ng/mL. The compounds were freshly dissolved as stock 
solutions in DMF. To each 35 μL aliquots of the enzyme solution each 35 μL buffer pH 7.0 
containing the compounds in graded concentrations or vehicle (DMF) without compounds 
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(control probe) were added and the resulting solutions (final concentration of DMF: max. 
0.5% V/V) were incubated with moderate shaking for 75 minutes at 37°C in a 96 well 
plate. To each well 25 µL of a 4 U/mL GR solution in water and 200 μL of reaction mixture 
(1000 μL reaction mixture consisted of 600 μL Hepes/TRIS-HCl 1:1 50 mM buffer pH 7.0, 
100 μL 50 mM EDTA solution pH 7.5, 100 μL 50 mM reduced glutathione solution, 100 μL 
of 50 mM NADPH solution and 100 μL of distilled water) were added and the reaction was 
started by addition of 25 μL of an 5 mM t-butylperoxide solution. After proper mixing, the 
reduction of NADPH was monitored with a microplate reader (Perkin Elmer VictorX4) at 
340 nm in 10 s intervals for 1 minute. The decrease in NADPH concentration over time 
followed a linear trend (r2 ≥ 0.99) and the enzymatic activities were calculated as the 
slopes (decrease in absorbance per second) thereof. For each tested compound the non 
interference with the assay components was confirmed by a negative control experiment 
using a GPx/GR-enzyme free solution. The IC50 values were calculated as the 
concentration of compound decreasing the GPx activity of an untreated control by 50% 
and are given as the means and error of 3 independent experiments. 
 
12.6.3 Disulfide reductase inhibition in cell suspensions[145] 
HCT-116 cells were grown in a 75 cm2 cell culture flask to a confluency of 75% at 37°C, 
5% CO2 and were then treated with different concentrations of 2a for 18 h. The activity of 
disulfide reductases was measured in cell culture lysates using the Ellmans reagent. For 
this purpose cells were trypsinized and centrifuged at 3000 g for 5 min. The obtained 
pellets were washed with PBS pH 7.4 and treated with 3.0 mL lysis buffer (Tris-HCl 10 
mM, NaCl 10mM, MgCl2 10mM, pH 7.4) for 10 minutes. Homogenisation was performed 
with a Dounce homogenisator (20 strokes) and an aliquot of 1.0 mL of a 1.0 M sucrose 
solution was added to the resulting lysate. The activity of cellular disulfide reductases in 
an 50 μL aliquot of this solution was monitored at 405 nm according to the TrxR/GR 
inhibition assay described in the main text (the reaction mixture and DTNB solution were 
added to the aliquots, the other procedures were essentially the same as described in the 
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main text). The resulting values were corrected for the protein contents (measured by the 
Bradford method) of the respective cellular lysates. The final results were expressed as 
percentage of an untreated control and the IC50 value was calculated thereof. 
 
12.7 Mass spectrometry studies 
 
MS-studies on TPPG reaction with glutathione and on the decamer peptide were 
performed by Dr. Marilena Stefanopoulou from the research group of Prof. Dr. William S. 
Sheldrick, Lehrstuhl für Analytische Chemie, Ruhr-Universität Bochum, 44780 Bochum, 
Germany 
 
12.7.1 MS/MS stability studies on the phosphine degradation of TPPG[145] 
The reaction was performed analogously as presented above (chapter 12.5.3) excepted 
for that a 20 mM KH2PO4 pH=6.0 buffer solution was used instead of the potassium 
phosphate buffer pH 7.0 solution. ESI-MS and MS/MS spectra were taken directly after 
addition of DTNB with a Finnigan LTQ XL mass spectrometer (Thermo Electron Corp., 
San Jose, CA, USA), which was operated in the positive and negative ion mode with a 
capillary temperature of 200 ºC and a spray voltage of 1.8 kV. Delivery to the mass 
spectrometer was performed at a flow rate of 1.0 μL·min-1. The relative collision energy for 
collision-induced dissociation was set at 35%. 
 
12.7.2 Binding studies with a selenopeptide[153] 
The substances were dissolved in 10% acetonitrile to a concentration of 5 mM and 
incubated at 37°C for 48 hours with a selenium-containing decamer AGUVGAGLIK at a 
molar ratio of complex-to-peptide of 5:1. The peptide was previously treated at a 1:5 ratio 
with dithiothreitol for 1 h. ESI-MS and MS/MS spectra were recorded with a Finnigan LTQ 
XL mass spectrometer (Thermo Electron Corp., San Jose, CA, USA), which was operated 
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in the positive ion mode with a capillary temperature of 200 ºC and a spray voltage of 1.8 
kV. Direct injection of samples into the mass spectrometer was performed at a flow rate of 
1.0 μL·min-1. The relative collision energy for collision-induced dissociation was set at 
35%. 
 
MS-studies on undecamer peptide were performed by Dr. Chiara Gabbiani from the 
research group of Prof. Dr. Luigi Messori, Facoltá di Chimica, Universitá degli studi di 
Firenze, Via della Lastruccia 13, 50019 Sesto Fiorentino, Firenze, Italy 
 
12.7.3 Interaction with a TrxR motif mimicking undecamer peptide 
The selected peptide acetyl-SGGDILQSGCUG-NH2 was treated with each of the three 
gold compounds 2a, 2b and 2c, in a 3:1 molar ratio. Treatment was performed for 20 
minutes at room temperature; then solutions were analysed by ESI-MS. ESI-MS spectra 
were recorded by direct injection at a 5 ml min-1 flow rate in a LCQ Advantage ion trap 
(Thermo, San Jose, California), equipped with a conventional ESI source. The specific 
conditions used for these experiments were as follows: the spray voltage was 4.0 kV, the 
capillary voltage was 1.7 V and the capillary temperature was kept at 270 °C. Sheath gas 
was set at 25 (arbitrary units) whereas auxiliary gas was kept at 0 (arbitrary units). All ESI 
spectra were elaborated using Xcalibur software (Thermo). 
 
Multidimensional protein identification technology experiments on complex 2b were 
performed by Dr. Marilena Stefanopoulou from the research group of Prof. Dr. William S. 
Sheldrick, Lehrstuhl für Analytische Chemie, Ruhr-Universität Bochum, 44780 Bochum, 
Germany 
 
12.7.4 MudPIT analysis[206] 
MCF-7 cells were cultured in a 175 cm2 flask at 37°C under 5% CO2 with 20 mL of culture 
medium (DMEM 4.5 g/L glucose, with L-glutamine, supplemented with 50 mg/L 
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gentamycine and 10% (V/V) FCS) till the 85% of confluence. Stock solution of 3.0 mM of 
complex 2b in DMF was freshly prepared and diluted with culture medium supplemented 
with 10% (V/V) FCS or with serum free medium (final concentration of DMF: 0.1% v/v). 
The cell culture medium of the flasks was replaced with medium containing complex 2b 
and incubated for 3 h at 37°C / 5% CO2. The intact cell pellets were collected after 
trypsinisation (trypsin 0.05%) and centrifugation (3000 g, 5 min.). The cell pellet was send 
to the group of Prof. Sheldrick at the Ruhr-Universität Bochum for MudPIT analysis. 
Multidimensional protein identification technology uses a biphasic microcapillary column 
packed with reversed phase (RP) and strong cation exchange (SCX) high performance 
liquid chromatography grade materials to load a complex protein mixture gained from the 
treatment of cell extracts with proteases.[206] The column is coupled with a quaternary 
HPLC arrangement, which in turn is connected directly to a tandem mass spectrometer. 
Thus the column acts as an ion source for the spectrometer. Peptides are eluted off of the 
biphasic microcapillary column by applying consecutive salt steps of increasing salt 
concentrations followed by a reverse phase gradients. This procedure is repeated till the 
whole peptide mixture is depleted by the SCX-phase. Depending on the composition of 
the peptide set, 10 to 15 salt steps can be applied. Peptides are directly ionized and the 
collision induced dissociation (CID) fragment ions are directed in the tandem MS where 
they are analyzed. A tandem MS is capable of fragmenting peptides in a predictable way 
which allows for the correlation of experimental tandem mass spectral data of peptides 
with the theoretical constructed tandem mass spectra (MS / MS) via the SEQUEST 
algorithm.[206] The SEQUEST algorithm is incorporated in the “BioWorksTM” and “Proteome 
Discoverer” software. On a first step the protein sequence database of the studied 
biological unit or individual protein of interest is loaded on the software and theoretic MS / 
MS spectra are generated from the theoretic expected protein segments depending on the 
appropriate cleavage conditions. The experimental MS and MS / MS data are 
subsequently submitted. When the search starts SEQUEST chooses automatically 500 
candidates extracted peptides that are in best agreement with the precursor mass of each 
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experimental MS / MS spectrum. A preliminary scoring analysis takes place where each 
one of the 500 peptides is scored according to the b- and y- type continuity (target MS / 
MS fragmentation) and the presence of immonium ions, as Eidhammer et al explained in 
their book.[264] SEQUEST is adapted for the identification of post-translational 
modifications or other kind of dynamic modifications (e.g. for chemical derivatisation). The 
initial segment selection step is changed so that the sequences with a mass equal or 
lower (in relation with a given threshold) than the precursor can be selected. In a case of a 
lower mass all different possible combinations of the considered modifications are added 
to it, and the resulting predicted mass is compared to the experimental precursor mass. If 
the masses are equal the segment is retained for comparison, using the residue masses 
for the potentially modified residues (experimental part extracted and reelaborated from 
reference 162). 
 
12.8 Biodistribution experiments 
 
12.8.1 Uptake into cells[153] 
MCF-7 breast cancer cells were grown until at least 80% confluence in 75 cm2 cell culture 
flasks. Stock solutions of 3.0 mM of the gold complexes in DMF were freshly prepared 
and diluted with culture medium supplemented with 10% (V/V) FCS or with serum free 
medium (final concentration of DMF: 0.1% v/v). The cell culture medium of the flasks was 
replaced with medium containing the substances and incubated for 0, 1, 2, 4, 6, and 12 h 
at 37°C / 5% CO2. The intact cell pellets were collected after trypsinisation (trypsin 0.05%) 
and centrifugation (3000 g, 5 min.). Cell pellets were lysed with a 1000 µL Tris-HCl buffer 
(Tris-HCl 10 mM, NaCl 10mM, MgCl2 10 mM, pH 7.4) in a pre-chilled dounce 
homogenisator on ice. For cellular uptake studies an aliquot of 20 µL was removed for 
protein quantification by Bradford method, 100 µL of the lysate were treated with 10 µL of 
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triton X100 1% and investigated by AAS (see above). Results were expressed as nmol 
gold / mg protein as mean and error of two independent experiments. 
 
12.8.2 Bradford assay for the determination of protein content in lysate samples 
To determine the protein content of a sample the Bradford reagent was been prepared as 
described in literature.[233] 250 mg of ServaBlue G were dissolved in 250 mL ethanol 96%, 
500 mL H3PO3 86% and 250 mL of bidistilled H2O and kept at -20 °C. Freshly prepared 
solutions were obtained distilling the stock solution 1 : 5 with bidistilled H2O. 200 µL were 
pipetted in a 96-wells plate, added with 20 µL protein solutions, the reaction allowed for 20 
minutes at room temperature and the absorbance read at 595 nm in a microplate reader. 
Bovine serum albumin was used as standard to quantify the samples. For values out of 
the calibration range an opportune 1 : 10 or 1 : 20 dilutions of the sample were operated. 
Results were expressed as mean and error of two series of two repetitions of independent 
experiments. 
 
12.8.3 Uptake into mitochondria and cytosol[153] 
MCF-7 breast cancer cells were grown until at least 80% confluence 175 cm2 cell culture 
flasks. Stock solutions of 3.0 mM of the gold complexes in DMF were freshly prepared 
and diluted with culture medium supplemented with 10% (V/V) FCS or with serum free 
medium (final concentration of DMF: 0.1% v/v). The cell culture medium of the flasks was 
replaced with medium containing the substances and incubated for 0, 1, 2, 4, 6, and 12 h 
at 37°C / 5% CO2. The intact cell pellets were collected after trypsinisation (trypsin 0.05%) 
and centrifugation (3000 g, 5 min.). Cell pellets were lysed, the mitochondrial fraction and 
cytosolic fraction were isolated and collected using the Thermo Scientific mitochondria 
isolation kit for cultured cells (batch number 89874) according to the manufacturer 
instructions with minor modification. The cytosolic fraction was used as obtained from the 
kit isolation. The mitochondrial fraction was dissolved in 1000 µL of water. An aliquot of 20 
µL was removed from the end-fractions for protein quantification by the Bradford method. 
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Aliquots of 100 µL were taken, treated with 10 µL of triton X100 1% and investigated by 
AAS. 100 µL of cytosolic fraction were directly treated with 10 µL of triton X100 1% and 
investigated by AAS. Results were expressed as nmol gold / mg protein as mean and 
error of two independent experiments. 
 
12.9 Antiproliferative experiments 
 
Experiments on immortalized healthy HEK-293 cells for complex 2a were performed by 
Dr. Yvonne Geldmacher from the research group of Prof. Dr. William S. Sheldrick, 
Lehrstuhl für Analytische Chemie, Ruhr-Universität Bochum, 44780 Bochum, Germany 
 
12.9.1 Antiproliferative effects in MCF-7, HT-29, HCT-116, HEP-G2 and HEK-293 
cells[145,153] 
The antiproliferative effects in MCF-7, HT-29, HCT-116, HEP-G2 and HEK-293 cells after 
72 h (HT-29, HCT-116 and HEK-293) or 96 h (MCF-7 and HEP-G2) exposure to the gold 
complexes were evaluated according to a procedure already described in the literature. 
For the experiments the compounds were prepared freshly as stock solutions in DMF and 
diluted with the cell culture medium to the final assay concentrations (0.1% V/V DMF). 
The cells were cultured in a 75 cm2 flask with 10 mL of cell culture medium. A volume of 
100 µL of 10000 cells / mL medium (MCF-7, HEP-G2 and HEK-293) or 4500 cells / mL 
(HT-29 and HCT-116) were seeded in 96-well plates and incubated for 48 h (HT-29 and 
HCT-116) or 72 h (MCF-7, HEP-G2 and HEK-293) at 37°C under 5% CO2. Afterwards, the 
medium was removed and replaced with medium containing the substances in different 
concentrations. The cells were exposed to the complexes for 72 h (HT-29 and HCT-116) 
or 96 h (MCF-7, HEP-G2 and HEK-293). The medium was removed, the cells washed 
with PBS and stained with 100 µL 0.02% crystal violet for 30 min. The excess of crystal 
violet was removed, the plates were washed with water, dried, 180 µL of 70% ethanolic 
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solution were added to each well, and the plates were read at 595 nm in a microplate 
reader (VictorX4, PerkinElmer) after 3 – 4 h of gently shaking. The IC50 values were 
calculated as the concentrations reducing proliferation of untreated control cells by 50% 
and are given as the means and error of two independent experiments (each performed 
with n=6) (see figure 12.2 for a schematic representation. 
 
 
 
Figure 12.4: flow diagram of antiproliferative assay procedure 
 
12.9.2 Phase contrast video microscopic imaging 
MCF-7 cells were grown in phenolred free medium (DMEM 4.5 g/L glucose, with L-
glutamine, supplemented with 50 mg/L gentamycine and 10% (V/V) FCS) in a 22.1 cm2 
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tissue culture dish until approximately 60% confluency. The medium was replaced with 
4.0 mL phenolred free medium containing 5.0 μM of 2a, or 1.0 µM of 2b or 2c (0.1 % V/V 
DMF) or only the DMF vehicle as a control. The tissue culture dish was placed under a 
EVOSxl digital microscope and pictures were subsequently taken in 5 min intervals for 14 
h. 
 
AnnexinV / PI experiments for 2a were performed by Dr. Igor Kitanovic from the research 
group of Prof. Dr. Stefan Wölfl, Institut für Pharmazie und Molekulare Biotechnologie, 
Ruprecht-Karls-Universität Heidelberg, Im Neuenheimer Feld 364, 69120 Heidelberg 
 
12.9.3 Annexin V/PI Staining[145,153] 
Jurkat cells were treated with the indicated concentration of the substance for 48 h, 
collected, and stained with Annexin V-FITC (eBioscience) according to the manufacturer 
recommendation. Briefly, approximately 5.0 x 105 cells were resuspended in 50 μL of 
Annexin V staining buffer (10 mM HEPES, 140 mM NaCl, and 2.5 mM CaCl2, pH 7.4), 2.5 
μL of AnnexinV-conjugate, and 1.25 μL of PI solution (1 mg/mL) were added and the 
probes were incubated in the dark at room temperature for 15 min. Signal intensity was 
analyzed using a FACS Calibur (Becton Dickinson) and CellQuest Pro (BD) analysis 
software. Excitation and emission settings were 488 nm, 515-545 nm (FL1 channel) for 
Annexin V-FITC and 564-606 nm (FL2 channel) for PI. Experiments were repeated with 
comparable results. 
 
Experiments on resistant cell lines, DNA fragmentation and LDH were performed by 
Liliane A. Onambele from the research group of Prof. Dr. Aram Prokop, department of 
Paedriatric Oncology, Childrens Hospital Cologne, Amsterdamer Strasse 59, 50735 
Cologne 
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12.9.4 LDH Release Assay[145] 
After incubation with different concentrations of 2 and 2a for 2 h, LDH released by BJAB 
cells was measured in cell culture supernatants using a cytotoxicity detection kit from 
Boehringer Mannheim (Mannheim, Germany). The supernatants were centrifuged at 300g 
for 5 min. Cell-free supernatants (20 μL) were diluted with 80 μL of PBS and 100 μL of 
reaction mixture were added. Then, the time-dependent formation of the reaction product 
was quantified photometrically at 490 nm. The maximum amount of LDH activity released 
by the cells was determined by lysis of the cells using 0.1% Triton X-100 in culture 
medium and was set as 100% cell death. 
 
12.9.5 Measurement of DNA Fragmentation[145] 
Apoptotic cell death was determined by a modified cell cycle analysis, which detects DNA 
fragmentation at the single cell level. For measurement of DNA fragmentation cells were 
seeded at a density of 1 x 105 cells / mL and treated with different concentrations of 2 and 
2a. After 72 h of incubation, cells were collected by centrifugation at 30 g for 5 min, 
washed with PBS at 4 °C, and fixed in PBS / 2 % (V/V) formaldehyde on ice for 30 min. 
After fixation, cells were incubated with ethanol / PBS (2:1, V/V) for 15 min, pelleted, and 
resuspended in PBS containing 40 μg / mL RNase A. After incubation for 30 min at 37 °C, 
cells were pelleted again and finally resuspended in PBS containing 50 μg / mL PI. 
Nuclear DNA fragmentation was then quantified by flow cytometric determination of 
hypodiploid DNA. Data were collected and analyzed using a FACScan (Becton Dickinson, 
Heidelberg, Germany) equipped with the CELLQuest software. Data are given in % 
hypoploidy (subG1), which reflects the number of apoptotic cells. 
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12.10 Effect on cell metabolism 
 
Experiments on isolated mitochondria MMP, cytochrome c release and oxygen 
consumption were performed by Suzan Can from the research group of Prof. Dr. Stefan 
Wölfl, Institut für Pharmazie und Molekulare Biotechnologie, Ruprecht-Karls-Universität 
Heidelberg, Im Neuenheimer Feld 364, 69120 Heidelberg 
 
12.10.1 Isolation of mouse liver mitochondria[145,153] 
Mitochondria were isolated according to described procedures with minor modifications. 
Mouse (wildtype, C57BL/6) liver mitochondria were isolated by Dounce homogenization 
and differential centrifugation. The entire isolation process took place in isolation buffer 
(300 mM trehalose, 10 mM HEPES-KOH pH 7,7, 10 mM KCl, 1 mM EGTA, 1 mM EDTA, 
0.1% fatty acid free BSA). The homogenate was centrifuged for 5 min at 1000 g and 4°C. 
The supernatant was collected and centrifuged for 2 min at 13000 rpm and 4°C. The 
mitochondrial pellet was resuspended in a small volume of isolation buffer and the last 
centrifugation step was repeated. After resuspending the final mitochondria pellet in 
isolation buffer the protein content was estimated by Bradford Assay. 
 
12.10.2 Measurement of mitochondrial oxygen consumption[145,153] 
The measurement was performed using OxoPlate® (PreSens, Germany), 96-well plates 
which contain an immobilized oxygen sensor at the bottom of each well. Fluorescence is 
measured in dual mode, excitation 540 nm and emission 650 nm, with reference emission 
590 nm. The signal ratio 650 nm / 590 nm corresponds to the oxygen partial pressure. 
The calibration of the fluorescence reader is performed using a two-point calibration with 
oxygen-free water (1 % Na2SO3) and air-saturated water with an oxygen partial pressure 
corresponding to 0 % and 100 % respectively. 18 µg of freshly isolated mitochondria were 
suspended in 100 µL of respiration buffer (25 mM sucrose, 100 mM KCl, 75 mM mannitol, 
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5 mM MgCl2, 10 mM KH2PO4, 0.5 mM EDTA, 10 mM TRIS, 0.1% fatty acid-free BSA, pH 
7.4) containing 10 mM pyruvate, 2 mM malate, 2 mM ADP and 0.5 mM ATP to activate 
oxidative phosphorylation. Fluorescence was measured continuously for 400 min with 
kinetic intervals of 5 min by a Tecan Safire2 (Tecan, Maennedorf, Switzerland) microplate 
reader at 37°C. During the measurements the plates were sealed with a breathable 
membrane (Diversified Biotech, Boston, MA). Additional controls were 5 µM rotenone 
(Sigma-Aldrich) as inhibitor of respiratory chain complex I and 1 µM CCCP (carbonyl 
cyanide 3-chlorophenylhydrazone, Sigma-Aldrich) as uncoupling agent, capable of 
increasing electron flow through the respiratory chain thereby increasing the oxygen 
consumption. Experiments were repeated with comparable results. 
 
12.10.3 Mitochondrial membrane potential (Δψm)
[153] 
Jurkat cells were cultivated in RPMI (PAA) with 10% FCS (PAA) at 37°C, 5% CO2 and 
95% humidity. 2.5 x 105 Jurkat cells were seeded in cell culture plates and treated with the 
indicated compounds for 0.5, 3, 6 and 8 hours. Cells were then stained with 500 nM JC-1 
(5,5,6,6-tetrachloro-1,1,3,3-tetraethylbenzimidazolylcarbocyanineiodide, Sigma-Aldrich) 
for 15 min at 37°C, collected and analyzed using a FACSCalibur (Beckton Dickinson) and 
CellQuest Pro analysis software (Beckton Dickinson). Excitation and emission settings 
were 488 nm, 515-545 nm (FL1 channel) for JC monomers and 564-606 nm (FL2 
channel) for JC aggregates. Experiments were repeated with comparable results. 
 
Experiments on ROS induction for 2a were performed by Dr. Igor Kitanovic from the 
research group of Prof. Dr. Stefan Wölfl, Institut für Pharmazie und Molekulare 
Biotechnologie, Ruprecht-Karls-Universität Heidelberg, Im Neuenheimer Feld 364, 69120 
Heidelberg 
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12.10.4 ROS formation[145,153] 
Jurkat cells were cultivated in standard conditions and cells were incubated with the 
compounds for 24h as indicated. After incubation cells were collected, centrifuged at 0.2 g 
(1500 rpm) and resuspended in FACS buffer (D-PBS, Gibco, + 1 % BSA, PAA). Cell 
suspensions were treated with DHE (dihydroethidium, SIGMA, 5 µL of 5 mM stock 
solution per 1.0 ml of cell suspension containing 106 cells) at room temperature in the dark 
for 15 min, washed one more time with FACS buffer and immediately analysed using a 
FACS®Calibur (Becton Dickinson) and CellQuest Pro (BD) analysis software. Excitation 
and emission settings were 488 nm and 564–606 nm (FL2 filter), respectively. Important 
note: although DHE is known to interact only with superoxide anion, the intensity of 
fluorescence is commonly considered as a reflection of total intracellular ROS. 
Experiments were repeated with comparable results. 
 
Bionas measurement for 2a were performed by Dr. Hamed Alborzinia from the research 
group of Prof. Dr. Stefan Wölfl, Institut für Pharmazie und Molekulare Biotechnologie, 
Ruprecht-Karls-Universität Heidelberg, Im Neuenheimer Feld 364, 69120 Heidelberg 
 
12.10.5 Effects on cell metabolism[145,153] 
Online measurement of cell metabolism and morphological changes was done using a 
Bionas 2500 biosensor chip system (Bionas, Rostock, Germany). The metabolic sensor 
chips (SC 1000) include ion-sensitive field-effect transistors to record pH changes, a Clark 
type electrodes to monitor oxygen consumption, and interdigitated electrode structures to 
measure impedance under the cell layer. Approximately 1.5 x 105 (150000 cell / chip) of 
MCF-7 cells were seeded directly onto each sensor chip in 450 μL of DMEM (PAA, E15-
883) with penicillin/streptomycin and 10% (v/v) FCS (PAA) and incubated at 37°C, 5% 
CO2, and 95% humidity for 24 h. The cell number used resulted in approximately 80-90% 
confluence of the cells on the chip surface after 24 h. This was the starting condition for 
online monitoring. Sensor chips with cells were then transferred to the Bionas 2500 
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analyzer in which medium is continuously exchanged in 8 min cycles (4 min exchange of 
medium and 4 min without flow), during which the parameters were measured. The 
running medium used during analysis was DMEM (PAN Biotech GmbH, Aidenbach, 
Germany) without carbonate buffer and only weakly buffered with 1 mM Hepes and 
reduced FCS (0.1%). For drug activity testing, the following steps were included: (1) 5 h 
equilibration with running medium (RM), (2) drug exposure with substances freshly 
dissolved in medium at indicated concentrations and indicated incubation time, (3) a drug 
free step in which cells are again fed with running medium without substances, and (4) at 
the end of each experiment, the cell layers are removed by adding 0.2% Triton X-100 to 
obtain basic signal without living cells on the sensor surface as a negative control. 
 
12.10.6 Protein electrophoresis 
To separate the different proteins a SDS-PAGE analysis has been established. The 
compounds were freshly dissolved in stock solution of 3 mM in DMF and MCF-7 cells 
were treated with a concentration of 3 µM for 3 h at 37°C / 5% CO2. Cells were 
trypsinized, the whole pellets collected and lysed with 500 µL RIPA buffer (150 mM 
NaCl, 1.0% Triton X100, 0.5% Na-deoxycholate, 0.1% SDS, 50 mM TRIS at a 8.0 pH) 
containing 0.05% of a proetase inhibitor cocktail (batch P8340, Sigma Aldrich) in a 
pre-chilled dounce homogenizator (60 strokes). The solutions were centrifugated at 
4°C, 13800 g for 20 minutes and the supernatants were collected. An aliquot of 20 µL 
of the sample was used for protein quantification by the Bradford method and the 
protein content in the probes normalized by dilution with distilled water. Aliquots of 10 
µL of the normalized sample were added with 5 µL deionized water and 5 µL of 
sample loading buffer (batch number NP0007, Invitrogen). The proteins were 
denaturated at 95°C for 5 minutes under gentle shaking and 8.5 µL loaded on the mini-
gel (8X8 mm). SDS-PAGE was performed as follows: separation gel 8% (4.0 mL 30% 
acryl-bisacrylamide mix, 3.8 mL 1.5 mM TRIS separation buffer pH 8.8, 150 µL 10% 
SDS, 150 µL 10% of ammonium persulfate (APS), 9 µL N,N,N',N'-
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Tetramethylethylendiamine (TEMED) and 6.9 mL deionized H2O), loading gel (670 µL 
30% acryl-bisacrylamide mix, 500 µL 1.5 mM Tris loading buffer pH 6.8, 40 µL 10% 
SDS, 40 µL 10% APS, 4 µL TEMED and 2.7 mL deionized H2O), running buffer (batch 
number NP0002, Invitrogen), 70 V for 2 h. For protein detection the gels were rinsed 
with deionized water twice and stained with a 0.25% solution of Coomassie Brilliant 
Blue for 1 h in a shaker. The excess of Coomassie Brilliant Blue was then washed off 
twice with deionized water. A first destaining solution (500 mL methanol, 100 mL ice 
acetic acid, 400 mL deionized water) was applied to the gel for 1 h and washed twice 
with deionized water. The step was repeated twice. A second destaining solution (165 
mL ethanol absolute, 50 mL ice acetic acid, 785 mL deionized water) was applied to 
the gel for 2 h, then washed off with deionized water and applied again for 10 h. The 
gel was analyzed by a CCD camera (Fusion Fx7, Peqlab) in fluorescence modus with 
a white epi-low light and a UV-visible filter and the MW calculations were performed 
with the Infinity Fusion® software. 
 
12.10.7 Western blot analysis of TrxR2 expression 
To determine the TrxR2 expression a western blot assay has been established. Stock 
solutions of anti-TrxR2 were diluted 1 : 5 in deionized water and again 1 : 100 with the 
diluents provided in the kit (batch number CB7110, Invitrogen) quickly before use. To 
blot the membrane and block the 1° and 2° antibody a semi-dry blotter module as 
been used (iBlotTM module, Invitrogen). The experiment has been performed according 
to the manufacture guide with minor modification (iBlot® Western detection kit batch 
numbers IB7010 and IB7210, Invitrogen). The membrane was analyzed by 
chemiluminescence in a CCD camera (Fusion FX7, Peqlab) with an exposure time of 
30 – 120 second. The RF distances were calculated with the Infinity Fusion® software. 
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Western blot experiments on Pgp expression Experiments were performed by Liliane A. 
Onambele from the research group of Prof. Dr. Aram Prokop, department of Paedriatric 
Oncology, Childrens Hospital Cologne, Amsterdamer Strasse 59, 50735 Cologne 
 
12.10.8 Western blot analysis of Pgp expression[145] 
Nalm-6 cells and its vincristin and daunorubicin resistant sublines were washed twice with 
PBS and lysed in buffer containing 10 mM Tris / HCl, pH 7.5, 300 mM NaCl, 1 % Triton X-
100, 2 mM MgCl2, 5 μM ethylenediamino tetraacetic acid (EDTA) and one protease 
inhibitor cocktail tablet (Roche Diagnostics, Germany). Protein concentration was 
determined using the bicinchoninic acid assay from Pierce (Rockford, IL, USA) and equal 
amounts of protein (40 μg per lane) were separated by SDS-PAGE. Then, immunoblotting 
of protein onto nitrocellulose membranes (Schleicher and Schuell, Dassel, Germany) was 
performed. After blotting, the membrane was blocked for 1 h in PBST (PBS, 0.05 % 
Tween-20) containing 5 % non-fat dry milk and incubated with the Monoclonal Anti-P-
Glycoprotein (Sigma-Aldrich, Saint-louis, USA) for 1 h. After the membrane had been 
washed three times in PBST, the Anti-Mouse IgG-HRP (Promega, Madison, USA) was 
applied for 1 h. Finally, the membrane was washed in PBST again and protein bands 
were visualized using the ECL enhanced chemiluminescence system (Amersham 
Buchler, Braunschweig, Germany). 
 
ELISA microarray experiments were performed by Pavlo Holenya from the research group 
of Prof. Dr. Stefan Wölfl, Institut für Pharmazie und Molekulare Biotechnologie, Ruprecht-
Karls-Universität Heidelberg, Im Neuenheimer Feld 364, 69120 Heidelberg 
 
12.10.9 Microarray[251,265] 
The phosphoprotein specific microarray analysis was based on the platforms 
ArrayTubeTM and ArrayStripTM (Alere Technologies, Jena, Germany). The Array-
TubeTM system is a 1.5-mL reaction vial where a 3 mm x 3mm glass microarray with a 
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spotted area of 2.4 mm x 2.4mm is mounted onto the bottom. The Array- StripTM system 
comprises a micro-titer plate size strip of eight wells with microarrays of 4.2mm_4.2mm 
and a spotting area of 3.4mm x 3.6mm. The microarrays utilize a sandwich ELISA format 
in which tyramide signal amplification (TSA) technology amplifies colorimetric signals. The 
microarrays were prepared using a proprietary robotic microarray contactprinter (Alere 
Technologies) to deliver nanoliter volumes of specific capture antibodies onto epoxy-
modified glass chips. Capture antibodies were printed without any detergents in four 
different concentrations (0.01 – 0.6 mg/mL) in Dulbecco’s PBS (D-PBS) (Invitrogen, 
Carlsbad, CA, USA) containing 5 mM trehalose. Spots were deposited in three copies with 
different localization on chips to improve statistical readout quality. Each capture antibody 
was spotted with its own spotting capillary suited for both spotting and storage. After 
manufacturing, antibody microarrays were sealed under argon atmosphere into non-
transparent bags and stored at 41°C until usage. We used commercially available 
optimized isotype specific capture antibodies and biotinylated phospho-specific detection 
antibodies developed for classical sandwich ELISAs (DuoSets IC kits, R&D Systems, 
Minneapolis, USA). Phosphorylated forms of seven human/mouse/rat signaling proteins in 
the focus of our interest, that is GSK-3β (S9), p38α (T180/Y182), ERK1 (T202/Y204) and 
ERK2 (T185/Y187) can be detected by our phosphoprotein-specific ArrayTubeTM 
microarrays. ArrayStripTM microarray analysis was designed to simultaneously detect 
these and ten additional phosphorylated proteins: ATM (S1981), MEK1/2 (S218/S222), 
p53 (S15), Src (Y419), mTOR (S2448). These phosphoproteins are known to be involved 
in different signaling pathways regulating cell survival and proliferation. Both microarray 
formats also contain an antibody pair against paxillin. Microarray calibration was 
performed with recombinant phosphoprotein standards (R&D Systems). For 
measurements, the following protocol was established. First, microarray surface was 
blocked with 200 mL of blocking buffer (1% BSA, 0.05% sodium azide in D-PBS, pH 7.2–
7.4) at 231 °C for 90 min in horizontal tube shaker ThermomixerTM (Eppendorf, Hamburg, 
Germany). All the following incubation / washing steps were carried out in the 
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ThermomixerTM under identical conditions. Blocking buffer was replaced with 10 mL of 
sample solution containing recombinant calibration standards in diluent buffer (1 mM 
EDTA, 0.5% Triton X-100, 5 mM sodium fluoride, 1.0 M urea in D-PBS, pH 7.2–7.4) 
applied directly onto the glass chip, and microarrays were incubated for 60 min. After 
incubation, microarrays were washed three times for 5 min with 200 mL washing buffer 
(0.05% Tween-20 in D-PBS, pH 7.2–7.4) and further incubated with 10 mL detection 
cocktail containing 18 biotin-labeled detection antibodies (R&D Systems) for 60 min. 
Concentration of detection antibodies was first adjusted according to manufacturer’s 
recommendation and further diluted (1 : 20) for preparation of detection cocktail. Three 
additional washing steps were performed prior to detection. Bound detection antibodies 
were visualized in two steps: first, incubation with 100 mL streptavidin–HRP conjugate 
(R&D Systems) for 30 min to allow biotin–streptavidin binding, followed by three washing 
steps; second, addition of 100 mL of TrueBlueTM (KPL, Gaithersburg, MD, USA) 
containing 3,30,5,50-tetramethylbenzidine (TMB) to start the dye precipitation reaction. 
The resulting precipitation patterns were recorded by transmission measurements with the 
ArraymateTM reader (Alere Technologies). The resulting pictures were analyzed 
automatically using PARTISAN IconoClustTM software (Alere Technologies) with defined 
scripts for the different microarray layouts. The software identified processed spots and 
measured mean values of the spots (MV) as well as the local background (BG). 
Normalized signal intensities (NSI) were calculated by the equation NSI51–MV/BG. 
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